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ABSTRACT 
The neurons in hippocampal subfield CA3 contain corticosteroid mineralocorticoid 
(MR) and glucocorticoid (GR) receptors. The neurons in subfield CA3 have a critical 
role in hippocampal neural signal processing, yet very little is known about the effects 
of corticosteroids on neural activity in this subfield. Therefore, the actions of chronic 
corticosteroid treatment on neuron membrane electrical properties and the 5-HT 1A 
receptor system (receptor-G protein-potassium channel) were examined in rat 
hippocampal subfield CA3 pyramidal cells. The treatment groups used in these 
investigations were: adrenalectomy, MR activation with aldosterone or low levels of 
corticosterone, MR and GR activation with high levels of corticosterone, and sham. 
Based on intracellular recording experiments, corticosteroid treatment altered the 
percentage of nonburst and burst firing neurons. There was a higher percentage of 
nonbursting cells from adrenalectomized animals compared to aldosterone and sham 
treated animals. The action potential duration was also longer in cells from 
adrenalectomized compared to cells from high corticosterone and aldosterone treated 
animals. 
Corticosteroids altered the 5-HT concentration-response curve characteristics for 
the 5-HT lA receptor. The ECso value was smaller in cells from adrenalectomized 
animals compared to the other treatment groups. The Emax value was smaller in cells 
IV 
from animals treated with high corticosterone levels compared to sham and 
adrenalectomized animals. G protein function was also altered by corticosterone 
treatment. G protein activation elicited a smaller current in cells from high 
corticosterone treated animals compared to the other treatment groups and in cells 
from sham compared to adrenalectomized animals. 
Western blot and immunohistochemistry techniques were used to determine the 
effects of corticosterone on G protein levels and distribution in the hippocampus. 
Treatment with high concentrations of corticosterone increased the levels of Gs, Gil and 2 
and Go a-subunits when compared to sham. Adrenalectomy had no effect on Gs, 
Gil and 2 or Go a-subunits levels. No change in the intracellular location of G protein 
a-subunits was detected using immunohistochemistry. 
This dissertation work has demonstrated that corticosteroids alter neuron electrical 
membrane properties and the 5-HT IA receptor signal transduction system in 
hippocampal subfield CA3 neurons. 
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CHAPTER I 
INTRODUCTION 
Corticosteroids are steroid hormones that maintain energy, ion, and endocrine 
homeostasis (de Kloet, 1991; Henkin, 1970; Munck et al., 1984). There are two classes 
of corticosteroids: glucocorticoids and mineralocorticoids. Glucocorticoids regulate 
glucose metabolism while mineralocorticoids maintain ion homeostasis (reviewed by 
Dallman et al., 1987, 1994; de Kloet, 1991; Tempel and Leibowitz, 1994). 
Corticosterone is the principal glucocorticoid in rats while in man the principal 
glucocorticoid is cortisol. Aldosterone is the principal mineralocorticoid in both man and 
rats. 
Corticosteroids regulate gene expression through the interaction with two receptor 
subtypes: mineralocorticoid receptor (MR) and glucocorticoid receptor (GR). MR has 
a high affinity for corticosterone, Kn = 0. 5 - 0. 7 nM, and aldosterone (Krozowski and 
Funder, 1983; Reul and de Kloet, 1985). GR has a lower affinity for corticosterone, 
Kn= 2.5 - 5 nM and aldosterone (Krozowski and Funder; 1983; Reul and de Kloet, 
1985). 
The synthesis and release of corticosteroids are regulated by the hypothalamic-
pituitary-adrenal axis (HP A) (reviewed by Feldman and Weidenfeld, 1995). In response 
to various stimuli, paraventricular (PVN) neurons in the hypothalamus release 
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corticotropin releasing factor (CRF) into the portal circulation. CRF then stimulates the 
synthesis and release of adrenocorticotropic hormone (ACTH) from the corticotropes in 
the anterior pituitary. ACTH enters the circulatory system and drives the synthesis and 
release of corticosteroids from the adrenal cortex. 
There are two physiological processes that drive HP A axis activity: circadian 
rhythm and stress (reviewed by Dallman et al., 1987, 1994). Corticosteroid plasma 
levels are lower ( < 10 µg/dl) during hours when the animals is resting (i.e., during day 
light for rats) and higher ( > 15 µg/dl) during hours when the animal is active (i.e., at 
night for rats) or stressed. The relative occupation of l\1R and GR changes with 
physiological fluctuations in the plasma corticosteroid levels. l\1R is 70-80% occupied at 
basal physiological corticosterone plasma levels (Reul and de Kloet, 1985; Reul et al., 
1987). GR occupancy changes from 15% at basal to 90% at peak and stress circulating 
corticosterone levels (Reul and de Kloet, 1985; Reul et al., 1987a,b). HPA axis activity 
is regulated by higher cortical and brainstem inputs that converge at the hypothalamus 
and influence CRF secretion (reviewed by Feldman and Weidenfeld, 1995). However, 
corticosteroids also modulate HP A axis activity through feedback inhibition via the 
activation ofl\1R and GR in the PVN, pituitary, and hippocampus (reviewed by Dallman 
eta/., 1987, 1994). 
The relationship between the serotonin (5-HT) system and HPA axis has been 
examined in different biological states including depression (reviewed by Lesch and 
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Lerer, 1991), development (reviewed by Meaney et al., 1994), and in animal strains 
characterized by altered HPA activity (Burnet et al., 1994). For example, it was 
demonstrated that postnatal handling of rat pups reduces the HP A response to stress 
(reviewed by Meaney et al., 1994). Meaney et al., (1994) hypothesize that the 
decreased HP A response to stress is due to a more sensitive corticosteroid feedback 
inhibition. Furthermore, the increased feedback inhibition may be related to an increase 
in 5-HT turnover (Smythe et al., 1994) and GR receptor expression in the hippocampus 
(Meaney and Aitken, 1985; O'Donnell et al., 1994). 
The hippocampus contains the highest concentration of corticosteroid receptors in 
the central nervous system (McEwen et al., 1968; Coirini et al., 1983, 1985; Reul and de 
Kloet 1985, 1986; Magarinos et al., 1989). Corticosteroid receptors have at least two 
physiological roles in the hippocampus: influencing HP A axis activity via a negative 
feedback mechanism and modulating hippocampus related behaviors (reviewed by 
Jacobson and Sapolsky, 1991; de Kloet et al., 1993). It is still not clear how cortico-
steroids influence neural signal processing in the hippocampus. Several important 
questions remained answered. For example, exactly where in the hippocampus are 
corticosteroids exerting their modulatory effect? 
The hippocampus is divided into three regions; hippocampus proper, dentate gyms, 
and the subiculum (reviewed by Knowles, 1992; Bernard and Wheal, 1994). The 
hippocampus proper is further divided into four subfields, CAl-4. The cells in the 
different hippocampal regions and subfields have unique roles in hippocampal signal 
processing based on their different positions within the trisynaptic circuit. The cells in 
subfield CA3 receive their inputs from the dentate gyms, perforant pathway axons, 
neighboring CA3 cells. The cells in subfield CAI receive their inputs almost entirely 
from subfield CA3 (reviewed by Knowles, I 992; Bernard and Wheal, I 994). 
Corticosteroid modulate pyramidal cell membrane properties and the response 
elicited by the activation of 5-HT IA receptors on subfield CAI cells (Joels and de Kloet, 
I994; Beck et al., I994, I996). Activation of the 5-HTIA receptor in the hippocampus 
hyperpolarizes the cell membrane potential (Andrade and Nicoll, I 987; Colino and 
Haliwell, I987; Beck and Choi, I99I; Beck et al., I992). The 5-HTIA receptor signal 
transduction system mediating the hyperpolarization is composed of a receptor, 
heterotrimeric guanine nucleotide binding protein (G protein), and potassium channel 
(Andrade et al., I 986; Okuhara and Beck, I 994). 
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The actions of corticosteroids on pyramidal cell membrane electrical properties and 
the 5-HT IA receptor signal transduction system in subfield CA3 are not known, yet this 
information is crucial towards elucidating the mechanism by which corticosteroids 
modulate signal processing in the hippocampus. In addition to their differences in 
neuronal organization and synaptic inputs, the pyramidal neurons in subfields CAI and 
CA3 have different cell membrane electrical properties (Nunez et al., I990; Beck et al., 
I 992; Spruston and Johnston, I 992), 5-HT IA receptor concentration-response curve 
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characteristics (Beck et al., 1992, Okuhara and Beck, 1994), and when these regions are 
stimulated their effects on HP A axis activity are not the same (Kawakami et al., 1968; 
Dunn and Orr, 1984; Daniels et al., 1994). Therefore information on the actions of 
corticosteroids on pyramidal cell membrane electrical properties and the 5-HT IA receptor 
signal transduction system in subfield CA3 will contribute to a basic understanding of 
how corticosteroids alter cell excitability, responses elicited by the activation of 
G protein-linked neurotransmitter receptors, and help to elucidate the role of 
corticosteroid receptors in information processing in the hippocampus. 
The goal of this dissertation is 1) to determine the effects of chronic corticosteroid 
treatment on neuron membrane electrical properties and/or 2) the 5-HT 1A receptor-
mediated response on pyramidal cells in hippocampal subfield CA3 and 3) determine 
which component(s) of the 5-HT IA receptor signal transduction system is modulated by 
corticosteroids. The underlying hypothesis of this dissertation is that chronic 
corticosteroid treatment modulates pyramidal cell excitability and/or the 5-HT 1A receptor 
signal transduction system in hippocampal subfield CA3. This hypothesis was tested 
with experiments designed to address four specific aims. 
Four treatment groups were used in this dissertation. Adult rats were surgically 
treated to achieve 1) no corticosteroid receptor occupancy, 2) MR occupancy only, 
3) occupancy of both MR and GR, and 4) sham. All treatments were for 13 -15 days. 
Specific Aim 1: Determine if corticosteroids alter pyramidal cell electrophysiological 
properties in hippocampal subfield CA3. 
Intracellular recording techniques were used in hippocampal slices maintained in 
vivo to measure passive and active membrane electrical characteristics. 
Specific Aim 2: Determine if corticosteroids alter the 5-HT concentration-response 
curve characteristics for the 5-HT IA receptor in hippocampal CA3 pyramidal cells. 
Intracellular recording techniques were used in hippocampal slices maintained in 
vivo to examine the 5-HT concentration-response curve characteristic for the 5-HT IA 
receptor. 
Specific Aim 3: Determine the effects of corticosteroids on the 5-HT IA signal 
transduction components: (1) The current evoked by direct activation of G proteins and 
(2) the current-voltage relationship for the potassium current linked to the 5-HT IA 
receptor. 
Corticosteroids may modulate one or more of the 5-HT1A signal transduction 
components (i.e., receptor, G protein, or ion channel). Therefore, intracellular 
recording techniques were used in hippocampal slices maintained in vivo to examine 
the action of corticosteroids on I) the outward current evoked by the activation of 
G proteins with GTPyS, and 2) the current-voltage (1-V) relationship of the potassium 
channels linked to the 5-HT IA receptor. 
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Specific Aim 4: Determine the effects of corticosteroids on the 5-HT lA signal 
transduction components: G protein expression in the hippocampus. 
Western blot and immunohistochemistry techniques were used to determine the 
effects of corticosteroids on G protein levels and distribution in the hippocampus. 
7 
CHAPTER II 
REVIEW OF RELATED LITERATURE 
Introduction 
Adrenal corticosteroids are divided into two classes, glucocorticoids and 
mineralocorticoids (Figure 1 ). Corticosteroids maintain homeostasis, influence mood, 
sensory detection, and perception (reviewed by Henkin 1970; Munck et al., 1984; de 
Kloet, 1991 ). T. Addison first published his results on the death of patients with adrenal 
destruction in 1855. Later, H. Cushing (1932) and Harris (1948) established that the 
hypothalamus-pituitary-adrenal (HP A) axis regulates corticosteroid synthesis and 
secretion. The actions of corticosteroids are mediated mainly through two receptor 
subtypes: glucocorticoid and mineralocorticoid receptors. 
The first section of this literature review covers the description, pharmacology, 
function, and regulation of corticosteroid receptors in mammals. Section two describes 
the components, function, and regulation of the HP A axis. The regulation of HP A axis 
activity is complex, involving several feedback loops and extrahypothalamic pathways. 
One system which has an important modulatory influence on HP A axis activity is the 
limbic system, in particular, hippocampal inputs into the HP A axis. Section three 
reviews the role of the hippocampus in regulating HPA activity. In addition to their 
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physiological effects in the periphery, corticosteroids also influence neural activity. 
Section four reviews the available information on corticosteroid-induced changes in 
neuron electrophysiological properties and the responses elicited by the activation of the 
5-HT IA receptor in the hippocampus. The final section summarizes the known and 
proposed roles of corticosteroids in pathological conditions. The scientific contribution 
of this dissertation is also addressed in this section. 
Corticosteroids Receptors 
9 
Glucocorticoids have a wide variety of effects on many cell functions (reviewed by 
Kraus-Friedmann, 1984; Pilkis and Granner, 1992). Glucocorticoids stimulate 
gluconeogenesis, increase amino acid uptake by the liver and kidney, increase amino acid 
release through muscle catabolism, and stimulate lipolysis. The primary role of 
glucocorticoids is to provide glucose for energy demanding tissues such as the brain and 
heart, especially under conditions of stress. Glucocorticoids also have immuno-
suppressive, anti-inflammatory, and anti-asthmatic properties (Falaschi et al., 1994; 
Derijk and Sternberg, 1994; Barnes, 1996; Laitinen and Laitinen, 1996; Schwiebert et 
al., 1996) while supraphysiological levels decrease muscle mass, leading to muscle 
weakness (Caldwell et., 1978; Goldberg et al., 1980; Fiorini, 1987; Smith et al., 1990). 
Glucocorticoids exert their effects directly by regulating the synthesis of key 
enzymes and proteins, or permissively, by influencing the sensitivity of cells to other 
hormones or extracellular signals. For example, glucocorticoids elevate blood glucose 
Corticosterone 
OH 
Cortisol Aldosterone 
Glucocorticoids Mineralocorticoid 
Figure 1. Major corticosteroids in rat and humans. The two classes of 
corticosteroids are glucocorticoids and mineralocorticoids. Corticosterone is the major 
glucocorticoid in rat, while cortisol is the major glucocorticoid in humans. 
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levels directly by increasing the synthesis of hepatic phosphoenolpyruvate carboxykinase 
(Beale et al., 1982; Lamers et al., 1982) and branched-chain a-ketoacid dehydrogenase 
(Block et al., 1970; Block and Buse, 1990), rate limiting enzymes for gluconeogenesis 
and skeletal muscle catabolism respectively. Glucocorticoids act permissively by 
increasing the sensitivity of adipose cells to catecholamines (reviewed by Munck and 
Guyre, 1986; Malbon et al., 1988). 
Mineralocorticoids maintain fluid and electrolyte homeostasis. Aldosterone 
primarily acts at the kidney to increase Na+ reabsorption and excretion ofK+ and Ir 
(O'Neil, 1990; Funder, 1993; Horisberger and Rossier, 1995; Eaton et al., 1995). 
Aldosterone affects electrolyte transport at the distal tubules and collecting ducts by 
increasing the synthesis ofNa+ (Chu and Edelman, 1972; Rousseau and Crabbe, 1972; 
Lahav et al., 1973; Rossier et al., 1978; Garty, 1986) and K+ channels (Kopppen et al., 
1983; Stokes, 1985; Sansom and O'Neil, 1986; Sansom et al., 1989; Illek et al., 1990; 
Schafer et al., 1990) and the Na+,K+-ATPase pump (Geering et al., 1982; Ewart and 
Klip, 1990; Verry, 1990; Shahedi et al., 1993). 
Glucocorticoids regulate gene expression through the interaction with at least two 
receptor subtypes; type I or MR and the type II or GR. Both types of corticosteroid 
receptors are intracellular receptors which bind to DNA and influence gene transcription 
(reviewed by Dahlman-Wright et al., 1992). The two receptors are distinguished 
pharmacologically by their relative affinity for corticosterone and other selective ligands. 
Structure and Mechanism of Action 
Corticosteroid receptors are intracellular receptors that regulate the expression of 
specific genes. Both l\1R and GR have been cloned and their sequences are highly 
homologous (Arriza et al., 1987; Patel et al., 1989). GR has been the focus for the 
majority of the biochemical and functional studies, therefore, the following section 
reviews the information available for GR. However, since both l\1R and GR belong to 
the same steroid receptor family, they have many functional similarities (Pearce, 1994). 
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The unoccupied receptor usually resides in the cytoplasm, translocating into the 
nucleus after binding to the steroid (Govindan, 1980; Papmichail et al., 1980; Antakly et 
al., 1984; Fuxe et al., 1985; Wikstrom, et al., 1987; Picard, 1987; Lafond et al., 1988; 
Gase et al., 1989). The unoccupied receptor is maintained in an inactive state by a multi-
protein complex. This complex contains GR (Okret, 1985) associated with heat shock 
proteins hsp56 (Sanchez, 1990), hsp70 (Sanchez, 1990; Sanchez et al., 1990), and hsp90 
(Catelli et al., 1985; Sanchez et al., 1985; Sanchez et al., 1990). Steroid binding 
dissociates hsp90 from GR (Mendel et al., 1986; Sanchez et al., 1987a), forming an 
'activated' receptor with increased affinity for DNA (Sanchez et al., 1987b; Howard and 
Distelhorst, 1988a,b ). Activated GRs dimerize and bind to specific DNA sequences 
(Tsai et al., 1988; Wrange et al., 1989; Chalepakis et al., 1990), known as gluco-
corticoid response elements (GRE) and influence gene transcription (Yamamoto, 1985). 
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A great deal of information is known about the structure of MR and GR. Purified 
GR is 90-100 kDa when resolved by SDS-gel electrophoresis (Govindan and Manz, 
1980; Bernard and Joh, 1984; Govindan and Gronemeyer, 1984; Grandics et al., 1984; 
Idziorek et al., 1985; Lustenberger et al., 1985; Webb et al., 1985). Based on 
nucleotide sequences of MR and GR, the two receptors are comprised of approximately 
780 amino acids and are highly conserved across different species (Hollenberg et al., 
1985; Danielsen et al., 1986; Miesfeld et al., 1986; Arriza et al., 1987; Patel et al., 
1989). Corticosteroid hormone receptors are single chain polypeptides containing three 
distinct functional domains: ligand binding, DNA binding, and N-terminal domains 
(Figure 2) (reviewed by Gustafsson et al., 1987; Dahlman-Wright et al., 1992; Wright et 
al., 1993). The different domains were first identified through limited proteolysis of the 
purified protein (Carlstedt-Duke et al., 1977, 1982, 1987; Wrange and Gustaffsson, 
1978; Westphal et al., 1984; Wrange et al., 1984). Point mutation analysis of the cDNA 
clones allowed researchers to identify the amino acid residues critical for the proper 
function of each domain (reviewed by Dahlman-Wright et al., 1992; Gehring, 1993). 
The ligand binding domain is in the carboxy-terminal end of the peptide, covering 
approximately 250 amino acids (Carlstedt-Duke et al., 1987; Hollenberg et al., 1987; 
Rusconi and Yamamoto, 1987). The hormone binding domain in MR and GR share a 
57 % homology in humans (Arriza et al., 1987) and 59 % in rats (Patel et al., 1989). 
Removal of this domain produces a constitutively active receptor (Danielson et al., 1987; 
ligand DNA N-terminal 
C~ •~~~--rN 
250 70 460 
Figure 2. Schematic representation of the MR and GR protein and its major 
domains. The domains are labeled at the top of the diagram while the approximate 
amino acid size of the domain is located at the bottom. 
Godowski et al., 1987; Hollenberg et al., 1987; Meisfeld et al., 1987). Biochemical 
analysis of this domain reveals that it folds into a complex secondary and tertiary 
structure, important for proper steroid binding (reviewed by Dahlman-Wright, et al., 
1992; Gehring 1993) and translocation into the nucleus (Picard and Yamamoto, 1987). 
The DNA binding domain is in the middle of the polypeptide. The MR and GR 
DNA binding domains are 94 % homologous in humans (Arriza et al., 1987) and 76 % 
in rats (Patel et al., 1989). This domain contains 70 amino acids which are highly 
conserved with other steroid receptors (Giguere et al., 1986; Carlstedt-Duke et al., 
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1987; Danielson et al., 1987; Hollenberg et al., 1987; Meisfeld et al., 1987; Rusconi and 
Yamamoto, 1987; Evans, 1988; Hard et al., 1990). The prominent feature of this 
domain is the coordination of cysteine residues and zinc ions to form the DNA binding 
structure (Freedman et al., 1988; Seveme et al., 1988; Hard et al., 1990). 
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The N-terminal domain sequence is highly variable with other intracellular steroid 
receptors (reviewed by Evans, 1988; Beato, 1989). The N-terminal domain in :MR and 
GR share only a 15 % homolgy in humans (Arriza et al., 1987) and 40 % in rats (Patel et 
al., 1989). Very little is known about the function of this domain and how the different 
amino acids contribute to the activity of the receptors. This domain may be important 
for the transactivation of GR with other transcription factors (Hollenberg et al., 1987; 
Danielson et al., 1987; Gehring and Segnitz, 1988; Hollenberg and Evans, 1988). 
Pharmacology and Distribution 
Several experimental techniques, including in situ hybridization, autoradiography, 
and immunohistochemistry were used to map the distribution of :MR and GR in the 
central nervous system (CNS). Convincing pharmacological evidence for the existence 
of two corticosteroid receptor subtypes came with the development of drugs that were 
selective for :MR and GR and allowed researchers to distinguish the two receptors and 
their differential distribution in the CNS. 
[ 3H]corticosterone binding macromolecules in the brain were initially identified in 
the early 1970's (McEwen and Plapinger, 1970; Grosser et al., 1971; Gerlach and 
McEwen, 1972; McEwen et al., 1972; Grosser et al., 1973). These early investigations 
demonstrated that corticosterone binding was not uniformly distributed. Corticosterone 
binding was much higher in limbic areas, especially the hippocampus, compared to other 
regions of the brain (McEwen et al., 1969, 1970, 1972; McEwen and Plapinger, 1970; 
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Grosser et al., 1971; Stevens et al., 1971; Gerlach and McEwen, 1972; Warembourg, 
1975; Stumpf and Sar, 1979; Sapolsky et al., 1983b). However, binding experiments 
with the native mineralocorticoid aldosterone (Anderson and Fanestil, 1976; 
Moguilevski and Raynaud, 1980; De Nicola et al., 1981; Veldhuis et al., 1982; 
Beaumont and Fanestil, 1983; Krozowski and Funder, 1983; Wrange and Yu, 1983) and 
synthetic glucocorticoid dexamethasone (de Kloet ER et al., 1975; Rees et al., 1975; 
Rhees et al., 197 5; Warembourg, 197 5) produced two different corticosteroid receptor 
distributions. The accumulated data lead investigators to suggest that two corticosteroid 
receptor populations existed in the brain. 
The development of selective MR antagonist RU 26752 and RU 26813 (Coirini et 
al., 1985), GR agonist RU 26988 and RU 28362 (Moguilewsky and Raynaud, 1980; 
Coirini et al., 1985), and GR antagonist RU 38486 (Gagne et al., 1985) allowed 
researchers to pharmacologically characterize and map the distribution of MR and GR in 
the CNS. The two receptor subtypes are distinguished by their relative affinities for the 
endogenous corticosteroids corticosterone and aldosterone. MR has a high affinity for 
corticosterone (Kn= 0.5 nM) and aldosterone. In contrast, GR has a low affinity for 
corticosterone (Kn = 2 - 5 nM) and aldosterone (Veldhuis et al., 1982; Beaumont and 
Fanestil, 1983; Krozowski and Funder, 1983; Coirini et al., 1985; Reul and de Kloet, 
1985; Sheppard and Funder, 1987). Dexamethasone is a synthetic glucocorticoid with a 
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higher affinity for GR (Veldhuis et al., 1982; Krozowski and Funder, 1983; Coirini et al., 
1985). 
The hippocampus contains the highest concentration of?\1R and GR in the CNS. 
MR binding is almost exclusively located in the hippocampus while GR binding is also 
found in other CNS areas including the cortex, ventromedial thalamic nuclei, arcuate, 
and lateral septum (Coirini et al., 1983, 1985; Reul and de Kloet 1985, 1986; Magarinos 
et al., 1989). 
Regulation 
Corticosteroid receptor levels in the brain are dynamically regulated by 
neuropeptides, neurotransmitters, and corticosteroids (via an autoregulatory mechanism) 
(reviewed by de Kloet et al., 1986a; Herman, 1993; Budziszewska and Larson, 1994). 
The regulation of?\1R and GR depends upon the brain area (i.e., hippocampus versus 
hypothalamus) and which physiological factor is evoking the change in J\1R and GR 
binding (i.e., neurotransmitters versus autoregulation). Furthermore, the regulation of 
corticosteroid receptors by neuropeptides, neurotransmitters, or corticosteroids may 
represent three independent physiological mechanisms underlying control of HP A axis 
activity (see Hypothalamic-Pituitary-Adrenal Axis). A large number of investigations 
have focused on the regulation of corticosteroid receptors in the hippocampus, where 
corticosteroid receptors have an important role in HP A axis feedback and behavior 
(Jacobson and Sapolsky, 1991). 
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Regulation by Neuropeptides 
HP A axis activity is regulated by two principal neuropeptides, CRF and ACTH (see 
Hypothalamic-Pituitary-Adrenal Axis). CRF and the ACTH analog ORG 2766 both 
modulate corticosteroid receptor levels. CRF decreases GR binding and mRNA levels in 
the anterior pituitary and in AT20 anterior pituitary corticotrope cell culture (Sheppard 
et al., 1990, 1991), but increases the GR mRNA levels in the hippocampus (Sheppard et 
al., 1990). ORG 2766 is an ACTH analog that has no effect on corticosteroid secretion 
from the adrenal gland (Greven and de Weid, 1973; de Weid and Jolles, 1982). 
However, ORG 2766 administration increases corticosteroid receptor binding in the 
hippocampus (Rigter et al., 1984; Reul et al., 1988). Selective MR and GR ligands were 
used to demonstrate that ORG 2766 selectively increases MR binding in the 
hippocampus (Reul et al., 1988). The effects ofORG 2766 in the pituitary and 
hypothalamus are not known. 
Another neuropeptide which is also released from the hypothalamus is vasopressin 
(Kiss et al., 1984; Plotsky et al., 1985; Davis et al., 1986; Holmes et al., 1986; Fink et 
al., 1988; Canny et al., 1989). Vasopressin is released by hypothalamic PVN neurons in 
response to stress (Plotsky et al., 1985; Canny et al., 1989) and influences water-intake, 
learning and memory (de Wied, 1971; Bohus et al., 1975; de Weid et al., 1975; de Kloet 
and de Wied, 1980). Vasopressin increases corticosteroid receptor binding capacity in 
the hippocampus and GR receptors in the anterior pituitary (Veldhuis and de Kloet, 
1982). 
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The mechanisms underlying the neuropeptide-induced changes in corticosteroid 
receptor binding are largely unknown. However, the neuropeptide actions are 
independent of corticosteroid hormones (Veldhuis and de Kloet, 1982; Reul et al., 1988; 
Shepherd et al., 1990). While the normal physiological roles ofCRF-, ACTH-, and 
vasopressin-induced changes in corticosteroid receptor levels are not known, these 
peptides generally display trophic effects in certain diseased and aged brains, restoring 
deficient corticosteroid receptors and HP A responsiveness (de Kloet et al., l 986a; Reul 
eta/., 1988). 
Regulation by Neurotransmitters 
One brain area in which neurotransmitters appear to have an important role in 
regulating corticosteroid receptor expression is the hippocampus (Siegel et al., 1983; 
Weidenfeld et al., 1983). Modulation of corticosteroid receptors in the hippocampus by 
neurotransmitters may be important in affecting mood, behavior, and neuroendocrine 
responses (Azmitia et al., 1984; Budziszewska and Larson, 1994). 
The 5-HT neurotransmitter system regulates corticosteroid receptor binding. 
Lesioning 5-HT neurons in the raphe nucleus or depleting neurons of 5-HT decreases 
corticosteriod receptor binding in the mediobasal hypothalamus and hippocampus (Siegel 
et al., 1983; Weidenfeld et al., 1983; Weidenfeld and Feldman, 199la; Novotney and 
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Lowy, 1995). Lesioning 5-HT neurons in the raphe nucleus also decreases GR and MR 
mRNA levels in the hippocampus (Seckl et al., 1990; Seckl and Fink, 1991). In cultured 
hippocampal neurons, 5-HT increases GR binding capacity without altering the binding 
capacity of MR (Mitchell et al., 1990). The 5-HT receptor mediating the upregulation 
of GR binding capacity in cultured hippocampal neurons is the 5-HT 2 receptor (Mitchell 
et al., 1992). In contrast to cultured neurons, 5-HT 1A agonists increase MR binding 
capacity in the hippocampus in vivo (Budziszewska et al., 1995). 
Other neurotransmitter systems which also modulate corticosteroid receptor binding 
capacity or mRNA levels in the brain are the noradrenergic (Maccari et al., 1990; 
1992a,b; Yau and Seckl, 1992; Kabbaj et al., 1995), cholinergic (Nyakas et al., 1979; 
Yau et al., 1992), and dopaminergic systems (Casolini et al., 1993). Interestingly, the 
different neurotransmitter systems have different effects on corticosteroid receptor 
binding capacity and mRNA levels. Noradrenaline (NA) alters corticosteroid receptor 
binding capacity and mRNA levels (Maccari et al., 1992a,b; Yau and Seckl, 1992; 
Kabbaj et al., 1995). Cholinergic neurotransmitters do not modulate MR and GR 
binding capacity but alter their mRNA levels (Nyakas et al., 1979; Yau et al., 1992). 
Dopamine does not alter MR and GR binding capacity but alters the affinity of GR for 
corticosterone (Casolini et al., 1993). 
The mechanisms underlying the neurotransmitter-induced changes in corticosteroid 
receptor binding capacity are not known. Changes in corticosteroid receptor mRNA 
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levels do not always parallel the changes in receptor binding capacity. Furthermore, in 
certain cases (i.e., 5-HT2 modulation of GR) (Mitchell et al., 1992), changes in 
corticosteroid receptor binding capacity are dependent on the production of second-
messengers by the activated neurotransmitter receptor. Indeed, protein kinase A 
dependent mechanisms (Kendal and Robinson, 1990) have been shown to phosphorylate 
corticosteroid receptors (Dalman et al., 1988; Smith et al., 1989) and convert them to 
their inactive form (reviewed by Sanchez et al., 1987; Dahlman-Wright et al., 1992), 
increasing their binding capacity in the cytosol. 
Modulation of corticosteroid receptors by neurotransmitters may be the initial phase 
leading to an eventual shift in HPA axis activity (Kabbaj et al., 1995). For example, 
activation of 5-HT or NA neurons increases HP A axis activity (Feldman and Weidenfeld, 
1995). However, prolonged activation of these receptors have opposite effects on 
hippocampal corticosteroid receptor binding capacity. NA decreases (Maccari et al., 
1992a; Kabbaj et al., 1995) while 5-HT increases (Seckl and Fink, 1991; Budziszewska 
et al., 1995) corticosteroid receptor levels. Clearly, the selective physiological activation 
of different neurotransmitter pathways will have different effects on corticosteroid 
receptor function and may underlie modulatory and pathophysiological processes. 
Autoregulation 
Receptor autoregulation is a mechanism which occurs for a large number of 
receptor systems, including corticosteroid receptors (reviewed by Schmidt and Meyer, 
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1994). A common feature of receptor autoregulation in all systems is a correlation 
between ligand availability and receptor binding capacity. What is different between 
receptor systems is how ligand availability and receptor binding correlate (directly or 
inversely) and their mechanism of autoregulation. An adrenalectomy-induced increase in 
hippocampal corticosteroid binding capacity was first demonstrated by McEwen et al., 
(1970). Later, it was reported that corticosteroid receptor binding capacity in the 
hippocampus was reduced by high levels of corticosterone or stress (Tomello et al., 
1982; Sapolsky et al., 1984a). Investigators then sought to determine the individual 
roles of hippocampal MR and GR in receptor autoregulation and their function in HP A 
axis feedback. 
The binding capacities of MR and GR are differentially regulated by changes in 
steroid levels. Hippocampal MR binding capacity may either increase (Chao et al., 
1989) or show no change (Reul et al., 1987b; Reul et al., 1989; Lowy, 1991; Spencer et 
al., 1991) with adrenalectomy. MR mRNA levels increase with adrenalectomy (Herman 
et al., 1989a, 1993). Activation of either MR or GR has different effects on MR binding 
capacity. The activation of MR does not alter MR binding capacity (Reul et al., 1987b; 
Spencer et al., 1991) while GR activation alone increases MR binding capacity and 
mRNA levels (Reul et al., 1987b; Reul et al., 1989). Coactivation of MR and GR 
decreases MR binding capacity and mRNA levels (Lowy, 1991; Spencer et al., 1991). 
MR binding capacity and mRNA levels also display circadian variation. However, there 
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are different reports supporting either a peak- (Reul et al., 1987b) or a nadir-associated 
(Chao et al., 1989) increase in MR binding capacity during the circadian cycle. MR 
mRNA levels are higher during the nadir (Herman et al., 1993; Holmes et al., 1995a). 
Unlike MR, hippocampal GR binding capacity shows a reproducible increase with 
adrenalectomy that returns to control levels with corticosterone or dexamethasone 
treatment (Reul et al., 1987; Chao et al., 1989; Lowy, 1991; Spencer et al., 1991). The 
adrenalectomy-induced increase in GR binding capacity is also paralleled by an increase 
in GR mRNA levels (Kalinyak et al., 1987; Herman et al., 1989a, 1993; Reul et al., 
1989; Sheppard et al., 1990; Peiffer et al., 1991 ). GR binding capacity in the 
hippocampus does not change with diurnal variation (Reul et al., 1987b) but GR mRNA 
levels are higher during the nadir of the circadian cycle (Herman et al., 1993; Holmes et 
al., 1995a). In contrast to MR, activating both or each corticosteroid receptor 
selectively, decreases GR binding capacity in hippocampal sections and tissue culture 
(Sapolsky et al., 1984a; Sapolsky and McEwen, 1985; Luttge et al., 1989; Vedder et al., 
1993; O'Donnell and Meaney, 1994). 
Corticosteroid receptor autoregulation does not occur in all brain areas. Adrenal-
ectomy increases MR and GR mRNA levels in the hippocampus and amygdala but not in 
the hypothalamus, neocortex, dorsomedial thalamus, hypothalamic PVN, and arcuate 
nucleus (Pfeifer et al., 1991; Herman et al., 1993). Corticosterone decreases 
corticosteroid receptor binding capacity in the rat hippocampus but not in the 
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hypothalamus, amygdala, or pituitary (Tornello et al., 1982; Sapolsky and McEwen, 
1985). Interestingly, dexamethasone decreases GR binding capacity in the pituitary and 
amygdala but not in the hippocampus (Sapolsky and McEwen, 1985). 
The autoregulation of corticosteroid receptors is an important feedback mechanism 
(Schmidt and Meyer, 1994). The mechanism underlying corticosteroid receptor 
autoregulation is complex. Influencing the transcription of their own gene (Burstein et 
al., 1991), mRNA stability, alternative splicing, and receptor protein turnover rate may 
all be involved in the autoregulation mechanism (Schmidt and Meyer, 1994; Herman and 
Watson, 1995). Finally, the pronounced autoregulation of corticosteroid receptors in the 
hippocampus as compared to other brain areas, supports the important role that the 
hippocampus has in influencing HP A axis activity and corticosteroid-induced behaviors 
(Jacobson and Sapolsky, 1991). 
Function 
It has been proposed by de Kloet ( 1991) that homeostasis is maintained by MR and 
GR via a 'corticosteroids receptor balance hypothesis'. This hypothesis simply states 
that the physiological functions of MR and GR depend on the differential occupation of 
the two receptors and is based on two important corticosteroid receptor properties. 
First, MR and GR have different affinities for corticosterone. Second, the fractional 
occupancy of MR and GR changes with physiological fluctuations in corticosterone 
plasma concentrations. MR has a high affinity for corticosterone (Kn= 0.5 - 0. 7 nM) 
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and is 70-80% occupied at basal physiological corticosterone plasma levels (Krozowski 
and Funder, 1983; Reul and de Kloet, 1985; Reul et al., 1987). GR has a lower affinity 
for corticosterone, Kn= 2.5 - 5 nM, and its occupancy changes from 15% at basal to 
90% at peak and stress circulating corticosterone levels (Reul and de Kloet, 1985; Reul 
et al., 1987a,b). One important point should be emphasized about the physiological 
function of MR and GR. GR occupation without concomitant MR occupation has not 
been demonstrated to occur physiologically. 
Brain MR and GR have distinct physiological functions that are often 
complementary and not antagonistic. For example, MR and GR are important in 
maintaining homeostasis. However MR maintains ion homeostasis while GR maintains 
glucose availability (Dallman et al., 1987, 1994; Tempel and Leibowitz, 1994). MR and 
GR influence different aspects of behavior. MR permits the proper acquisition of 
behavior reactivity in rats while GR facilitates memory storage (Micco et al., 1980; 
Jefferys et al., 1983; Veldhuis et al, 1985; McEwen and Brinton 1987; Oitzl and de 
Kloet, 1992, 1994; de Kloet et al., 1993). One example of the different roles MR and 
GR have on behavior is the performance of rats in the Morris water maze. MR 
activation is important in developing the strategy used by the animal to find the platform 
in the water while GR activation is important for acquiring and storing spatial 
information (Oitzl and de Kloet, 1992; Oitzl et al., 1994). 
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Concluding Remarks 
MR and GR are intracellular receptors that bind to DNA and regulate the expression 
of specific genes. MR and GR have different physiological functions. MR and GR also 
have different affinities for corticosterone. Therefore, homeostasis is maintained by MR 
and GR via changes in their fractional occupancy with fluctuating corticosteroid plasma 
levels. MR and GR are differentially expressed in the brain. The hippocampus contains 
the highest density of MR and GR binding sites and mRNA levels. 
Corticosteroid receptor levels are autoregulated and influenced by neuropeptides 
and neurotransmitters which may represent three different physiological mechanisms 
underlying the modulation of HP A axis activity. Neuropeptides provide trophic effects 
which may be important in maintaining normal corticosteroid receptor levels (reviewed 
by de Kloet et al., 1986a). Neurotransmitters provide a rapid mechanism for modulating 
corticosteroid receptor levels via the activation of selective neurotransmitter pathways. 
Finally, corticosteroids autoregulate their own receptor levels, providing a HP A axis 
feedback mechanism (reviewed by Schmidt and Meyer, 1994). Corticosteroid receptor 
regulation occurs in several brain areas~ however, the hippocampus shows the greatest 
sensitivity. 
Hypothalamic-Pituitary-Adrenal Axis 
The synthesis and release of corticosteroids are regulated by the hypothalamic-
pituitary-adrenal axis (HP A) (Figure 3) (reviewed by Feldman and Weidenfeld, 1995). 
CNS 
brain stem 
I NA+ 
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: LcTH+ : 
I t I 
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Figure 3. Schematic model of the HP A axis. The major components, peptides, and 
hormones are pictured in this diagram. The solid arrows depict released constituents, 
while the broken arrow depicts feedback. 
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In response to various stimuli, PVN neurons in the hypothalamus release CRF into the 
portal circulation. CRF then stimulates the synthesis and release of ACTH from the 
corticotropes in the anterior pituitary. ACTH enters the circulatory system and drives 
the synthesis and release of corticosteroids from the adrenal cortex. 
Regulation of The HP A axis 
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HP A axis activity is driven by two physiological mechanisms, circadian rhythm and 
stress. Circulating glucocorticoid levels in nocturnal rats are lowest during 'lights-on', 
peak during 'lights-off (Guillemin et al., 1959; Scheving and Pauly, 1966; Zimmermann 
and Critchlow, 1967; Ader et al., 1968; Retiene, 1970; Dunn et al., 1972), and increase 
in response to stress (Ganong, 1963; Mangili et al., 1966; Yates, 1967; Ader et al., 
1968; Gibbs, 1970; Dunn et al., 1972). It is well established that extrahypothalamic 
structures regulate circadian rhythm and stress-induced HP A axis activity (Slusher, 1964; 
Davidson and Feldman, 1967; Halasz et al., 1967; Palka et al., 1969; Wilson and 
Critchlow, 1975; Phelps et al., 1978). Extrahypothalamic structures affect HPA axis 
activity through the release ofvasopressin, oxytocin, epinephrine or 5-HT at the 
hypothalamus (Weiner and Ganong, 1978; Fuller, 1981; Swanson et al., 1983; Plotsky 
1985, 1987; Antoni, 1986; Plotsky et al., 1987, 1989; Feldman et al., 1990, Feldman and 
Weidenfeld, 1991 ). 
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Neurotransmitter Systems Influencing HP A Axis Activity 
5-HT neurons arising from raphe nuclei innervate the parvocellular region of the 
PVN in the hypothalamus (Palkovits et al., 1977; Sawchenko et al., 1983). 5-HT 
neurons innervate CRF synthesizing neurons in the PVN (Lipositis et al., 1987) and 
stimulate the synthesis and release of CRF in vivo (Saphier and Feldman, 1989; 
Swanson and Simmons, 1989; Feldman et al., 1991) and from isolated rat hypothalamic 
cells (Calogero et al., 1989). 
5-HT neurons facilitate circadian- and stress-induced release of CRF or corti-
costerone (Szafarczyk et al., 1980; Fuller, 1981; Feldman et al., 1995). The 5-HT 
receptors mediating the release ofCRF, ACTH or corticosterone are the 5-HT1A and 
5-HT2 receptors (Koenig et al., 1987, 1988: Lorens and Van de Kar, 1987; Gilbert et 
al., 1988; King et al., 1989; Fuller and Snoddy, 1990). 
NA fibers located in the ventral noradrenergic ascending bundle (VNAB) have an 
important role in regulating HP A axis activity (Feldman et al., 1984; Plotsky et al., 1989; 
Feldman and Weidenfeld, 1995, Feldman et al., 1995). VNAB fibers originate in the 
brainstem, mainly from the locus coeruleus. A subset of these fibers innervate the 
hypothalamic PVN, via the medial forebrain bundle (Cunningham and Sawchenko, 1988; 
Cunningham et al., 1990; Saphier and Feldman, 1991), and stimulate CRF release 
(Guillaume et al., 1987; Plotsky, 1987; Weidenfeld and Feldman, 199lb). 
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Lesioning the VNAB or medial forebrain bundle with the catecholamine neurotoxin 
6-hydroxy-dopamine (6-0HDA) prevents the circadian release of ACTH and 
corticosterone (Szafarczyk et al., 1985) and the stress-induced release of CRF (Feldman 
et al., 1984; Szafarczyk et al., 1985, 1987; Plotsky, 1987; Sawchenko, 1988). The NA 
receptors mediating the release of CRF are the a.1- and a.2-receptors (Saphier and 
Feldman, 1991; Daniels et al., 1993). 
The cholinergic system also influences HP A axis activity. Cholinergic agonists 
stimulate CRF, ACTH, and corticosterone release (Makara and Stark, 1976; Plotsky et 
al., 1987; Weidenfeld et al., 1989a). Cholinergic antagonists attenuated both basal- and 
stress-induced release of ACTH (Hedge and Smelik, 1968; Kaplanski and Smelik, 1973; 
Makara and Stark, 1976; Guillaume et al., 1987). The cholingeric receptors mediating 
the release of corticosterone are nicotinic receptors (Brenner et al., 1986; Weidenfeld et 
al., 1989a). 
Feedback Regulation by Corticosteroids 
While extrahypothalamic pathways are important for the initial stimulation (or 
inhibition) of HP A axis activity, more direct control of the HP A axis is mediated through 
feedback loops within the axis (Figure 3) (reviewed by Feldman and Weidenfeld, 1995). 
Corticosteroids act at both the hypothalamus and pituitary to directly inhibit their own 
synthesis and secretion. Some controversy still exists surrounding the mechanism by 
which corticosteroids directly act at the hypothalamus to decrease ACTH secretion 
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(reviewed by Bradbury et al., 1991; Dallman et al., 1994; Feldman et al., 1995). 
Corticosteroid receptors and CRF are both present within the same cells in the PVN 
(Ceccatelli et al., 1989). Adrenalectomy or stress (initiated via photic, acoustic, or 
sciatic nerve stimulation) increases hypothalamic CRF peptide and mRNA levels (Paull 
and Gibbs; 1983; Westlund et al., 1985; Plotsky and Sawchenko, 1987; Sawchenko, 
1987; Beyer et al., 1988; Fink et al., 1988; Weidenfeld et al., 1989b; Feldman et al., 
1992; Kwak et al., 1993), resulting in an increase in ACTH secretion from the pituitary. 
However, corticosteroid implants in the hypothalamus attenuated only the neural 
(photic) stimulated CRF mRNA levels and peptide secretion (Feldman et al., 1992) and 
did not reliably decrease the adrenalectomy stimulated ACTH secretion in animals 
(Dallman et al., 1985; Kovacs et al., 1986; Sawchenko, 1987; Kovacs and Makara, 
1988; Levin et al., 1988). Therefore, HP A axis feedback inhibition may occur at other 
brain sites in addition to the hypothalamus (Feldman et al., 1992). 
Corticosteroids also act in the pituitary to inhibit ACTH secretion (reviewed by 
Dallman et al., 1987). GR and ACTH are both localized within the same cells in the 
pituitary (Cintra and Bortolotti, 1992). Corticosteroids decrease CRF- (Koch et al., 
1979; Dallman et al., 1985), adrenergic- (Giguere et al., 1982), and stress- (Walker et 
al., 1986) stimulated ACTH release from the pituitary. The inhibitory effect of 
corticosteroids on ACTH secretion occurs within 10-30 min (Brattin and Portanova, 
1977; Buckingham and Hodges, 1977; Mulder and Smelik, 1977; Gilles and Lowry, 
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1978; Widmaier and Dallman, 1984; Abou-Samra et al., 1986; Dayanithi and Antoni, 
1989) and requires protein synthesis (Dayanithi and Antoni, 1989). The requirement for 
protein synthesis suggests that corticosteroids decrease CRF and/or ACTH synthesis by 
increasing the synthesis of inhibitory transcription factors (Dayanithi and Antoni, 1989). 
MR and GR have different roles in HPA axis feedback (Dallman et al., 1987, 1994; 
de Kloet and Reul, 1987; Dayanithi and Antoni, 1989; Ratka et al., 1989; Sapolsky et 
al., 1990; Bradbury et al., 1991, 1994). MRs mediate HPA axis feedback inhibition 
during the circadian trough, when MR is 70-80% occupied at basal physiological 
corticosterone plasma levels (Krozowski and Funder; 1983; Reul and de Kloet, 1985; 
Reul et al., 1987a,b ). GRs mediate HP A axis negative feedback regulation during the 
diurnal peak or stress, when its occupancy changes from 15% at basal to 90% at peak 
and stress circulating corticosterone levels (Reul and de Kloet, 1985; Reul et al., 
1987a,b). 
Interestingly, the hypothalamus-pituitary brain areas are important in feedback 
during the circadian trough while other brain areas are important during the peak (Akana 
et al., 1986; Suemaru et al., 1995). Stress-induced increase in HPA axis activity is 
mediated through several different neural pathways (Feldman, 1985; Canny et al., 1989) 
and feedback is provided by both the HP A axis and other cortical areas (Kaneko and 
Hiroshige, 1978a,b; Keller-Wood and Dallman 1984; Dallman et al., 1987; Canny et al., 
1989). 
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The Hippocampus and HP A Axis Feedback Regulation 
The hippocampus has a significant role in regulating HP A axis activity. While it is 
well established that the hippocampus is a site of negative feedback for the HP A axis, it 
is not known how the hippocampus exerts its influence on the axis (reviewed by 
Jacobson and Sapolsky, 1991). The neural circuit in the hippocampus is complex. The 
hippocampal structure is divided into different regions: hippocampus proper, dentate 
gyros, and subiculum. These regions are interconnected to form the hippocampal 
circuitry. The neurons within these regions have different cell properties, 
neurotransmitter receptor-mediated responses, and when these regions are stimulated 
their effects on HP A axis activity are not the same. 
Hippocampal Anatomy 
The hippocampus is divided into three regions; hippocampus proper, dentate gyros, 
and the subiculum (reviewed by Knowles, 1992; Bernard and Wheal, 1994). The 
hippocampus proper is further divided into several subfields, CAl-4. Pyramidal cells are 
the primary projection neurons in the hippocampal subfields (Knowles, 1992; Bernard 
and Wheal, 1994) and share the same general shape as the pyramidal cells in the cortex 
(Peters and Jones, 1984). They have triangular or ovoid shaped cell bodies with one to 
three long apical dendrites. There are also a wide variety of interneurons in the 
hippocampus. The interneurons mainly release y-aminobutyric acid (GABA) as their 
neurotransmitter and are classified by their shape, neurophysiology, and location 
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(Knowles, I992; Bernard and Wheal, I994). 
The hippocampal circuitry is established through a hierarchy of connections that 
produce unidirectional signal processing within the structure (Andersen et al., I97Ib; 
Andersen, I975; Bernard and Wheal, I994). Figure 4 illustrates a diagrammatic model 
of the trisynaptic circuit. The major hippocampal inputs are received at the dentate gyros 
granule cells from the entorhinal cortex through the perforant pathway. Mossy fibers 
from the dentate gyros project to subfield CA3 pyramidal cells, which in turn, send 
Schaffer collaterals to subfield CAI pyramidal cells. Subfield CAI cells then provide the 
major output for the hippocampus through the fornix and subiculum. 
There are several important differences in the cellular organization and physiology 
between the various subfields. The pyramidal cells in subfield CA3 are larger and more 
densely packed compared to the cells in subfield CAI (Knowles, I992). The pyramidal 
cells in subfields CAI and CA3 are interconnected differently. The pyramidal cells in 
subfield CA3 are highly interconnected with nearby pyramidal cells and interneurons 
through an extensive local network of axon collaterals (Miles and Wong, I 986; Ishizuka 
et al., I 990). In contrast, the pyramidal neurons in subfield CAI have few excitatory 
collaterals between neighboring pyramidal cells (Knowles and Schwartzkroin, I98Ia,b). 
The extensive interconnection of cells in subfield CA3 are hypothesized to be important 
in the synchronized burst firing of these cells (Miles and Wong, I 986; Ishizuka et al., 
I990). 
dentate perforant pihway axons 
gyrus 
CA3 
CA1 
pyramidal cell 
Schaffer collateral 
pyramidal cell 
output via 
the subiculum 
Figure 4. Schematic representation of the hippocampal trisynaptic circuit. Only 
the major cell types, projections, and synapses are depicted in this diagram. 
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Hippocampal pyramidal cell excitability is determined by at least two factors: 
membrane electrical properties and neurotransmitter responses and both of these factors 
are different among the various subfields. For example, in subfields CAI and CA3, the 
pyramidal cell's passive and active membrane properties are different (Nunez et al., 
I990; Beck et al., I992; Spruston and Johnston, I992). Therefore, the cells in these two 
subfields may integrate synaptic potentials and encode their outputs differently. The 
responses elicited by the activation of at least two neurotransmitter receptors are 
different between subfield CAI and CA3. The 5-HT or baclofen concentration-response 
curve characteristics for the 5-HT IA and y-aminobutyric acids (GABA8 ) receptors, 
respectively, are different between subfields CAI and CA3 (Beck et al., I992, I995). 
Corticosteroid Receptor Distribution and Regulation 
in the Hippocampus 
There is some uncertainty concerning the relative distribution of corticosteroid 
receptors in the individual hippocampal subfields. Based on radioligand binding assays, 
MR binding density is greatest in subfield CAI and least in subfield CA3. This is also 
supported by in situ hybridization and immunohistochemistry investigations with probes 
for the MR mRNA and protein (Arriza et al., I988; Van Eekelen et al., I988; Herman et 
al., I989a; Ahima et al., I99I). GR binding density is higher in subfield CA3 compared 
to CAI. However, the results from in situ hybridization and immunohistochemistry 
experiments indicate that subfield CA3 has very little GR mRNA and immunoreactivity 
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(Fuxe et al., I985; Van Eekelen et al., I988; Herman et al., I989a). In a recent 
immunohistochemistry investigation, Ahima and Harlan (I990) reported that GR labeling 
is equally intense throughout subfields CAI-CA3. There has been no attempts to 
resolve the differences in GR binding, immunoreactivity, and mRNA distribution in the 
hippocampus. Some of the possible explanations for the disparate results are differences 
in GR mRNA translation, stability, or post-translation modifications between subfields 
CAI and CA3 ( Herman et al., I 989a). 
As reviewed above, the hippocampus is highly sensitive to corticosteroid receptor 
autoregulation compared to other brain areas. Interestingly, corticosteroid receptor 
autoregulation in the hippocampus is different between subfields CAI and CA3. 
Corticosterone decreases corticosteroid receptor binding sites in hippocampal subfields 
CAI and CA2, not in CA3 (Sapolsky and McEwen, I 985). Adrenalectomy increases 
GR and MR mRNA levels in subfield CAI but not in subfield CA3 (Herman et al., 
I989a). 
Hippocampus Influence on HP A Axis Activity 
Based on several lines of evidence, the hippocampus is an important site for HP A 
axis negative feedback regulation. First, corticosterone is capable of decreasing its own 
release by acting through the hippocampus. Corticosterone or dexamethasone implants 
into the dorsal hippocampus decreases adrenalectomy-induced ACTH secretion 
(Davidson and Feldman, I967; Kovacs and Makara, I988). Second, the hippocampus 
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exerts a negative influence on HP A axis activity. Dorsal hippocampectomy decreases 
the diurnal variation in circulating corticosterone levels by increasing basal (nadir) ACTH 
and corticosterone plasma levels (Fendler et al., 1961; Moberg et al., 1971; Fischette et 
al., 1980; Wilson et al., 1980; Margarinos et al., 1987; Sapolsky et al., 1989;). 
Hippocampectomy also increases CRF and vasopressin mRNA levels in the PVN 
(Herman et al., 1989b, 1992). 
Hippocampal lesions alter stress-induced HPA axis activity (Sapolsky et al., 1984b). 
Corticosterone levels increase during stress and return to pre-stress levels approximately 
one hour after the stressor is terminated (Sapolsky et al., l 984b ). Rats with hippocampal 
lesions have higher circulating plasma corticosterone levels in response to stress and the 
high level is maintained for at least four hours after the stressor is terminated (Kant et 
al., 1984; Sapolsky et al., 1984b). A common test for corticosterone feedback inhibition 
is the use of dexamethasone to suppress the stress-induced corticosterone secretion in 
rats. When the hippocampus or fornix are lesioned, the efficacy of dexamethasone to 
suppress stress-induced corticosterone secretion is significantly diminished (Feldman and 
Conforti, 1976; Margarinos et al., 1987). 
Finally, hippocampal regulation of the HP A axis is also supported by investigations 
using electrical stimulation of the hippocampus. Electrical stimulation of subfield CA2-
CA3 or the dentate gyrus decreases while stimulating subfield CAI increases plasma 
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corticosterone levels in rats (Kawakami et al., I968; Dunn and Orr, I984; Daniels et al., 
I994). 
Concluding Remarks 
Several lines of evidence suggest that corticosteroids have an important role in 
modulating hippocampal neural activity. The hippocampus has the highest density of 
corticosteroid receptors in the brain. The distribution of MR and GR may be different 
between subfields CAI and CA3; therefore, the two receptors may selectively modulate 
the hippocampal circuitry at specific sites. The hippocampus is a site of HP A axis 
negative feedback, influencing both circadian and stress driven corticosteroid secretion. 
However, it is not known how the feedback signal is processed in the hippocampus. 
Neuronal signal processing in the hippocampus is complex and corticosteroid 
modification of hippocampal neural activity is not completely understood. 
Corticosteroid Modulation ofHippocampal Neuron Properties 
Neuron Membrane Electrical Properties 
One way that corticosteroids may influence signal processing in the hippocampus is 
by modulating the electrical properties ofhippocampal neurons. Indeed, it has been 
demonstrated that corticosteroids alter neuron membrane electrical properties in 
hippocampal CAI pyramidal cells. Chronic (two weeks) MR activation with basal levels 
of corticosterone increases the membrane input resistance and time constant of pyramidal 
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cells in subfield CAI (Beck et al., I994). The membrane input resistance and time 
constant determine the decay of synaptic potentials in the dendrites and soma, which in 
tum, influences the integration of postsynaptic potentials in the cell (Rall, I 977). 
Therefore, corticosteroids may alter the integration of postsynaptic potentials in subfield 
CAI cells. 
Chronic MR activation with basal levels of corticosterone also increases the action 
potential peak amplitude and duration (Beck et al., I994). Altering the shape of the 
action potential may be physiologically important. Wheeler et al., (I 996) recently 
reported that increasing the action potential duration leads to an increase in Ca2+ influx at 
the presynaptic terminal and enhances synaptic strength. Consequently, MR activation in 
subfield CAI neurons may increase the release of neurotransmitters at the nerve terminal. 
Corticosteroids alter two characteristics that rely on a Ca2+ -dependent K+ current: 
spike accommodation and slow afterhyperpolarization (sAHP) (Madison and Nicoll, 
I984~ Lancaster and Nicoll, I987). When a prolonged (300 - 500 ms) depolarizing 
current pulse is injected into hippocampal pyramidal cells, the cell fires a short train of 
action potentials at the beginning of the pulse. The frequency of action potentials then 
decreases over the duration of the pulse. Accommodation is a term used to describe the 
neuron's ability to adapt and prevent the firing of action potentials during the 
depolarizing pulse. Once the depolarizing pulse is terminated, a sAHP is apparent. 
Accommodation is determined by the magnitude and duration of the sAHP. 
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In subfield CAI, the sAHP is smaller in cells from adrenalectomized animals 
compared to cells from adrenally-intact animals (Joels and de Kloet, 1989; Kerr et al., 
1989). Short term (20 min to 4 hrs) and chronic MR activation decreases spike 
accommodation and the sAHP (Joels and de Kloet, 1989, 1990; Kerr et al., 1989; Beck et 
al., 1994). MR and GR activation or GR activation alone increases accommodation and 
the sAHP (Joels and de Kloet, 1989, 1990; Kerr et al., 1989). 
The actions of corticosteroids on several ionic conductances in the hippocampus 
have also been examined. The L- and T - type Ca2+ currents are larger in cells from 
adrenalectomized as compared to intact animals (Karst and Joels, 1994). Short-term 
MR activation returns the magnitude of the L- and T- type Ca2+ currents to control 
values (Karst and Joels, 1994). Due to conflicting reports, the effects of GR activation 
on Ca2+ currents in the hippocampus is still unclear. There are reports that GR activation 
induces either larger (Kerr et al., 1992) or smaller (Karst and Joels, 1994) Ca2+ currents 
in subfield CAI pyramidal cells compared to cells from adrenalectomized animals. IQ is 
also modulated by MR and GR activation. The IQ current is small when either MR or 
GR are occupied alone but increases when both MR and GR are occupied (Karst et al., 
1993). 
Hippocampus 5-HT 1A Signal Transduction System 
in Subfields CAI and CA3 
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In addition to altering cell membrane electrical properties, corticosteroids may also 
influence neural activity by modulating the responses elicited by the activation of 
neurotransmitter receptors. Corticosteroids have been shown to modulate 
neurotransmitter receptor systems in the brain including NA, muscarinic, glutamate, and 
5-HT systems (reviewed by Joels and de Kloet, 1994; McEwen. 1996). The action of 
corticosteroids on the 5-HT 1A receptor system has been reported by several different 
groups (Joels and de Kloet, 1994; Chaouloff, 1995; Beck et al., 1996). However, the 
mechanism by which corticosteroids alter the responses elicited by the activation of the 
5-HT 1A receptor is still not known. One reason the mechanism remains elusive is the 
effects of corticosteroids on the different components of the 5-HT1A receptor signal 
transduction pathway are not known. 
The hippocampus receives an extensive 5-HT innervation from the dorsal and 
median raphe (Azmitia and Segal 1978; Molliver, 1987). Stimulation of ascending 5-HT 
containing axons from the rap he decreases the cell firing rate of hippocampal subfield 
CA3 pyramidal cells (Segal, 1975). Locally applied 5-HT also decreases pyramidal cell 
firing rate (De Montigny and Aghajanian, 1978; Otmakhov and Bragin, 1982). 
Activation of the 5-HT1A receptor in the hippocampus hyperpolarizes the cell membrane 
potential (Andrade and Nicoll, 1987; Colino and Haliwell, 1987; Beck and Choi, 1991; 
Beck et al., 1992). The 5-HT 1A receptor signal transduction system mediating the 
hyperpolarization is composed of a receptor, heterotrimeric guanine nucleotide binding 
protein (G protein), and potassium channel (Andrade et al., 1986; Okuhara and Beck, 
1994). 
5-HT lA Receptor Structure and Distribution 
The 5-HT iA receptor belongs to the family of G protein-coupled receptors 
(reviewed by Iismaa and Shrine, 1992). G protein-coupled receptors are single chain 
polypeptides that contain seven putative membrane-spanning domains. The human 
5-HT1A receptor was first cloned in the late 1980's (Kobilka et al., 1987; Fargin et al., 
1988). The rat 5-HT lA receptor was later cloned by two separate groups (Albert et al., 
1990; Fujiwara et al., 1990) and encoded a protein approximately 420 amino acids in 
length. 
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There are three important features of G protein-coupled receptors which is also 
shared by the 5-HT1A receptor. First, the three dimensional arrangement of the seven 
transmembrane domains are proposed to form a ligand binding pocket (Hartig, 1989; 
Sylte et al., 1993) (Figure 5). The three dimensional arrangement places specific amino 
acid residues, located within the transmembrane domains, in areas critical for the 
interaction with receptor agonists and antagonists (Guan et al., 1992; Ho et al., 1992; 
Chanda et al., 1993). Second, the third cytoplasmic loop is the proposed site where 
G protein coupling occurs. The amino acids in the third cytoplasmic loop are highly 
divergent as compared with other G protein-coupled receptors (El Mestikawy et al., 
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Figure 5. Diagrammatic representation of the 5-HT1A receptor. The seven 
transmembrane regions (cylinders labeled in roman numerals) are shown in a hypothetical 
arrangement. The amino terminal (N) is located outside the cell while the carboxy 
terminal (C) is in the cytoplasm. The third cytoplasmic loop is also displayed. 
45 
I99I). The amino acids bordering each end of the third cytoplasmic loop are thought to 
confer G protein selectivity (Strader et al., I987; Kobilka et al., I988; O'Dowd et al., 
I 988). Finally, 5-HT iA receptor binding is modulated by phosphorylation. In a cell line 
where the 5-HT lA receptor was stably transfected, protein kinase C activation 
phosphorylated and desensitized the receptor (Raymond, I99I). 
The 5-HT1Areceptor is expressed through out the periphery and brain. The 
distribution of 5-HT lA receptors has been examined in several mammalian species (i.e., 
rat, pig, cat, mouse, and human) with similar results. The highest density of 5-HT lA 
binding sites and mRNA are located in limbic system structures: hippocampus, amygdala, 
septum, and cortical limbic areas (reviewed by Zifa and Fillion, I992; Boess and Martin, 
I 994). Within the hippocampus, the number of 5-HT IA receptor binding sites is different 
between subfields CAI and CA3. Subfield CAI has approximately a two times higher 
density of receptor binding sites compared to CA3 (Verge et al., I986; Radja et al., 
I99I). 
G protein Structure and Function 
G proteins are heterotrimeric proteins that bind guanine nucleotides (reviewed by 
Bimbaumer and Bimbaumer, I 995). G proteins that are involved in receptor signal 
transduction systems function as transducers. These G proteins couple, or link, the 
activation of specific plasma membrane receptors to other cellular proteins (commonly 
referred to as effector proteins) located within the membrane. 
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The G protein complex is composed of three subunits: a, p, and y . The a-subunit 
binds to guanosine triphosphate (GTP) and hydrolyzes it to guanosine diphosphate 
(GDP). The a-GTP complex is capable of dissociating from the py subunits (Fung, 
1983; Northup et al., 1983a,b). The PY subunits anchor the G protein complex to the 
plasma membrane and facilitates the interaction between G proteins and receptors 
(Kanaho et al., 1984; Florio and Stemweis, 1985, 1989; Watkins et al., 1985; Navon 
and Fung, 1987). All three subunits have been reported to interact with effector 
molecules (reviewed by Bimbaumer, 1992; Bimbaumer and Bimbaumer, 1995). There 
are at least three major G protein families; Gs, Gi, and Gq. The G protein families, and 
their respective subtypes, were originally classified by their ability to either stimulate (Gs) 
or inhibit (Gi) adenylyl cyclase, or other effector molecules. Presently, they are classified 
by their a-subunit sequences (reviewed by Bimbaumer et al., 1990). 
Activation of receptors coupled to G proteins initiates a cycle which is the hallmark 
ofG protein-coupled receptor signal transduction systems (reviewed by Bimbaumer and 
Bimbaumer, 1995). The signal transduction cycle is described in Figure 6. The 
activated receptor couples with a G protein. The G protein a-subunit binds a molecule 
of GTP and begins to hydrolyze it to GDP. The a-GTP complex dissociates from the py 
subunits. The a-GTP and/or py subunits interact with effector molecules. The 
hydrolysis of GTP to GDP terminates the interaction of the a-subunit with the effector 
molecule and the apy complex is reformed. 
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Figure 6. Cartoon illustration of the G protein cycle. 1. The activated receptor 
couples with the inactive G protein (GDP bound to the a-subunit). 2. The G protein 
a-subunit binds a molecule of GTP and begins to hydrolyze it to GDP. 3. The a-GTP 
complex dissociates from the py subunits. The a-GTP and/or py subunits interact with 
their effector proteins (El and E2). 4. The hydrolysis of GTP to GDP terminates the 
interaction of the a-su.bunit with the effector molecule. The mechanism (?) underlying 
the dissociation of the py subunits from their effector molecule is not known. 5. The 
G protein subunits dissociate from their effector proteins and reform the apy complex. 
47 
48 
A tool that is commonly used to determine which G protein subtypes are involved in 
a receptor signal transduction system is the Bordetella pertussis toxin (PTX). PTX 
covalently modifies (process known as ADP-ribosylation) particular G protein a-
subunits (i.e., Gi and Go, not Gs) and inhibits the coupling between the receptor and 
G protein (Gilman, I984; Watkins et al., I985). Using PTX, it was demonstrated that 
the 5-HT IA receptor couples to a PTX-sensitive G protein in hippocampal subfields CAI 
and CA3 (Andrade et al., I986; Okuhara and Beck, I994). 
Potassium Channel Linked to the 5-HT1A receptor 
Activation of the 5-HT1A receptor on hippocampal subfield CAI pyramidal cells 
evokes an inward rectifying potassium current that hyperpolarizes the cell membrane 
potential (Andrade and Nicoll, I 987; Colina and Haliwell, I 987; Beck et al., I 992). 
Activation of the 5-HT IA receptor on subfield CA3 pyramidal cells also produces a 
hyperpolarization via an increase in an inward rectifying potassium current (Beck and 
Choi, I99I; Beck et al., I992; Okuhara and Beck, I994). 
Very little is known about the potassium channel linked to the 5-HT1A receptor 
signal transduction system. The channel is probably a member of the recently cloned 
G protein inward rectifying potassium (GIRK) channel family (Lesage et al., I 994, I 995; 
Kobayashi et al., I995; Ponce et al., I996; Spausches et al., I996). The potassium 
channels linked to the 5-HT1A receptor in subfield CAI appear to be activated by 
G protein J3y subunits, and the channel gating kinetics modified by ATP (Oh et al., 
I995). 
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While the 5-HT 1A receptor signal transduction system is composed of similar 
components in subfields CAI and CA3, the pharmacological properties of the receptor is 
different between the two subfields. For example, 5-HT is less potent and elicits a 
greater hyperpolarization response in subfield CA3 cells compared to cells from subfield 
CAI (Beck et al., I 992). 5-HT 1A receptor antagonist that are competitive in subfield 
CAI are insurmountable in subfield CA3 (Beck et al., I 992). The different 
pharmacological properties of the 5-HT 1A receptor signal transduction system in subfield 
CAI and CA3 may be due to differences in signal transduction components (i.e., 
G protein or potassium channel subtype) or coupling affinity between components. 
Corticosteroid Modulation of the 5-HT 1AReceptor System in Subfield CAI 
Corticosteroids modulate the 5-HT 1A receptor system in the hippocampus. Short-
term (20 min to 4 hrs) activation of MR with basal levels of corticosterone or 
aldosterone decreases the 5-HT 1A receptor-mediated hyperpolarization compared to cells 
from adrenalectomy or sham animals (Joels et al., I99I, Joels and de Kloet, I992; Beck 
et al., I996). Short-term GR activation does not affect the magnitude of the 5-HT1A 
receptor-mediated hyperpolarization (Joels and de Kloet, I 992; Beck et al., I 996) but 
increases the EC50 value of the 5-HT concentration-response curve (Beck et al., I996). 
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Due to conflicting results, the effects of corticosteroids on the number of 5-HT IA 
binding sites is not clear. Adrenalectomy either increases (Chalmers et al., 1993; Tejani-
Butt and Labow, 1994) or has no effect on the number of 5-HT IA binding sites in 
subfield CAI (de Kloet et al., 1986b; Mendelson and McEwen, 1992a,b; Meijer and de 
Kloet, 1994; Kuroda et al., 1994; Holmes et al., 1995b). In the reports where 
adrenalectomy increased the number of 5-HT IA binding sites, corticosterone treatment 
reversed the adrenalectomy-induced effect. 
The corticosteroid-induced alterations in the 5-HT IA receptor-mediated responses 
cannot always be explained by changes in the number of 5-HT IA receptor binding sites. 
For example, an increase in the number of 5-HT IA receptor binding sites (Chalmers et 
al., 1993; Tejani-Butt and Labow, 1994) in adrenalectomized animals would predict a 
greater or more sensitive 5-HT IA receptor-mediated response. However, there is no 
difference in the 5-HT IA receptor-mediated hyperpolarization between adrenalectomized 
and adrenally-intact animals (Joels et al., 1991, Joels and de Kloet, 1992; Beck et al., 
1996). Therefore, corticosteroids may be altering the 5-HT IA receptor signal 
transduction system at sites downstream of the receptor. 
In addition to changes in the number of 5-HT IA receptor binding sites, 
corticosteroids may alter G protein expression or activity. The regulation of G protein 
levels by glucocorticoids has been examined in several tissue types including liver (Kawai 
et al., 93), aorta (Haigh et al., 1990) vascular smooth muscle (Schelling et al., 1994), 
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fetal forebrain tissue (Slotkin et al., 1994), cortex (Saito et al., 1989), and hippocampus 
(Wolfgang et al., 1994; Gannon et al., 1995). 
The action of glucocorticoids on G protein expression is different in the cortex and 
hippocampus. In the cerebral cortex, adrenalectomy decreases Gi, increases Gs, and has 
no effect on G0 a-subunit levels when compared to sham (Saito et al., 1989). 
Corticosterone replacement reversed the adrenalectomy-induced effects on G protein 
levels in the cortex. In contrast to the cortex, adrenalectomy has no effect on Gi and G1 
a-subunit levels in the hippocampus (Gannon et al., 1994). Only one study has 
examined the effects of high corticosteroid exposure on G protein levels in the 
hippocampus. Chronic stress increases Gs and Go but does not affect Gi a-subunit levels 
(Wolfgang et al., 1994). 
Finally, corticosteroids may also alter effector molecule activity. To date, 
corticosteroid-induced changes were only examined in effector proteins that regulate 
second messenger production. For example, glucocorticoids alter adenylyl cyclase 
activity and mRNA levels in the rat hippocampus (Gannon et al., 1994; Wolfgang et al., 
1994). The effects of corticosteroids on the properties of the potassium channel linked 
to the 5-HT lA receptor signal transduction system in the hippocampus are not known. 
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Concluding Remarks 
Corticosteroids modulate hippocampal neural activity at two known levels. First 
corticosteroids alter the electrical membrane properties of pyramidal cells. Second they 
modulate the responses elicited by the activation of neurotransmitter receptors. Current 
research has focused on the action of corticosteroids on the electrical membrane 
properties and responses elicited by the activation of the 5-HT 1A receptor on 
hippocampal pyramidal cells in subfields CAI. Nothing is known about effects of 
corticosteroids on the electrical membrane properties and 5-HT 1A receptor-mediated 
responses in subfield CA3. This deficiency of information makes it difficult to elucidate 
the role of corticosteroids in hippocampal information processing. As reviewed in the 
previous section (The Hippocampus and HPA Axis Feedback Regulation) signals in the 
hippocampus are processed along a trisynaptic pathway~ the neurons and the local 
network in each subfield have distinct properties. Therefore, it is important to determine 
the effects of corticosteroids in each subfield to understand how neural signaling in the 
hippocampus is influenced by the steroids. 
Clinical Importance 
Corticosteroids maintain homeostasis by regulating sugar metabolism, ion balance, 
immune responses and the responses to stress. Prolonged altered corticosteroid secretion 
induces pathological conditions that often become neurotoxic (Uno et al., 1994). There 
are several conditions that are associated with altered corticosterone secretion including 
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prolonged or chronic stress, senescence, and depression. The following section reviews 
the current information on stress, senescence, and depression and their relationship to 
corticosteroids. 
Stress 
One of the key physiological responses to stress is an increase in corticosteroid 
secretion, thereby increasing energy sources and limiting non-vital processes (Selye, 
1936, 1946; Munck et al., 1984). Normally, corticosterone levels are brought back to 
basal levels through feedback regulation. Prolonged stress is known to produce brain 
damage and psychiatric disorders (reviewed by Sapolsky, 1992). Cerebral cortical 
atrophy and hippocampal cell loss are commonly found in the brains of torture or abuse 
victims (Jensen et al., 1982; Uno et al., 1989). Cognitive functions are also disrupted 
with prolonged stress (reviewed by McEwen and Sapolsky, 1995). For example, certain 
types of learning and memory performances are impaired in rats exposed to repeated 
stress (Luine et al., 1994a,b ). 
Hippocampal neurons are particularly sensitive to prolonged stress and high 
concentrations of glucocorticoids. Stress or high glucocorticoid levels induces neuronal 
cell loss, (Sapolsky et al., 1985a; Uno et al., 1989; Stein-Behrens et al., 1995) atrophy, 
and reduced branching of subfield CA3 pyramidal cell apical dendrites (Woolley et al., 
1990; Watanabe et al., 1992; Magarinos and McEwen, 1995a,b). Furthermore, stress or 
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high glucocorticoid levels exacerbate hippocampal cell damage induced by a number of 
different insults, i.e., ischemia (Sapolsky, 1985). 
The exact mechanism underlying the toxic effects of glucocorticoids in hippocampal 
subfield CA3 are not known. There is some indication that part of the deleterious effects 
of glucocorticoids is due to the disruption of energy availability (Sapolsky, 1986; 
Kadekaro, et al., 1988; Freo et al., 1992). Another important factor in glucocorticoid-
induced toxicity in the hippocampus is the involvement of excitatory amino acid 
neurotransmitters and calcium. Briefly, glucocorticoids increase excitatory amino acid 
neurotransmission and they impair the ability of hippocampal neurons to maintain 
intracellular calcium concentrations (reviewed by Sapolsky, 1994). 
Senescence 
Senescence is associated with elevated HP A axis activity in rats (reviewed by 
Sapolsky et al., 1986; Sapolsky, 1992) and humans (Raskind et al., 1994). Aged rats 
display higher ACTH and/or corticosterone plasma levels, and prolonged corticosterone 
plasma levels following the removal of the stressor (Sapolsky et al., 1984b; 1985b; 
Landfield, 1987). 
The mechanism underlying the senescence-induced changes in HP A axis activity 
involves the hippocampus (reviewed by Landfield and Eldridge, 1994). The hippo-
campus in aged rats display several physiological changes that may influence HP A axis 
activity. For example, hippocampal corticosteroid receptor binding is decreased in aged 
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rats (Sapolsky et al., l 983a; Rigter et al., 1984; Reul et al., 1988) and their regulation is 
altered (Eldridge et al., 1989a,b). The changes in HPA axis activity in senescent rats 
resemble the changes that occur with hippocampectomy (Fendler et al., 1961; Feldman 
and Conforti 1976, 1980; Kant et al., 1984; Sapolsky et al., l 984b, 1989; Margarinos et 
al., 1987). An age related loss in hippocampal neurons has also been reported (Coleman 
et al., 1987; Sapolsky, 1992). 
Based on the association between high glucocorticoid levels and hippocampal 
neuron damage with stress and aging, Sapolsky and colleagues (1986) put forth a 
glucocorticoid cascade hypothesis of neuronal damage. Briefly, a prolonged exposure to 
elevated glucocorticoid levels, due to either stress or prolonged excitatory neural inputs 
into the HP A axis, decreases corticosteroid receptor levels in the hippocampus. The 
reduced corticosteroid receptor levels attenuate HP A axis feedback, further prolonging 
the elevated glucocorticoid exposure. Eventually, the glucocorticoids produce toxic 
effects (discussed above), inducing hippocampal cell loss. 
Depression 
Altered HP A axis activity is often associated with depression. The abnormalities of 
the HP A system in depression are manifested as an: 1) increased level of cortisol in the 
urine (free cortisol), plasma, and cerebral spinal fluid; 2) alterations in cortisol levels 
during the diurnal rhythm; 3) an attenuation of the CRF-induced release of ACTH; and 
4) decreased ability of dexamethasone to suppress cortisol secretion (reviewed by 
Murphy 1991a; Checkley et al., 1992). Similar abnormalities are also observed in aged 
rats (Issa et al., 1990). 
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It is not known why the HP A axis activity is elevated in depression, or how 
corticosteroids and depression are linked. However, several lines of evidence implicate 
corticosteroids in the etiology and treatment of depression (Barden et al., 1995). For 
example, suppressing hypercortisol secretion has been reported to abate depression in 
several independent studies (Jeffcote et al., 1979; Kelly et al., 1980; 1983; Nieman et al., 
1985; Murphy 1991b; Murphy et al., 1991a,b). Also chronic treatment with 
antidepressant agents increases MR and GR binding capacity (Reul et al., 1993) and 
mRNA levels in the rat hippocampus (Brady et al., 1991; Seckl and Fink, 1992; Yau et 
al., 1995). 
Cushing Syndrome and Hypercorticosteroid Secretion 
Drugs targeting the HP A axis may be a viable resource for treating pathological 
conditions associated with hypercorticosteroid secretion. It is well documented that 
hypersecretion of corticosteroids is associated with prolonged stress, aging, and 
depression. However, it has been difficult for investigators to show directly that 
hypercorticosteroid secretion can precipitate these conditions. The best evidence 
available supporting a direct link between hypercorticosteroid secretion with stress and 
depression is derived from Cushing' s syndrome patients. 
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One of the clinical features of Cushing' s syndrome is a persistent elevation in plasma 
corticosteroid levels (Cushing, 1932). These patients also display many of the same 
features characteristic of prolonged stress. For example, cerebral cortical atrophy and 
hippocampal cell loss are commonly found in the brains of patients with Cushing' s 
syndrome (Jensen et al., 1982; Uno et al., 1989; Starkman et al., 1992). Depression is a 
clinical symptom in approximately half of the Cushing's syndrome cases (Jeffcoate et al., 
1979; Cohen, 1980) and suppressing the hypercorticosteroid secretion in these patients 
dramatically reduces their depression (Jeffcote et al., 1979; Kelly et al., 1980, 1983; 
Nieman et al., 1985). 
Concluding Remarks 
The hippocampus contains the highest density of corticosteroid receptors in the 
brain, which leads to the suggestion that corticosteroids may have a profound influence 
on hippocampal signal processing. Previous investigations have demonstrated that 
corticosteroids modulate several cell membrane electrophysiological characteristics and 
responses elicited by the activation of several different neurotransmitter receptors on 
pyramidal cells in the hippocampus (Joels et al., 1991, Joels and de Kloet, 1992; Beck et 
al., 1994; Birnstiel and Beck, 1995; Beck et al., 1996). The mechanism by which 
corticosteroids modulate signal processing in the hippocampus is not completely 
resolved. One piece of information that is missing is the effects of corticosteroids on 
neural activity in all of the different hippocampal regions and subfields. The effects of 
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corticosteroids on pyramidal cell membrane electrophysiological properties and 5-HT IA 
receptor signal transduction system are not known in subfield CA3. This is an important 
point since the neurons in subfield CA3 have a critical role in processing synaptic 
information based on their unique synaptic organization (Knowles, 1992; Bernard and 
Wheal, 1994), electrophysiological characteristics (Nunez et al., 1990; Beck et al., 1992; 
Spruston and Johnston, 1992) and responses elicited by the activation of neurotrans-
mitter receptors (Beck et al., 1992, 1995). Information on the actions of corticosteroids 
on pyramidal cell membrane electrophysiological properties and the 5-HT IA receptor 
signal transduction system will contribute to a basic understanding of how 
corticosteroids alter cell excitability, alter responses elicited by the activation of 
G protein-linked neurotransmitter receptors, and will help to elucidate the role of 
corticosteroid receptors in information processing in the hippocampus. 
CHAPTER III 
CORTICOSTEROIDS ALTER PYRAMIDAL CELL ELECTROPHYSIOLOGICAL 
CHARACTERISTICS IN HIPPOCAMP AL SUBFIELD CA3 
Abstract 
The hippocampus contains the highest density of MR and GR in the central 
nervous system. The modulation of neuron excitability by corticosteroids in 
hippocampal subfield CAI is well documented. However, it is not known if 
corticosteroids produce different effects across the various hippocampal subfields. 
Therefore, we used intracellular recording techniques to examine the actions of chronic 
corticosteroid treatment (2 weeks) on the electrophysiological properties of rat 
hippocampal subfield CA3 pyramidal cells. The treatment groups used in this 
investigation were, adrenalectomy (ADX), selective MR activation with aldosterone 
(ALD), MR and GR activation with high levels of corticosterone (HCT), and SHAM. 
Corticosteroid treatment altered the percentage of nonburst and burst firing 
neurons. The largest differences were observed with ADX animals where the 
percentage ofnonbursting cells was 74% compared to 42% and 41% in ALD and 
SHAM animals. Corticosteroids did not alter the membrane input resistance, 
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resting potential, or time constant. Corticosteroids also had no effect on the slow- or 
fast-afterhyperpolarizing potential amplitude or duration. The action potential duration 
was longer in cells from ADX animals compared to cells from HCT and ALD animals. 
Based on our results, we conclude that corticosteroids altered the firing mode and 
decreased the action potential duration in subfield CA3 pyramidal cells. Both of these 
findings are novel results which are distinct from those previously reported for subfield 
CAI, suggesting that corticosteroids have different effects across hippocampal 
subfields. 
Introduction 
Corticosteroids (glucocorticoids and mineralocorticoids) are steroid hormones that 
maintain homeostasis by influencing energy production and electrolyte balance (Henkin, 
1970; Munck et al., 1984, de Kloet, 1991). Corticosteroids are synthesized in the 
adrenal cortex and their release regulated by the hypothalamic-pituitary-adrenal (HP A) 
axis. Corticosteroids regulate gene expression through two receptor subtypes: MR (or 
type I) and GR (or type II) (Joels et al., 1994b). MR has a high affinity for 
corticosterone (Kn= 0.5 - 0. 7 nM) and is 70-80% occupied at basal physiological 
corticosterone plasma levels (Krozowski and Funder, 1983; Reul and de Kloet, 1985; 
Reul et al., 1987a,b). GR has a lower affinity for corticosterone, Kn= 2.5 - 5 nM, and 
its occupancy changes from 15% at basal to 90% at peak and stress circulating 
corticosterone levels (Reul and de Kloet, 1985; Reul et al., 1987a,b). 
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The hippocampus contains the highest concentration of corticosteroid receptors in 
the CNS (McEwen et al., I968; Warembourg, I975; Sapolsky et al., I983b; Sarrieau et 
al., I984; Reul and de Kloet, I985, I986; Magarinos et al., I989). Corticosteroids 
have a profound influence on cells in the hippocampus (de Kloet et al, I 993; McEwen 
et al., I993). The effects of MR and GR activation on pyramidal cell excitability and 
ionic currents are well documented for subfield CAI. Generally, MR activation 
increases CAI pyramidal cell excitability while GR activation decreases cell excitability 
(Beck et al., I994; Joels and de Kloet, I994). 
It is not known if corticosteroids have a different effect on neuron 
electrophysiological properties in subfield CA3. This is an important issue since the 
hippocampus processes information along a trisynaptic lamellar pathway (Andersen et 
al., I971b; Andersen, I975) with the pyramidal cells in subfield CAI receiving their 
inputs via Schaffer collaterals from the pyramidal cells in subfield CA3. It is important 
to determine how corticosteroids modulate synaptic transmission along this pathway. 
Neurons in each subfield have a distinct role in processing synaptic transmission based 
on their different local intemeuron circuits (Knowles, I 992), electrophysiological 
characteristics (Brown et al., I98I; Nunez et al., I990; Beck et al., I992; Spruston and 
Johnston, I 992) and neurotransmitter-mediated responses (Beck et al., I 992, I 995). 
Furthermore, the MR/GR ratio is greater in subfield CAI (6.5:I) compared to CA3 
(I: I) as determined by a receptor binding investigation (Reul and de Kloet, I 985). 
We used intracellular recording techniques to examine the effects of chronic 
corticosteroid treatment on the electrophysiological properties of pyramidal cells in 
hippocampal subfield CA3. Our hypothesis is that corticosteroids will produce a 
different modulatory action in subfield CA3 neurons as compared to those previously 
reported for subfield CAI. These results will contribute to a basic understanding of 
how corticosteroids alter cell excitability and will help to elucidate the role of 
corticosteroid receptors in information processing in the hippocampus. 
Materials and Methods 
Materials 
Corticosterone pellets were purchased from Innovative Research of America 
(Sarasota, FL). Aldosterone was purchased from Steraloids Inc. (Wilton, NH). 
Osmotic minipumps were purchased from Alzet Cooperation (Palo Alto, CA). All 
other chemicals were obtained from standard commercial sources. 
Animals 
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Four different treatment groups were used for the experiments in this investigation 
(Table 1 ). The adrenalectomy was performed as described previously (Beck et 
al., 1994, 1996; Birnstiel and Beck, 1995). Male Sprague-Dawley rats (Harlan) 75-
1 OOg were used for all treatment groups. Bilateral adrenalectomies were performed on 
all treatment groups, except the SHAM group, to remove circulating corticosteroids. 
Table 1.- Treatment groups 
Treatment 
SHAM 
ADX 
ALD 
HCT 
Surgery 
Intact 
Adrenalectomy 
Adrenalectomy 
Adrenalectomy 
Nothing 
Nothing 
Implant 
Aldosterone ( 10 µg/h 
minipump) 
200 to 300 mg 
corticosterone 
ACSF 
1 nM corticosterone 
no steroid 
3 nM aldosterone 
100 nM corticosterone 
Animals were anesthetized with ether. A small incision was made into the abdominal 
cavity, just below the rib cage, and the adrenal glands carefully removed. The muscle 
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wall was then sutured and the skin closed using wound clips. The ADX group received 
no further treatment. The ALD group had an osmotic minipump containing 
aldosterone (Alzet model 2002) implanted subcutaneoulsy at the time of 
adrenalectomy, to selectively activate MR. The minipump delivered 10 µg/h 
aldosterone dissolved in propylene glycol. MR and GR were activated in another 
group of animals (HCT) by subcutaneously implanting 200-300 mg corticosterone 
pellets, 2 to 3 week release, in the back of the neck at the time of adrenalectomy. The 
SHAM group of animals was produced by visualizing the adrenal glands but leaving 
them intact. After surgery the animals were maintained on a standard twelve hour 
light/dark cycle and rat chow, ad libitum. SHAM animals were given standard drinking 
water while the ADX, ALD, and HCT animals were given 0.9 % NaCl drinking water 
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ad libitum. At the end of 13 - 15 days, the animals were sacrificed in the morning and 
hippocampal slices immediately prepared for electrophysiological recording. At the 
time of sacrifice, trunk blood was collected to determine the plasma corticosterone 
levels by radioimmune assay (Burgess and Randa, 1992). 
Hippocampal Slice Preparation 
Hippocampal slices were prepared for electrophysiological recording as previously 
described (Okuhara and Beck, 1994). Rats were sacrificed by decapitation and the 
brain rapidly removed and placed in ice cold artificial cerebrospinal fluid (ACSF) 
containing in mM: NaCl 125, KCl 3, NaH2P04 1.25, MgS04 2, CaCli 2.5, dextroselO, 
and NaHC03 28. The ACSF was also supplemented with steroids, as outlined in 
Table 1, to maintain the treatment paradigm. We previously reported that steroids 
must be present in the ACSF to preserve the corticosteroid-induced effects on neuron 
cell properties (Beck et al., 1994). The hippocampus was dissected free and the dorsal 
section cut in 500 - 550 µm sections on a vibratome. The hippocampal slices were then 
placed in a holding vial containing ACSF bubbled with 95% Oi-5% C02 at room 
temperature. The slices remained in the holding vial for at least one hour after 
dissection before being transferred to the recording chamber. In the recording 
chamber, the slice was stabilized between two nylon nets and continuously perfused 
with ACSF bubbled with 95% 0 2-5% C02 at a rate of2-3 ml/min, at 3 l-32°C. 
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Intracellular Recording 
Intracellular recordings were made as previously described (Okuhara and Beck, 
1994). Electrodes were pulled from borosilicilate capillary tubing on a Brown and 
Flaming electrode puller (Sutter Instruments) to a resistance of 30-35 Mil (2 M KCl). 
Pyramidal cells were impaled with brief ejections of positive current through the 
electrode. The impaled cells were sealed by applying 1 nA hyperpolarizing current. 
Electrical signals were collected and amplified using an Axoclamp 2A and Cyberamp 
320 amplifier (Axon Instruments, Foster City, CA) and recorded on a Gould Series 
3200 chart recorder (Gould Electronics, Valley View, OH). Data were collected on-
line with pCLAMP software (Axon Instruments). 
Statistical Analysis 
Statistical comparisons were performed using analysis ofvariance (ANOVA). The 
Student-Newman-Keuls method was used for post-hoc tests. A chi-square test was 
used to determine if the percentage of bursting and nonbursting cells was different with 
corticosterone treatment. All values are reported as mean± S.E.M. A p < 0.05 was 
considered significant. 
Results 
Corticosterone Plasma Levels 
SHAM corticosterone plasma levels ranged from 0 - 4.13 µg/dl (1.23 ± 0.24 µg/dl, 
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n = 22). ADX corticosterone plasma levels ranged from 0 - 0.5 µg/dl (0.21±0.05 
µg/dl, n = 20). ALD corticosterone plasma levels ranged from 0 - 0.6 µg/dl (0.12 ± 
0.05 µg/dl, n = 18). The lower and upper limits of the corticosterone radioimmune 
assay were 0.05 and 50 µg/dl respectively. Adrenalectomies that produced 
corticosterone concentrations :::; 0. 6 µg/ di were considered successful. Two SHAM, 12 
ADX, and 13 ALD animals had corticosterone levels less than 0.05 µg/dl. The 
concentration of aldosterone used in our experiments was based on an investigation by 
Kuroda et al., ( 1994 ). The ALD treatment decreased MR binding by 61 % ( n = 5 
animals) in the cytoplasm (data not shown) as determined using a homogenate binding 
assay. HCT plasma concentrations greater than 20 µg/dl were considered successful. 
HCT corticosterone plasma levels ranged from 25 to> 50 µg/dl (39.96 ± 2.90 µg/dl, 
n = 11). 
Passive Membrane Properties 
The analysis of cell characteristics was as described previously (Beck et al., 1994). 
Two different firing modes have been described for neurons in subfield CA3 (Wong 
and Prince, 1978, 1981; Masukawa et al., 1982; Bilkey and Schwartzkroin, 1990). 
One type of firing mode is a regular spiking pattern of action potentials in response to a 
long depolarizing pulse (nonbursting cells) while the other mode is a cluster of spikes 
which reside on a slow depolarizing potential (bursting cells). We also observed burst 
67 
and nonburst firing in the present investigation (Figure 7). A chi-square analysis 
indicated that the percentage of bursting and nonbursting cell types was dependent on 
the type of corticosteroid treatment (Table 2). Since it is not known if corticosteroids 
have different effects on nonbursting and bursting cell types, the pyramidal cell 
characteristics data were divided into nonbursting and bursting cell types. The data 
were first analyzed using a two-way ANOV A with treatment as one variable and cell 
type as the other variable. If there were no significant effects between cell type, the 
data were then analyzed using one-way ANOV A, collapsing across cell type and 
grouping according to treatment only. 
The membrane potential was read directly from the amplifier display. Corrections 
for the input offset were done after the electrode was withdrawn from the cell. The 
membrane input resistance and membrane time constant were calculated from current-
voltage plots. The current-voltage plot data were generated by injecting 300 ms pulses 
of -900 to 0 pA in 100 pA increments into the cell while recording the cell's membrane 
potential. The membrane input resistance was calculated from the slope of the linear 
portion of the current-voltage plots. The membrane time constant corresponded to the 
length of time required for the membrane potential to reach 63% of its final value 
during a 300 ms pulse of -100 pA. There were no differences in resting membrane 
potential, input resistance, or membrane time constant between either cell type or 
corticosteroid treatment (Table 3). 
A 
20 mV ~ ___,.-J-,__.. _ __, 
100ms 
8 
Figure 7. Membrane potential changes in a nonbunting and bunt firing cell. 
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A: Nonbursting cell. B: Bursting cell. The cells received an injection of -700 and 
400 pA current pulses, 300 ms in duration. Plots were generated from digitized data, 
therefore, action pote11tials appear truncated. Notice the slow depolarizing envelope in 
the bursting cell (arrow). 
Table 2.--Number of nonbursting and bursting cells recorded from 
the different corticosterone treatment groups 
SHAM ADX ALD HCT 
nonbursting 13 29 11 16 
bursting 19 10 15 10 
% nonbursting 41 74 42 62 
Proportion of nonbursting and bursting cells are different between 
treatment groups. 
x2 = 9.592, d.f = 3, P = 0.022. 
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Table 3.--The effects of corticosteroids on passive membrane electrophysiological 
properties 
Treatment & cell type RMP Resistance Tau 
(mV) (Mn) (ms) 
SHAM NB 68.4 ± 1.4 (13) 50.1 ± 2.8 (13) 49.3 ± 4.2 (13) 
B 72.0 ± 1.2 (19) 51.0 ± 1.9 (19) 49.3 ± 3.6 (19) 
ADX NB 68.8 ± 0.9 (29) 51.6 ± 2.3 (29) 42.8 ± 2.4 (29) 
B 69.3 ± 1.4 (10) 48.6 ± 3.0 (10) 53.4 ± 5.7 (10) 
ALD NB 68.4 ± 1.8 (11) 45.2 ± 2.3 (11) 43.8 ± 5.4 (11) 
B 71.7± 1.2 (15) 49.8± 2.9 (15) 48.1 ± 6.0 (15) 
HCT NB 68.6 ± 1.5 (16) 54. 7 ± 1. 7 ( 16) 44.5 ± 4.3 (15) 
B 68.6 ± 2.1 (10) 47.7 ± 4.8 (9) 55.1±6.1 (9) 
All values are reported as mean± SEM (n) 
Cell type NB, nonbursting; B, bursting 
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Action Potential and fAHP Properties 
Table 4 summarizes the effects of corticosteroids on action potential and fAHP 
properties. Action potentials were generated with short 2-4 ms depolarizing pulses. 
The action potential threshold was the membrane potential value just before the action 
potential spike began to rise. The action potential threshold was used as the baseline 
value to calculate its height and baseline duration. The action potential height was 
measured from baseline to the peak of the spike. The action potential half-width was 
the width of the spike at 50% of its peak amplitude. The action potential baseline 
duration was the spike width along its baseline. fAHP' s were generated with 20 ms 
pulses of enough current (300-600 pA) to generate a single action potential. The fAHP 
amplitude was measured from threshold to the peak hyperpolarizing amplitude which 
occurred 1-4 ms after the end of the spike. The fAHP t 112 corresponds to the amount 
of time for the fAHP to decrease from its peak amplitude to one-half of its value. 
Based on a two-way ANOV A examination, neither corticosteroid treatment nor 
cell type had an effect on the action potential threshold. The action potential peak 
amplitude was smaller in bursting cells (80.3 ± 0.7 mV, n = 52.) compared to 
nonbursting cells (82.7 ± 0.6 mV, n = 69) (F = 6.252; d.f = 1, 113; P = 0.014). 
However, corticosteroid treatment had no effect on the action potential peak amplitude 
(F = 2.021; d.f. = 3, 113; P = 0.115). Corticosteroid treatment did alter the action 
potential duration. The action potential half- and baseline widths were wider in cells 
from ADX animals compared to cells from ALD and HCT animals (Figure 8). The 
action potential half-width was also wider in cells from SHAM animals compared to 
ALD. 
sAHP and Accommodation 
71 
The effects of corticosteroids on sAHP and accommodation properties are 
summarized in Table 5. sAHP's were generated by injecting 300-500 ms pulses of 
800-1200 pA to elicit a train of sodium action potentials. A train of sodium action 
potentials usually generate two types of afterhyperpolarizing potentials, a medium-
afterhyperpolarizing potential followed by a sAHP (Madison and Nicoll, 1984). 
Therefore, the sAHP amplitude was measured after the medium-afterhyperpolarizing 
potential ended (approximately 100 to 250 ms after the current pulse terminated). The 
sAHP t 112 corresponds to the amount of time for the sAHP to decrease from its peak 
amplitude to one-half of its baseline value. Spike accommodation corresponds to the 
number of action potentials that occurred during a 300 ms depolarizing pulse. 
Two-way ANOV A analysis of the data indicated that the sAHP amplitude was 
smaller in nonbursting cells (10.8 ± 0.5 mV, n = 65) compared to bursting cells (12.4 ± 
0.5 mV, n = 38) (F = 5.822; d.f = 1, 111; P = 0.017). Consistent with the larger sAHP 
in bursting cells, accommodation was also greater in bursting cells (4.5 ± 0.47 spikes, n 
= 53) compared to nonbursting cells (5.7 ± 0.3, n = 64) (F = 5.743; d.f = 1, 110; 
Table 4.-The etTect of corticosteroids on action potential and fAHP properties. 
Action Potential fAHP 
Treatment Threshold Amplitude Half-width a Baseline width b Amplitude t112 
& cell type (mV) (mV) {f:!s} (ms) (mV) (ms) 
SHAM NB 50.9 ± 0.6 (13) 82.2 ± 1.4 (13) 963 ± 40 (13) 1.67 ± 0.06 (13) 7.8 ± 0.4 (13) 3.3 ± 0.3 (13) 
B 50.8 ± 0.4 (I9) 79.7 ± 0.8 (I9) 926 ± 20 (I9) I .60 ± 0.04 (I 9) 7.7 ± 0.4 (17) 3.0 ± 0.2 (I 7) 
ADX NB 51.4 ±-0.5 (29) 84.0 ± I. I (29) ·975 ± 20 (28) I .68 ± 0.04 (28) 7.8 ± 0.6 {26) 2:9·± 0.2 (26) 
B 51.7 ± 0.7 (IO) 82.5 ± 0.5 (IO) 940 ± 30 (10) 1.64 ± 0.07 (10) 6.7 ± 0.5 (9) 2.4 ± 0.2 (9) 
ALD NB 51.9 ± 0.7 (11) 83.5 ± 1.3 (I I) 877 ± 20 (I I) 1.52 ± 0.04 (I I) 7.2 ± 0.8 (I I) 2.7 ± 0.2 (11) 
B 50. I ± 0.5 (I4) 79.9 ± 1.4 (I4) 862 ± 20 (I4) I .49 ± 0.05 (I4) 7.6 ± 0.5 (15) 2.9 ± 0.3 (I5) 
HCT NB 52.0 ± 0.7 (I6) 81.0 ± 1.3 (I6) 896 ± 20 (I6) 1.53 ± 0.04 (16) 9.0 ± 0.6 (I4) 2.8 ± 0.2 (I4) 
B 51.7 ± 0.6 (9) 79.2 ± I .4 (9) 896 ± 30 (9) I .58 ± 0.06 (9) 8.4 ± 0.7 (10) 3.1 ± 0.4 (10) 
All values are reported as mean± SEM (n) 
Cell types NB, nonbursting; B, bursting 
• ADX (966 ± 20 µs, n =38) different from ALD (869 ± I 0 µs, n = 25) and HCT (896 ± 20 µs, n = 25) 
SHAM (94I ± 20 µs, n =32) different from ALD. One-way ANOVA F = 4.419; d.f = 3,I 13; P = 0.006. 
Student-Newman-Keuls p < 0.05 
b ADX (I .67 ± 0.04 ms, n = 38) different from ALD (1.5 I ± 0.03 ms, n = 25) and HCT (1.55 ± 0.03 ms, n = 15) 
t:j 
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P = 0.018). Corticosteroid treatment had no effect on the sAHP amplitude (F = 2.096, 
d.f = 3, 111; P = 0.105) or accommodation properties (F = 0.04; d.f = 3, 110; P = 
0.989). 
2omvl 
1 ms 
Figure 8. Superimposed action potentials in a cell from an ADX and HCT 
animal. Each trace represents an average of five action potentials in a cell from either 
an ADX (solid line) or HCT (broken line) treated animal. 
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Table 5.-The effect of corticosteroids on sAHP and accommodation 
properties 
Treatment & cell sAHP sAHP Accommodation 
type AmElitude {m V} ti12 {ms} {no. of SEikes 2 
SHAM NB 11.8 ± 0.9 {13) 1001±86 (6) 5.2 ± 0.6 {13) 
B 13.7 ± 0.8 {19) 945 ± 55 {11) 5.1±0.4 {19) 
ADX NB 11.7± 0.6 (28) 1126 ± 84 (19) 6.4 ± 0. 7 (26) 
B 11.3 ± 1.1 (10) 961±65 (9) 4.0 ± 0.7 (9) 
ALD NB 9.9 ± 1.2 {11) 1186 ± 238 (10) 4.9 ± 0.5 {11) 
B 13.8± 1.1 {15) 1022 ± 55 (12) 4.1±0.5 (15) 
HCT NB 9.7 ± 1.0 (13) 853 ± 106 (11) 6.3 ± 0.9 (14) 
B 10.9 ± 1.1 {9} 1052 ± 58 {6} 3.9 ± 0.5 {10} 
Discussion 
We examined the effects of corticosteroids on pyramidal cell electrical properties 
in subfield CA3. The primary finding was that the percentage of nonbursting and 
bursting cell types was dependent upon corticosterone treatment. Therefore, we 
analyzed the cell characteristics according to treatment and cell type. There were 
several cell characteristics that were different between nonbursting and bursting cell 
types. Nonbursting cells had a larger action potential peak amplitude, less 
accommodation, and a smaller sAHP amplitude compared to bursting cells. However, 
corticosteroid treatment had no effect on the these cell characteristics. Corticosteroids 
also had no effect on the passive membrane properties (membrane potential, input 
resistance, and time constant), fAHP amplitude and duration. Corticosteroids did 
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increase the action potential duration in cells from ADX animals compared to ALD and 
HCT. The action potential duration was also longer in cells from SHAM animals 
compared to ALD. 
Percentage ofNonbursting and Bursting Cells 
The pyramidal cells in subfield CA3 are divided into bursting and nonbursting cell 
types, depending on their firing pattern. Bursting cells produce a burst of 3-5 action 
potentials on top of a slow depolarizing envelope (Wong and Prince, 1978, 1981; 
Masukawa et al., 1982; Bilkey and Schwartzkroin, 1990). The percentage of 
nonbursting cells we observed in subfield CA3 in SHAM and ALD animals ( 41 % -
42%) is similar to the values reported for naive animals (40% - 41%) (Masukawa et 
al., 1982; Bilkey and Schwartzkroin, 1990). ADX produced the largest shift in the 
percentage of nonbursting cells, increasing the amount of nonbursting cells to 74%. 
The effect of corticosteroids on the ratio of burst and nonbursting cells do not 
appear to be secondary to changes in cell viability. The cell resting membrane 
potential, resistance, and time constant were not altered by corticosterone treatment, 
and were comparable to those reported in naive animals (Beck et al., 1992). 
Adrenalectomy has been reported to induce granule cell degeneration in the 
dentate gyrus. While the most severe cell loss occurs between 4 or more months after 
adrenalectomy (Sloviter et al., 1989; 1993; Roy et al., 1990; McNeil et al., 1991; 
Sapolsky et al., 1991; Jaarsma et al., 1992), granule cell degeneration was also 
reported to occur between 1 to 3 weeks after adrenalectomy (Gould et al., 1990; 
Sloviter et al., 1993). Granule cells form synapses with subfield CA3 pyramidal cells 
and the loss of granule cells induced by adrenalectomy may account for the large shift 
in the percentage of nonbursting cells. However, there is no evidence to support that 
the degenerating granule neurons are altering the physiological or biochemical 
properties of CA3 pyramidal cells. 
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Based on several lines of evidence it is unlikely that the large shift in percentage on 
nonbursting cells observed with ADX treatment is due to the loss of dentate granule 
cells. First, Sloviter et al. (1993, 1995) report a large variation in granule cell 
degeneration at any given time point and the percentage of degenerating granule cells 
following 14 days of adrenalectomy was not reported. The large variation in 
degenerating granule cells may have a significant effect on the results if only a small 
number of animals were used. However, we examined the effects of ADX in twenty 
rats, a sample size comparable if not greater then that used by Sloviter et al., (1993). 
Second, it is unlikely that the massive loss of granule cells only influenced the firing 
pattern and action potential duration of CA3 neurons. Such a huge loss in synaptic 
inputs should attenuate numerous electrical membrane properties. Finally, it was 
reported that within one week of adrenalectomy both cell loss and mitosis was induced 
(Cameron and Gould, 1996), therefore, the overall synaptic integrity between the 
dentate and subfield CA3 may not altered with adrenalectomy. While the loss of 
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granule cells following 14 days of adrenalectomy is important and may have a 
significant effect on neuronal signaling between the dentate and subfield CA3, it does 
not readily explain or diminish the significance of the large difference in the percentage 
of nonburstings cells observed in ADX treated animals. 
A possible explanation for the increased number of nonbursting cells is that 
corticosteroids modulate the ionic current that influences the bursting firing mode. The 
exact nature of burst firing is not known. Early investigations reported that burst firing 
is due to a slow Ca2+ current (Wong and Prince, 1978, 1981 ), however, there is also 
evidence supporting the role ofNa+ current in burst firing, possibly a persistent Na+ 
current (Konnerth et al., 1986; French et al., 1990; Azouz et al., 1996; Jensen et al., 
1996). The ionic conductances underlying pyramidal cell burst firing may be different 
across hippocampal subfields (Azouz et al., 1996; Jensen et al., 1996). Burst firing in 
subfield CA3 may depend on both Na+ and Ca2+ currents (Wong and Prince, 1978, 
1981; Konnerth et al., 1986), whereas, burst firing in subfield CAI cells depend upon 
Na+ currents only (Azouz et al., 1996; Jensen et al., 1996). Since corticosterone 
treatment influences burst firing in subfield CA3 neurons, it may be possible to 
determine the exact ion currents and channels underlying burst firing in subfield CA3 
cells by comparing the isolated ion currents in cells from adrenalectomized and 
corticosterone treated animals. 
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The effects of corticosteroids on isolated Ca2+ and Na+ currents in subfield CA3 
are not known. The action of corticosteroids on Ca2+ currents in subfield CAI have 
been determined but the results are not straight forward. Adrenalectomy decreased the 
Ca2+ action potential area (Kerr et al., I 989; I 992) but increased Ca2+ currents (Karst 
and Joels, I994). Corticosteroids also modulate Ca2+ homeostasis (Elliott and 
Sapolsky, I993), which in turn, may influence the Ca2+ driving potential and/or ion 
channels. Other factors contribute to burst and nonburst firing and include the relative 
densities and distribution of Ca2+ -independent K+ channels along a neuron (Migliore et 
al., I995) and neuron morphology (Bilkey and Schwartzkroin, I990). 
Passive Membrane and Action Potential Properties 
The membrane input resistance and time constant are determined by passive and 
voltage-dependent ion channels that normally function near the cell's resting membrane 
potential (Rall, I 977). The membrane input resistance and time constant determine the 
decay of synaptic potentials in the dendrites and soma, therefore, influencing the 
integration of postsynaptic potentials (Rall, I 977). Corticosteroids did not alter the 
resting membrane potential, input resistance, or time constant in subfield CA3 
pyramidal neurons. In contrast, the membrane input resistance and time constant in 
subfield CAI pyramidal cells are altered by corticosteroids. The changes in CAI cells 
may be due to alterations in IQ (Karst et al., I993; Beck et al., I994), which is less 
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prominent in CA3 cells (Spruston and Johnston I 992). Therefore, corticosteroids may 
alter the integration of postsynaptic potentials in CAI but not in CA3 cells. 
The decrease in action potential half- and baseline width in cells from ALD and 
HCT animals suggest that corticosteroids may play a role in the shaping of action 
potentials. Furthermore, corticosteroids appear to have different effects on action 
potential characteristics in cells from subfields CAI and CA3. Chronic low (basal) 
levels of corticosterone increased action potential height and duration in pyramidal cells 
from subfield CAI and decreased the fAHP amplitude (Beck et al., I994) when 
compared to cells from adrenalectomized animals. In the present study we observed a 
decrease in the action potential duration and no change in the action potential height 
and fAHP amplitude in cells from ALD animals when compared to ADX. 
The broader action potential duration in cells from SHAM and ADX animals may 
be physiologically important. Wheeler et al., (I 996) reported that increasing the action 
potential duration leads to an increase in Ca2+ influx at the presynaptic terminal and 
enhances synaptic strength. Therefore, MR activation could conceivably have different 
effects on Ca2+ influx at the axon terminals arising from subfields CAI and CA3. The 
narrowing of action potentials may result from changes in any of the K+ and Ca2+ ion 
currents which shape the action potential (Rutecki, I 992). Further experiments are 
required to determine which current( s) are altered by corticosteroids. 
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sAHP and Accommodation 
The sAHP and accommodation characteristics in cells from subfield CAI were the 
first electrophysiological membrane characteristics identified that were altered by 
corticosteroids (Joels and de Kloet, I989; Kerr et al., I989; Joels and de Kloet, I990). 
Both of these properties rely on a Ca2+ -dependent K+ current (Madison and Nicoll, 
I984; Lancaster and Nicoll, I987). In subfield CAI, short term and chronic MR 
activation decreased spike accommodation and sAHP amplitude (Kerr et al., I989; 
Joels and de Kloet, I990; Beck et al., I994). 
Unlike the cells in subfield CAI, corticosteroids did not alter the sAHP or 
accommodation in subfield CA3 neurons. This is an interesting result because both the 
sAHP and burst firing are triggered by Ca2+ currents (Wong and Prince, I 978, I 98 I; 
Schwartzkroin and Stafstrom, I 980; Konnerth et al., I 986; Sah and Isaacson, I 995), 
yet corticosteroids only appear to alter the cell's firing mode. The relationship between 
burst firing and sAHPs is not well known. There are several lines of evidence 
suggesting that burst firing and sAHP may be independent properties. The channels 
underlying burst firing and sAHP's may be located in different areas of the neurons 
(soma versus dendrites) (Wong et al. I979; Bernardo et al., I982; Wong and Stewart et 
al., I992; Sah and Bekkers, I996). In subfield CAI, the ionic currents mediating the 
sAHP and burst firing appear to be separate (Azouz et al., I996). Finally, in subfield 
CA3, both Na+ and Ca2+ currents influence burst firing (Wong and Prince, I978, I98I; 
Konnerth et al., 1986). Under our experimental conditions, it was not possible to 
determine the nature of the current( s) that shifted the fraction of nonbursting and 
bursting cells. 
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In conclusion, corticosteroids have numerous effects on neurons located in the 
hippocampus. Corticosteroids modulate neuron electropysiological properties (Beck et 
al., 1994; Joels and de Kloet, 1994; Joels et al., 1994a, 1994b), morphology (Woolley 
et al., 1990; Gould et al., 1991; Watanabe et al., 1992; Magarinos and McEwen, 1995a, 
I 995b) and neurotransmitter receptor-mediated responses in the hippocampus (Joels 
and de Kloet, 1994; Birnstiel and Beck, 1995; Beck et al., 1996). Corticosteroids may 
alter signal processing in the hippocampus through a complex mechanism, producing 
different effects in each area of the trisynaptic circuitry (dentate-CA3-CAI). For 
example, corticosteroids selectively alter dendritic morphology within subfield CA3 
(Woolley et al., 1990; Watanabe et al., 1992; Magarinos and McEwen, 1995a,b). 
Corticosteroids also have different effects on the neuron's electrophysiological 
properties in subfields CAI and CA3. This distinct role of corticosteroid modulatory 
actions among the different hippocampal subfields may be very important in signal 
processing in the hippocampus. 
CHAPTER IV 
CORTICOSTEROIDS ALTER 5-HT1A SIGNAL 
TRANSDUCTION SYSTEM IN HIPPOCAMP AL 
SUBFIELD CA3 PYRAMIDAL CELLS 
Abstract 
Corticosteroids influence neuron activity in the hippocampus through the 
activation of MR and GR receptors. For example, corticosteroids modulate the 
responses elicited by the activation of several different neurotransmitter receptors on 
hippocampal pyramidal cells. However, the effects of corticosteroids on the 5-HT iA 
receptor signal transduction system (receptor-G protein-potassium channel) in subfield 
CA3 are not completely known. Therefore, we used single-electrode voltage clamp 
techniques to examine the actions of chronic corticosteroid treatment on the 5-HT lA 
signal transduction system in rat hippocampal subfield CA3 pyramidal cells. The 
treatment groups used in this investigation were: ADX, ALD, HCT, and SHAM. 
Corticosteroids altered the 5-HT concentration-response curve characteristics for 
the 5-HTiA receptor. The ECso value was smaller in cells from ADX compared to the 
other treatment groups. The Emax value was smaller in cells from HCT compared to 
SHAM and ADX animals. G protein function was also altered by corticosterone 
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treatment. Less current was elicited by GTPyS in cells from HCT compared to the 
other treatment groups and in cells from SHAM compared to ADX animals. 
Corticosteroid treatment did not alter the current-voltage relationship or the reversal 
potential of the potassium current linked to the 5-HTIA receptor. Based on these new 
findings we conclude that corticosteroids alter the 5-HT IA receptor mediated-response 
in hippocampal subfield CA3 neurons. Furthermore, corticosteroids alter the 5-HT IA 
signal transduction system at site(s) downstream of the receptor. 
Introduction 
Activation of corticosteroid receptors in the hippocampus influences hippocampus-
related behaviors (de Kloet et al., 1993) and modulates HPA axis activity (Jacobson 
and Sapolsky, 1991 ). Corticosteroid hormones (glucocorticoids and mineralo-
corticoids) regulate gene expression through the interaction with two receptor 
subtypes: MR and GR (Joels et al., l 994b ). MR and GR have a 5-10 fold difference in 
their affinity for the rat corticosteroid hormone corticosterone. MR has a high affinity 
for corticosterone and is 70-80% occupied at basal corticosterone plasma levels 
(Krozowski and Funder, 1983; Reul and de Kloet, 1985; Reul et al., 1987a,b). GR has 
a lower affinity for corticosterone and its occupancy changes from 15% at basal to 90% 
at peak circadian or stress-induced circulating corticosterone levels (Reul and de 
Kloet, 1985; Reul et al., 1987a,b). 
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One way corticosteroids alter neural activity in the hippocampus is by modulating 
the responses elicited by the activation of neurotransmitter receptors (Joels and de 
Kloet, I 994; McEwen, I 996), including the 5-HT tA receptor (Joels and de Kloet, I 994; 
Beck et al., I 996). The 5-HT tA receptor is a G protein-coupled receptor. Activation 
of the 5-HT tA receptor in the hippocampus increases an inward rectifying potassium 
current linked to a PTX sensitive G protein (Andrade et al., I986; Andrade and Nicoll, 
I987; Colino and Halliwell, I987; Beck I989; Beck and Choi, I99I; Okuhara and 
Beck, I 994). Corticosteroids alter the 5-HT tA receptor-mediated responses in 
hippocampal subfield CAI (Joels et al., I99I, Joels and de Kloet, I992; Beck et al., 
I996). However, the effects of corticosteroids on the 5-HT1A receptor-mediated 
responses in subfield CA3 are not known. 
Previous studies have examined the effects of corticosteroids on the number of 5-
HT tA binding sites and mRNA levels (Chaouloff, I 995). Corticosteroids appear to 
alter 5-HT tA receptor binding sites in subfield CA3, but not in subfield CAI 
(Mendelson and McEwen, I992a,b; Kuroda et al., I994). Recently, we reported that 
chronic exposure to high levels of corticosteroids increased the protein levels of Gs, 
Giland 2, and Go a-subunits in the hippocampus (Okuhara et al., I996a). However, the 
actions of corticosteroids on G protein function in the individual hippocampal subfields 
and on G protein-evoked currents are not known. 
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In the present study, we examined the effects of chronic corticosteroid treatment 
on different components of the 5-HT lA signal transduction system in hippocampal 
subfield CA3 pyramidal cells. Single-electrode voltage clamp techniques were used in 
the brain slice preparation. We hypothesized that chronic corticosteroid treatment 
would alter the 5-HT lA receptor signal transduction system in subfield CA3. The 
results from these experiments will contribute to a basic understanding of how 
corticosteroids alter responses elicited by the activation of G protein-linked 
neurotransmitter receptors and help to elucidate the role of corticosteroids in 
hippocampus-related behaviors and HP A axis feedback. 
Materials and Methods 
Materials 
Corticosterone pellets were purchased from Innovative Research of America 
(Sarasota,1FL). Aldosterone was purchased from Steraloids Inc. (Wilton, NH). 
Osmotic minipumps were purchased from Alza Cooperation (Palo Alto, CA). 
Tetrodotoxin and 5-HT hydrochloride were purchased from Sigma Chemicals (St. 
Louis, MO). GTPyS was purchased from Boerhinger Mannheim (Indianapolis, IN). 
All other chemicals were obtained from standard commercial sources. 
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Animals 
Four different treatment groups were used for the experiments in this investigation 
(Table 1, pg. 64). The adrenalectomy was performed as described previously (Beck et 
al. 1994, 1996; Bimstiel and Beck, 1995). Male Sprague-Dawley rats (Harlan) 75-
1 OOg were used for all treatment groups. Bilateral adrenalectomies were performed on 
all treatment groups, except the SHAM group, to remove circulating corticosteroids. 
The animal was anesthetized with ether, a small incision was made into the abdominal 
cavity, just below the rib cage, and the adrenal glands carefully removed. The muscle 
wall was then sutured and the skin closed using wound clips. The ADX group received 
no further treatment. The ALD group had an osmotic minipump containing 
aldosterone (Alzet model 2002), implanted subcutaneoulsy at the time of 
adrenalectomy, to selectively activate l\1R. The minipump delivered 10 µg/h 
aldosterone dissolved in propylene glycol. l\1R and GR were activated in another 
group of animals (HCT) by subcutaneously implanting 200-300 mg corticosterone 
pellets, 2 to 3 week release, in the back of the neck at the time of adrenalectomy. The 
SHAM group of animals was produced by visualizing the adrenal glands but leaving 
them intact. After surgery the animals were maintained on a standard twelve hour 
light/dark cycle and rat chow, ad libitum. SHAM animals were given standard drinking 
water while the ADX, ALD, and HCT animals were given 0.9 % NaCl drinking water 
ad libitum. At the end of 13 - 15 days, the animals were sacrificed in the morning and 
hippocampal slices immediately prepared for electrophysiological recording. At the 
time of sacrifice, trunk blood was collected to determine the plasma corticosterone 
levels by radioimmune assay (Burgess and Handa, 1992). 
Hippocampal Slice Preparation 
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Hippocampal slices were prepared for electrophysiological recording as previously 
described (Okuhara and Beck, 1994). Rats were sacrificed by decapitation and the 
brain rapidly removed and placed in ice cold artificial cerebrospinal fluid (ACSF) 
containing in mM: NaCl 125, KCl 3, NaH2P04 1.25, MgS04 2, CaCli 2.5, dextroselO, 
and NaHC03 28. The ACSF was also supplemented with steroids, as outlined in 
Table 1 (pg. 64), to maintain the treatment paradigm. We previously reported that 
steroids must be present in the ACSF to preserve the corticosteroid-induced effects on 
neuron cell properties (Beck et al., 1994). The hippocampus was dissected free and the 
dorsal section cut in 500 - 550 µm sections on a vibratome. The hippocampal slices 
were then placed in a holding vial containing ACSF bubbled with 95% Oi-5% C02 at 
room temperature. The slices remained in the holding vial for at least one hour after 
dissection before being transferred to the recording chamber. In the recording 
chamber, the slice was stabilized between two nylon nets and continuously perfused 
with ACSF bubbled with 95% Oi-5% C02 at a rate of 2-3 ml/min, at 3 l-32°C. 
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Intracellular Recording 
Intracellular recordings were made as previously described (Okuhara and Beck, 
1994). Electrodes were pulled from borosilicilate capillary tubing on a Brown and 
Flaming electrode puller (Sutter Instruments) to a resistance of 30-35 Mn (2 M KCl). 
Pyramidal cells were impaled with brief ejections of positive current through the 
electrode. The impaled cells were sealed by applying 1 nA hyperpolarizing current. 
Electrical signals were collected and amplified using an Axoclamp 2A and Cyberamp 
320 amplifier (Axon Instruments, Foster City, CA) and recorded on a Gould Series 
3200 chart recorder (Gould Electronics, Valley View, OH). Data were collected on-
line with pCLAMP software (Axon Instruments). 
Discontinuous single-electrode voltage clamp ( dSEVC) technique was used under 
the following conditions. Briefly, the slice was perfused with 1 µM tetrodotoxin and 
the capacitance compensation was set and switching frequency adjusted to 4 kHz at the 
beginning of the experiment. The cells membrane potential was clamped at a gain of 8 
nA/m V and headstage continuously monitored. 
5-HT Concentration-Response 
Cells were voltage clamped at -65 mV and data for the 5-HT concentration 
response curves were collected by perfusing the slice with increasing 5-HT 
concentrations (3, 10, 30, and 100 or 110 µM) and the maximum current response 
evoked during the drug application was recorded. During drug perfusion, if the 
voltage clamp deviated by more than 1 mV, the data was discarded. 
The magnitude of the current response was fitted to a hyperbolic function 
(Okuhara and Beck, 1994; Beck et al., 1996): 
E = Emax I [l+(ECso I [5-HT]t] 
where Eis the current produced at the 5-HT concentration [5-HT], Emax is the 
maximal current response, ECso is the 5-HT concentration which produces half the 
Emax response, and N is the slope index. The fitted Emax , EC5o and N values within 
each experimental group were used for statistical comparisons. 
Experiments with GTPyS 
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The effect of corticosteroids on G protein activity was determined by measuring 
the magnitude of outward current evoked by 15 mM GTPyS which was included in the 
recording electrode. After the cell's membrane potential stabilized, the cell was voltage 
clamped at its resting membrane potential (i.e., the potential where no current was 
required to maintain the voltage clamp). The voltage clamp was then moved to -60 
m V and the amount of current required to maintain the clamp was recorded. 
1-V Relationship 
The effect of corticosteroids on the potassium current linked to the 5-HT IA 
receptor was determined by plotting the I-V curve for the outward current evoked by 
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the activation of the 5-HT1A receptor. After the cell's membrane potential stabilized, 
the cell was voltage clamped at its resting membrane potential (the potential where no 
current was required to maintain the voltage clamp). Data for IV plots were obtained 
by running voltage ramps in the presence and absence of 100 µM 5-HT. Voltage 
ramps were run from approximately-125 mV to -30 mV at a rate of 1 mV/s. The 1-V 
plot for the potassium current evoked by the activation of the 5-HT 1A receptor was 
constructed by subtracting the control ramp values (no 5-HT) from the ramp values in 
the presence of 100 µM 5-HT. The reversal potential and potential where inward 
rectification occurred were analyzed for each curve. 
Statistical Analysis 
Statistical comparisons were performed using analysis of variance (ANOVA). The 
Student-Newman-Keuls method was used for post-hoc tests. All values are reported 
as mean± SEM. A p < 0.05 was considered significant. 
Results 
Corticosterone Plasma Levels 
SHAM corticosterone plasma levels ranged from 0 - 4.13 µg/dl (1.35 ± 0.32 µg/dl, 
n = 15). ADX corticosterone plasma levels ranged from 0 - 0.22 µg/dl (0.06 ± 0.03 
µg/dl, n =12). ALD corticosterone plasma levels ranged from 0 - 0.56 µg/dl (0.07 ± 
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0.05 µg/dl, n = 16). The lower and upper limits of the corticosterone radioimmune 
assay were 0.05 and 50 µg/dl respectively. Adrenalectomies that produced 
corticosterone concentrations_:::: 0.6 µg/dl were considered successful. Two SHAM, 8 
ADX, and 14 ALD animals had corticosterone levels less than 0.05 µg/dl. The 
concentration of aldosterone used in our experiments was based on an investigation by 
Kuroda et al., (1994). The ALD treatment decreased MR binding by 61% (n=5 
animals) in the cytoplasm (data not shown) as determined using a homogenate binding 
assay. HCT plasma concentrations greater than 20 µg/dl were considered successful. 
HCT corticosterone plasma levels ranged from 25 to> 50 µg/dl (34 ± 3 µg/dl, n = 16). 
5-HT Concentration Response Curve Characteristics 
for the 5-HT iA Receptor 
Activation of the 5-HT1A receptor evoked an outward current in a concentration-
dependent manner (Figure 9A). The 5-HT concentration-response curve 
characteristics recorded from cells from corticosterone treated animals are summarized 
in Table 6. The EC5o obtained in cells from ADX treated rats was smaller compared to 
cells from either SHAM, ALD, or HCT treated animals (Figure 9B). The Emax value 
was also smaller in cells from HCT when compared to cells from SHAM or ADX 
treated animals (figure 9B). Corticosterone treatment did not alter the slope index. 
Perfusion ofhippocampal slices with 5-HT may activate a number of different 5-
HT receptor subtypes. Two 5-HT receptors subtypes which may be activated by 5-HT 
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and thereby modulate the 5-HT IA current are the 5-HT 4 and 5-HT 1 receptors. Both of 
these receptors are located in the hippocampus (Lovenberg et al., 1993; Meyerhor et 
al., 1993; Ruat et al., 1993; Jakeman et al., 1994; Roychowdhury et al., 1994; Waeber 
et al., 1994) and are positively coupled to adenylyl cyclase (Lovenberg et al., 1993; 
Ruat et al., 1993; Shen et al., 1993; Tsou et al., 1994). Activation of the 5-HT4 
receptor produces a slow depolarizing response in subfield CAI pyramidal cells 
(Andrade and Chaput, 1991). Since the 5-HT4 and 5-HT1 receptors have not been 
characterized in subfield CA3, we determined if activation of these receptors altered the 
5-HT induced outward current recorded in subfield CA3. The magnitude of the 
outward current elicited by 30 µM 5-HT was not altered by the administration of I µM 
GRI 13808 and ritanserin (n = 6) (Figure 10), 5-HT4 and 5-HT1 receptor antagonists, 
respectively (Boess and Martin, 1994; Torres et al., 1994). Perfusion of the slice with 
30 µM 5-HT while blocking the 5-HT IA receptor with either I µMWAY I 00635 or 
3 µM spiperone did not produce either a depolarizing or inward current response (n=3) 
(data not shown). 
Activation of G proteins with GTPyS 
The injection of GTPyS into neurons produced a hyperpolarization of the resting 
membrane potential. There was no difference in the resting membrane potential 
between treatment groups. The resting membrane potentials were SHAM -76 ± I m V, 
ADX-79 ± 2 mV, ALD -74 ±I mV, and HCT-76 ±I mV. The relative amount of 
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Figure 9. Concentration-dependent response of subfield CA3 pyramidal cells to 
5-HT perfusion. A: Chart recording of the concentration-dependent current response 
of a CA3 cell to 5-HT perfusion. The drug was applied for the duration depicted by 
the line above the chart record. B: Concentration-response curves from data collected 
from all of the cells from SHAM (open circles), ADX (closed circles) and HCT (closed 
squares) treated animals. The data were fit to a hyperbolic function as described in 
MATERIALS AND METHODS in this chapter. 
Table 6.-The effect of corticosteroids on the 5-HT concentration-
response curve characteristics for the 5-HT tA receptor 
Treatment ECso (-log) Emax (pA) N 
SHAM 4.96 ± 0.06 (15) 551±46 (15) 2.0 ± 0.1 (15) 
ADX 5.12 ± 0.04• (18) 540 ± 47 (16) 2.3 ± 0.1 (18) 
ALO 4.96 ± 0.03 (16) 469 ± 39 (15) 2.4 ± 0.2 (16) 
HCT 4.85 ± 0.04 (15) 360 ± 30 (15)b 2.3 ± 0.2 (15) 
All values are reported as mean± SEM (n) 
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a ANOVA F = 11.631; d.f = 3, 60; P < 0.001. Student-Newman-Keuls, ADX different 
from SHAM, ALO, and HCT, p < 0.05. 
b ANOVA F = 4.302; d.f = 3, 60; P < 0.008. Student-Newman-Keuls, HCT different 
from SHAM and ADX, p < 0.05. 
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Figure 10. The outward current elicited by the perfusion of 30 µM 5-HT in the 
presence and absence of 5-HT4 and 5-HT7 receptor antagonists. The outward 
current elicited by the perfusion of30 µM 5-HT in the presence and absence of 1 µM 
of the 5-HT4 and 5-HT7 receptor antagonists GRl 13808 and ritanserin. The drugs 
were applied for the duration depicted by the line above the chart record. The 
magnitude of the outward current evoked by 5-HT was not different (p = 0.141, n = 6, 
paired t-test) in the presence or absence of GR 113 808 and ritanserin. 
current evoked by the activation of G proteins with GTPyS was determined by voltage 
clamping the cell's membrane at its resting potential (when zero current is required to 
maintain the voltage clamp). The voltage clamp was then moved to -60 m V for several 
minutes (Figure llA). The amount of current required to maintain the voltage clamp 
at -60 m V was used as a measure of the amount of current evoked by the activation of 
G proteins with GTPyS. Figure llB summarizes the results of these experiments. 
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Significantly less current was required in cells from HCT when compared to cells from 
SHAM, ADX, and ALD treated animals. The amount of current measured in cells 
from SHAM was also smaller compared to cells from ADX treated animals. 
1-V relationship 
1-V plots for the 5-HT lA evoked potassium current were analyzed in 2 to 3 cells 
from ADX, SHAM and HCT treated animals. Representative 1-V plots in Figure 12A-
C demonstrate that corticosterone does not appear to alter the reversal potential nor 
the inward rectification properties for the potassium current linked to the 5-HT lA 
receptor. The reversal potential was between -97 to -104 m V and rectification started 
at approximately-SO mV. 
Discussion 
The 5-HT1A receptor is a member of the G protein-linked receptor family. In the 
present study, we report the effects of chronic corticosteroid treatment on different 
components of the 5-HT iA signal transduction system in hippocampal subfield CA3 
pyramidal cells using electrophysiological techniques. The EC50 value for the 5-HT 
concentration-response curve was shifted to the left in cells from ADX treated animals 
compared to SHAM, ALD, and HCT. The Emax value was smaller in cells from HCT 
animals compared to ADX and SHAM. The shift in the 5-HT1A response may be due 
to alterations at sites downstream of the 5-HT iA receptor. Therefore, we compared the 
Figure 11. The outward current evoked by GTPyS. A: Chart recording of a cell 
injected with GTPyS. The cell's membrane potential was first voltage clamped at its 
resting potential (-74 mV, I= 0 pA). The clamp was then moved to -60 mV and the 
current recorded (I = 340 pA). Perfusion of 100 µM 5-HT (duration depicted by the 
line above the chart record) did not elicit a current response, indicating all the 
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G proteins linked to 5-HT receptors were activated by GTPyS. B: Summary graph 
depicting the amount of current evoked by GTPyS in cells from corticosterone treated 
animals. Treatment group and number of cells are labeled at the bottom axis. 
ANOVA F = 12.691; d.f = 3, 61; P < 0.001. 
•HCT different from SHAM, ADX, and ALD. Student-Newman-Keuls, p < 0.05, 
# ADX different from SHAM. Student-Newman-Keuls, p < 0.05. 
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Figure 12. 1-V plots of steady-state 5-HT mediated current in corticosteroid 
treated animals. I-V plot of steady-state 5-HT mediated current in a cell from either a 
A: SHAM, B: ADX, or C: HCT treated animal. 
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magnitude of the outward current evoked by the activation ofG proteins with GTPyS. 
Less current was evoked by GTPyS in cells from HCT animals compared to ADX, 
SHAM, and ALD. Furthermore, less current was evoked by GTPyS in cells from 
SHAM compared to ADX animals. Finally, we determined the effects of 
corticosteroids on the I-V relationship of the potassium current elicited by the 
activation of the 5-HT iA receptor. Corticosteroid treatment did not alter the reversal 
potential or inward rectification properties of the potassium current linked to the 
5-HT iA receptor. Based on our results and those previously reported by other 
investigators, we conclude that corticosteroids alter the response elicited by the 
activation of 5-HT iA receptors by modulating the receptor's signal transduction system 
at different sites. 
Alterations in the number of 5-HT1A binding sites may account for some of the 
changes we observed in the 5-HT concentration response curve characteristics. 
Previous investigators reported that adrenalectomy increases the number of 5-HT iA 
receptor binding sites in subfield CA3 when compared to either SHAM, aldosterone, 
low or high corticosterone treated animals (Mendelson and McEwen, 1992a,b; 
Chalmers et al., 1993; Kuroda et al., 1994; Tejani-Butt and Labow, 1994). The 
increased number of 5-HT iA receptor binding sites may account for the shift in ECso, 
with no change in Emax, for the 5-HT concentration-response curve that we observed 
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in cells from ADX compared to SHAM and ALD treated animals. A shift in ECso, with 
no change in Emax, may occur with spare receptors (Stephenson, 1956; Yocca et al., 
1992). 
It is not clear if the smaller Emax in cells from HCT compared to SHAM treated 
animals is due to a decrease in the number of 5-HT 1A binding sites. It has been 
reported that high levels of corticosterone (plasma concentrations > 40 µg/dl) do not 
change the number of 5-HT 1A binding sites in subfield CA3 compared to sham treated 
animals (Mendelson and McEwen, 1992a). However, social and restraint stress does 
decrease the number of 5-HT IA binding sites in the hippocampus (Watanabe et al., 
1993; McKittrick et al., 1995). One possible explanation for the discrepancy is the 
treatment length. Mendelson and McEwen (1992b) treated their animals with a 
corticosterone pellet implant for 7 days. The investigations that examined the effects of 
stress treated their animals for 14 days (Watanabe et al., 1993; McKittrick et al., 
1995). It is possible that exposure to elevated corticosterone plasma levels must 
exceed 7 days before the down regulation of 5-HT 1A binding sites occurs. 
Alternatively, the stress response may be activating other physiological processes, in 
addition to increasing corticosterone plasma levels, that induces the down regulation of 
5-HT 1A binding sites. 
Corticosteroids also alter the 5-HT 1A signal transduction system downstream of 
the receptor. ADX increased while HCT decreased the magnitude of the current 
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evoked by the activation of G proteins with GTPyS. Corticosteroids could be altering 
G protein levels, G protein coupling, or the properties of the channels linked to the 
G proteins. However, the attenuated 5-HT1A mediated-response and G protein-evoked 
current cannot be attributed to a decrease in G protein expression. We observed that 
HCT treatment increased G0 and Gil&2 a-subunit levels in the hippocampus (Okuhara et 
al., 1996a), the PTX-sensitive G proteins thought to be linked to the 5-HT1A receptor 
(Andrade et al., 1986; Okuhara and Beck 1994). Based on our present results, we 
propose that the increased G protein levels may be a compensatory response to a 
decrease in G protein function. 
Interestingly, while corticosterone clearly had an effect on the magnitude of the 
outward current evoked by GTPyS, there was no change in the resting membrane 
potential of pyramidal cells between treatment groups. A simple explanation for this 
observation is the non-liner relationship between voltage and resistance (shunting). 
Shunting accounts for large changes in current with only small changes in membrane 
potential. Therefore, the activation by GTPyS of ion channels with non-linear 1-V 
relationships (i.e., GIRK) could evoke different amounts of current but produce similar 
changes in membrane potential in cells from the different treatment groups. Alterations 
in the 5-HT IA receptor-mediated response and G protein-linked current could be 
attributed to a change in pyramidal cell resting input resistance. However, 
corticosteroid treatment did not alter neuron resting input resistance in subfield CA3 
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pyramidal cells (Okuhara et al., I 996b ). While we were able to detect corticosteroid-
induced changes in the current evoked by the activation of G proteins we do not know 
if corticosterone is altering G protein function or the coupling between the G protein 
and potassium channel. We also do not know which G protein-linked current(s) was 
modulated by corticosterone. 
The potassium channel linked to the 5-HT lA receptor signal transduction system is 
probably a member of the recently cloned G protein inward rectifying potassium 
(GIRK) channel family (Lesage et al., I994, I995; Kobayashi et al., I995; Ponce et al., 
I 996; Spausches et al., I 996). ADX, ALD, and HCT treatment did not alter the 
reversal potential or inward rectification properties of the potassium current linked to 
the activation of the 5-HT1A receptor. However, alterations in potassium channel 
kinetic properties cannot be ruled out. 
ADX had different effects on the 5-HT concentration response curve 
characteristics in cells from subfield CAI and CA3. Previous studies reported that the 
concentration-response curve characteristics for the 5-HT lA mediated hyperpolarization 
in subfield CAI was not altered by adrenalectomy or chronic activation of MR with 
low levels of corticosterone as compared to sham (Joels et al., I99I, Joels and de 
Kloet, I 992; Beck et al., I 996). In the present investigation, ADX shifted the EC50 
value for 5-HT1A mediated outward current compared to SHAM and ALD (chronic 
MR activation). Previously, we reported that the 5-HT iA receptor signal transduction 
system is not identical between subfields CAI and CA3, based on different 5-HT 
concentration-response curve characteristics for the 5-HT iA receptor in the two 
subfields (Beck et al., I992; Okuhara and Beck, I994). Therefore, it is possible that 
corticosteroids have different effects on the 5-HT lA receptor-mediated response in 
subfields CAI and CA3. 
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In conclusion, chronic corticosterone treatment alters the response elicited by the 
activation of 5-HT iA receptors in hippocampal subfield CA3 pyramidal cells. Some of 
the modulatory actions of corticosterone occur downstream of the receptor, at the 
G protein level. Furthermore, ADX and high corticosterone treatment have opposite 
effects on the 5-HT iA signal transduction system. Our results provide important 
information towards understanding how corticosterone modulates neurotransmitter 
receptor-mediated responses in the hippocampus. 
CHAPTER V 
DIFFERENTIAL IMMUNOHISTOCHEMICAL LABELING OF 
Gs, Gil and 2 AND Go a-SUBUNITS IN RAT FOREBRAIN 
Abstract 
In the previous chapter, it was concluded that corticosterone treatment alters the 
5-HT1A receptor signal transduction system at sites downstream of the receptor. The 
5-HT lA receptor couples to a PTX-sensitive G protein, therefore, corticosteroids may 
influence G protein levels and/or their intracellular location. Since a comparative study 
of the anatomical and morphological distribution of the G proteins G0 , Gil and 2, and Gs 
a-subunits in the hippocampus has not been reported, such an investigation was 
conducted using immunohistochemical techniques with rat forebrain sections prepared 
from naive animals. Diffuse G0 labeling occurred in the neuropil throughout the cortex, 
superficial layers of the entorhinal cortex, thalamus, several white matter fiber tracts and 
hippocampus. Gil and 2 immunoreactivity was also located in the neuropil but produced a 
more fibrous pattern. Fibrous labeling of Gi1 and 2 was observed in the cortex, amygdala, 
hippocampal subfield CA3 and several white matter fiber tracts. Both G0 and Gil and 2 
labeling was present in the pencil fibers within the striatum and lateral geniculate nucleus. 
Gs labeling, in contrast to G0 and Gi1 and 2, was generally cytoplasmic. Cytoplasmic 
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Gs labeling was observed in the thalamus, habenula, dentate, geniculate nucleus, 
hypothalamus, and hippocampus. Intense Gs labeling was observed in the striatum 
parenchyma, choroid plexus and infundibular stem. 
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Based on our results, we conclude that the G proteins G0 , Giland 2, and Gs are 
anatomically distributed differently throughout the brain. The diffuse neuropil labeling 
of G0 , fibrous neuropil labeling of Gil and 2 and cytoplasmic labeling of Gs strongly 
suggests that the G proteins are also differentially distributed morphologically within a 
neuron. The differential anatomical and cellular location of G proteins in the CNS may 
contribute to the coupling specificity between neurotransmitter receptors and G proteins. 
Introduction 
Heterotrimeric G proteins transpose extracellular signals into a cell by coupling 
plasma membrane receptors with effector molecules. G proteins are composed of three 
subunits: a, f3, and y. The a-subunit binds and hydrolyzes GTP and modulates effector 
molecule activity (Gilman, 1987). There are several subtypes of G proteins based on 
the sequence of their a-subunits. Four of these are Gi, G0 , Gs and G1 (Bimbaumer et al., 
1990). The different G protein a-subunits are differentially sensitive to ADP-
ribosylation by several toxins. The G proteins Gi and G0 are ADP ribosylated by PTX 
while Gs is sensitive to cholera toxin (Gilman, 1987). The f3y subunits anchor the 
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G protein complex to the cytoplasmic membrane and also modulate the activity of the 
effector molecule (Birnbaumer et al., 1990). 
The effector molecules are either ion channels or proteins that synthesize second 
messenger molecules (i.e., cyclic AMP or inositol triphosphate), which in turn, modulate 
enzyme activity in the cell (reviewed by Birnbaumer et al., 1990; Clapham, 1994). For 
example, Gs increases adenylyl cyclase activity and modulates Ca2+ activated-potassium 
channels, Gi decreases adenylyl cyclase activity and activates potassium channels while 
G0 decreases the current linked to Ca2+ channels in the central nervous system. 
Current research has focused on elucidating the specificity between receptor and 
G protein coupling. A cursory examination indicates that a cell may express more types 
of receptors than G proteins and that these multiple receptor subtypes can share the same 
G protein (Birnbaumer, 1992). The specificity of receptor-G protein coupling is 
probably established at several different levels. Factors that contribute to the receptor-
G protein specificity are: amino acid sequences in the different G protein subunits 
(Gilman, 1987; Kleuss et al., 1993), cytoskeletal proteins (Rodbell, 1990; Sarndahl et 
al., 1991), and compartment localization (i.e., golgi and mitochondria) (Ercolani et al., 
1990). The asymmetrical distribution of G proteins within rat enterocytes (Van den 
Berghe et al., 1991) and in the kidney (Stow et al., 1991) suggests that the cellular 
location of G proteins may also contribute to G protein-receptor coupling specificity. 
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In the brain, two other factors also contribute to the coupling specificity between 
receptors and G proteins: the intracellular (i.e., soma and dendrites) and anatomical 
location of the G protein. There is information on the distribution of G proteins in only a 
few brain areas including the cortex (Asano et al., 1987, 1990a,b; Aoki et al., 1992), 
hippocampus (Asano et al., 1990b; Aoki et al., 1992), basal ganglia (Herve et al., 1993), 
cerebellum (Asano et al., 1987, 1990a; Nishida et al., 1991) and olfactory bulb (Asano et 
al., 1990a; Shinohara et al., 1992). In the previous chapter, it was concluded that 
corticosterone treatment alters the 5-HT 1A receptor signal transduction system at sites 
downstream of the receptor. The 5-HT 1A receptor couples to a G protein, therefore, 
corticosteroids may influence G protein levels and/or their intracellular location. Since 
the comparative anatomical and morphological distribution of the G0 , Gi1 and 2, and Gs a-
subunits in the hippocampus are not known, in the present study, we examined the 
anatomical and intracellular distribution of Git and 2, G0 , and Gs a-subunits in the rat 
forebrain using immunohistochemical techniques with rat forebrain sections prepared 
from naive animals. 
Materials and Methods 
Materials 
Primary anti-G protein polyclonal antibodies were purchased from Dupont-New 
England Nuclear (Boston, MA). Monoclonal rabbit peroxidase-antiperoxidase antibody 
was purchased from Cappel (Durham, NC). Picric acid was purchased from Aldrich 
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(Milwaukee, WI). 3,3'-diaminobenzidine tetrachloride (DAB) was purchased from 
Sigma (St. Louis, MO). All other chemicals were obtained from commercial sources. 
Immunohistochemical Procedure 
Four male Sprague-Dawley rats (170-230g) were sacrificed with a lethal injection of 
phenobarbital and perfused with 200 ml PBS (10 mM NaHP04, pH 7.4, and 
150 mM NaCl) via the aorta at 650 ml/hr followed by 250 ml PA fixative 
( 4% paraformaldehyde, 1 % glutaraldehyde, 0.2% picric acid, 2% sucrose, 0.1 M acetate 
buffer, pH 6.0) as described previously (Asano et al., 1990b). After fixation, the brain 
was removed, blocked, and placed in PA for 4-6 hrs. After rinsing and overnight 
incubation in TBS (10 mM Tris, pH 7.6 and 150 mM NaCl) with 10% sucrose, the tissue 
was embedded in paraffin, sectioned at 7 µm, and mounted on microscope slides. 
Immunohistochemistry was performed following protocols described by Sternberger 
et al., (1970). Briefly, tissue sections were blocked with TBS/5% bovine serum albumin 
(BSA)/3% normal goat serum (NGS) for one hour at room temperature. After washing 
the sections with TBS, three times for 10 minutes each, they were incubated with 1 :50 
anti-Gsa (RMI}, 1:50 anti-Giat and2 (AS7}, or 1:100 anti-Goa (GC2) overnight at room 
temperature. Several sections were incubated with 2% NGS in place of primary 
antibody to determine the level of nonspecific labeling. Sections were then washed with 
TBS, three times for 10 minutes each, and incubated with 1 :20 goat anti-rabbit lgG. 
After one hour, sections were washed with TBS and incubated with rabbit peroxidase-
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antiperoxidase for one hour. Subsequently, the sections were washed in TBS and 
developed with hydrogen peroxide and DAB as the chromagen. All antibody dilutions 
were made in TBS/5% BSA/3% NGS. 
Silver Intensification 
Selected DAB developed sections were intensified with silver as described by Kitt et 
al., (1994). All reagents used for intensification were freshly prepared. Briefly, after 
developing the sections with DAB and hydrogen peroxide, sections were dehydrated and 
rehydrated through a graded series of deionized water, alcohol, and xylenes. Sections 
were then placed in a 2.5% silver nitrate solution for 1 hour at 56°C. After washing in 
deionized water for 10-15 min, the sections were incubated in 2% gold chloride solution 
for 10 min at room temperature. Sections were then rinsed in deionized water for 5 min 
and incubated in a 5% sodium thiosulfate solution for 5 min at room temperature. 
Sections were washed for I 0 min in deionized water and immediately dehydrated 
through a series of graded alcohols and xylenes. 
Western Blot Analysis 
Western blots were performed on membrane protein preparations from the 
hippocampus as described elsewhere (Sternweis and Robinshaw, 1984). Protein 
isolation procedures were carried out at 4°C. The hippocampus was homogenized with 
a hand-held dounce homogenizer in TBS, 10% sucrose, and 0.5 mM phenylmethan-
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sulfonyl fluoride. The homogenate was then centrifuged at 20,000 X g for 30 min. The 
supernatant was removed and the membrane pellet resuspended in a second identical 
wash and centrifuged again at 20,000 X g for 30 min. The supernatant was discarded 
and the membrane pellet resuspended in TBS, I mM EDT A and I% sodium cholate and 
incubated for 60 min. with constant mixing. The soluble membrane protein was 
collected by centrifugation at 35,000 rpm for 60 min. and stored at -80 °C. 
Western blotting techniques used are described elsewhere (Lesch and Manji, 1992). 
Membrane proteins were resolved by SDS-P AGE and electrophoretically transferred to 
nitrocellulose membrane filters. After transfer, the nitrocellulose was blocked with TBS, 
0.2% NP-40, and 5% nonfat dry milk at room temperature. After blocking for 60 min. 
the nitrocellulose was incubated with a 1/10,000 dilution of AS7, RMI, or GC2 
overnight at 4°C. The nitrocellulose was then incubated with a 1/10,000 dilution of goat 
anti-rabbit IgG for 60 min. at room temperature followed by an incubation with 1/10,000 
dilution of rabbit PAP. The blots were developed with the ECL detection kit 
(Amersham, Arlington Heights, IL) and exposed to x-ray film. All antibody dilutions 
were in TBS, 5% BSA, and 0.2% NP-40. The nitrocellulose filter was washed with 
TBS/0.2% NP-40 between every antibody incubation and prior to development with the 
ECL kit. 
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Results 
W estem blot analysis 
The RMI antibody consistently labeled a 45 kDa protein band in the Western blots 
(Figure 13) corresponding to the short form of Gs (Bray et al., 1986; Robinshaw et al., 
1986; Kozasa et al., 1988). A 54 kDa band (long form of Gs) was also detected but its 
detection was not consistent (data not shown). When the band was detected, it was faint 
and indistinct. The AS7 and GC2 antibodies labeled a single 40 kDa band (Figure 13) 
corresponding to the appropriate size for Gi1 and 2 and G0 respectively (Goldsmith et al., 
1987; Cooper et al., 1990). 
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Figure 13. Western blot of G proteins in the rat hippocampus. 
Lane 1 : Gs (RM 1 antibody). Lane 2: Gil and 2 (AS 7 antibody). Lane 3: Go ( GC2 
antibody). 
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Immunohistochemical Techniques 
The immunohistochemical labeling with the primary antibodies described in this 
investigation is very sensitive to variations in labeling and tissue preparation protocols. 
For instance, we found that the inclusion of0.05% NP-40 detergent decreased Gs and 
Gil and 2 labeling throughout the entire brain and the exclusion ofBSA from the blocking 
solution increased nonspecific Gs labeling. The fibrous neuropil staining pattern observed 
with Gil and 2 in paraffin embedded tissue was distorted in cryostat cut sections. Tissue 
prepared with a paraformaldehyde-lysine-periodate (PLP) fixative produced less intense 
but similar antibody labeling patterns as the picric acid fixed tissue. In the present study, 
the tissue preparation and immunohistochemical protocols were maximized and identical 
for all three antibodies. Silver intensification and dark field microscopy were used to 
increase visualization of the specific staining in selected sections. 
In control sections (2% NGS in place of primary antibody), nonspecific labeling was 
faint under normal light microscopy. Under dark field, a low level of nonspecific labeling 
was detected in some white matter fiber tracts, cortical cell bodies and hippocampal 
pyramidal cell bodies (data not shown). Serial dilutions of the primary antibody 
decreased the intensity of labeling. The differential labeling by the three antibodies used 
in this study also demonstrates the specificity of antibody binding. 
The technical data sheets supplied by Du Pont NEN also provided information on 
the specificity of the three antibodies. The GiaI and 2 antibody, AS7, is specific for only 
Gial and 2 . The Gsa antibody, RMI, cross reacts with Golf· The G0 antibody, GC2, is 
specific for Goa. 
Cortex 
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We observed G0 and Gi1 and 2 immunoreactivity in the neuropil of the rat cortex but 
with different labeling patterns. G0 immunoreactivity was very intense and diffuse. 
Gil and 2 immunoreactivity was very fibrous and less intense than G0 • Diffuse G0 labeling 
was observed in the neuropil throughout the entire cortex while neuronal cell bodies 
were not labeled. The immunoreactivity in the molecular layer (layer I) of the cortex 
was more intense than layers II-VI. The pyramidal cell bodies and dendritic processes in 
layer V were immunonegative and stood out against the positive neuropil (Figure 14A). 
Gi1 and 2 labeling in the cortex, and throughout the forebrain, was characterized by a 
fibrous pattern in the neuropil. The antibody also labeled individual fibers extending 
from the external capsule into the deep cortical layers V and VI (Figure 14B). The G0 
or Gs antibody labeled the neuropil in a diffuse pattern and fiber labeling was not 
observed. In the entorhinal cortex, the superficial layers adjacent to the cortical 
amygdala and piriform cortex were also strongly immunopositive for Gi and G0 , 
however, we were not able to distinguish the different nuclei in the amygdala. 
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Figure 14. Photographs of G protein labeling in the cortex. 
A: G0 labeling in the superficial cortical layers. Immunolabeling was located in the 
neuropil, while the neuronal cell body (large arrow) and processes (small arrow) were 
immunonegative. Note the intense labeling of G0 in layer I of the cortex (located near 
the top of photomicrograph). X200. B: Gi1 and 2 labeling (intensified with silver) in the 
deep cortical layers adjacent to the external capsule (ec). Fibers arising from the external 
capsule (arrow) were intensely stained. X200. C: Cytoplasmic Gs labeling in a cell 
(arrow) located in the lateral middle cortical layers. X200. Insert: The same neuron 
(arrow) viewed at X300. 
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Gs labeling in the cortex displayed a generally light diffuse neuropil staining. However, 
in a few sections, cytoplasmic staining was present in cortical cells (Figure 14C). In the 
entorhinal cortex, the G8 antibody labeled the neuropil in a diffuse pattern. The Gs 
antibody did not label neuronal cell bodies in the entorhinal cortex. 
Hippocampus 
G protein immunoreactivity in the hippocampus was different for all three 
antibodies. In subfield CAI, G0 and Gi1 and 2 labeling were detected in the neuropil while 
the pyramidal cell bodies were immunonegative (Figure 15A,C). G0 staining was more 
intense than Gil and 2 and dendritic processes were often distinguished against the heavily 
stained neuropil. Gs immunoreactivity was also detected in subfield CAI but as a thin 
cytoplasmic ring near the perimeter of the pyramidal cells (Figure 15E). G0 labeling in 
subfield CA3 was similar to subfield CAI (Figure 15B). Gil and 2 and Gs labeling in 
subfield CA3 was different from the patterns observed in subfield CAI. Gi1 and 2-like 
immunoreactivity was detected as fibrous patches surrounding the pyramidal cells in 
subfield CA3 (Figure 15D). Gs immunoreactivity in subfield CA3 was found throughout 
the entire neuronal cytoplasm (Figure 15F). Intense G0 and Gi1 and 2-like 
immunoreactivity was also detected in the fimbria. 
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Figure 15. Photographs of G protein labeling in the hippocampus. 
The labeling ofG proteins in the hippocampal subfields CAI (A,C,E) and CA3 (B,D,F). 
The radiata (Rad), orien (Or), and pyramidal striata (Py) in subfield CAI (Panel A) and 
CA3 (Panel B) are indicated. All photomicrographs are at X200. A: G0 labeling in 
hippocampal subfield CAI. Location of the alveus (alv) is marked by an arrow. 
Arrowheads point to immunonegative dendrites. B: G0 labeling in subfield CA3 . The 
diffuse labeling makes it difficult to delineate the different striata. Location of the 
fimbria (fi) is marked by an arrow. C: Gi1 and 2 labeling (intensified with silver) in subfield 
CAI. alv, alveus. D: Gi1 and 2 labeling (intensified with silver) in subfield CA3 . A fibrous 
patch ofGi1 and 2 labeling (small arrow) surrounding a pyramidal cell (hallow circle). 
Location of the fimbria (fi) is marked by the larger arrow. E: Gs labeling in the perimeter 
(arrowhead) of subfield CAI pyramidal cells. alv, alveus. F: Cytoplasmic labeling of Gs 
in a pyramidal cell (arrowhead) located in subfield CA3. fi, fimbria. 
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Subcortical Nuclei 
The three antibodies produced different labeling patterns in several subcortical 
nuclei. Generally, the G0 antibody labeled the neuropil in a diffuse pattern; Gil and 2 
immunoreactivity was also detected in the neuropil but produced a fibrous pattern; and 
Gs staining was located in the cytoplasm. 
G protein labeling with all three antibodies in the striatum appears as irregular 
patches surrounding immunonegative cell bodies. Intense G0 and Gil and 2 -like 
immunoreactivity was detected in the white matter pencil fibers of the striatum and a 
much lighter label in the parenchyma (Figure 16A). In contrast, Gs staining was absent 
from the pencil fibers but diffusely present within the striatum parenchyma and not 
detected in the cell cytoplasm (Figure 16B). In the habenula, G0 and Gil and 2 
immunoreactivity was located in the neuropil (Figure 16C) while Gs immunoreactivity 
was localized to the cell cytoplasm (Figure 16D). 
G protein labeling in the thalamus also produced different immunoreactive patterns. 
Intense G0 and Gil and 2 -like immunoreactivity was located in the neuropil of the ventral 
posterior thalamic nuclei {VPT) (Figure 17 A). G0 and Gil and 2 immunopositive 
myelinated fibers were also detected in the VPT. These fibers probably arise from the 
medial lemniscus and internal capsule. Moderate G0 and Gil and 2 -like immunoreactivity 
was detected throughout the lateral thalamic posterior nuclei (LP), and dorsal and 
ventral lateral geniculate nuclei (DLG, VLG). Moderate Gs labeling was detected in the 
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Figure 16. Photographs of G protein labeling in the striatum and habenula. 
A: Gil and 2 labeling (intensified with silver) in the striatal pencil fibers (pf) and 
parenchyma (stm). XIOO. B: Gs labeling in the striatum. pf pencil fibers~ stm, 
parenchyma XlOO. C: G0 labeling in the neuropil of the habenula. Note the 
immunonegative cell bodies (arrowhead). 3v, third ventricle. X25. D: Cytoplasmic Gs 
labeling of a cell (arrowhead) in the habenula. The third ventricle is indicated (3v). X25. 
cytoplasm of cells in the VPT, LP, DLG, VLG nuclei, central medial thalamic nuclei, 
mediodorsal thalamic nuclei, and paraventricular thalamic nuclei. 
Light to moderate G0 and Gil and 2 -like immunoreactivity was observed in the 
hypothalamus and median eminence. Moderate to intense cytoplasmic Gs labeling was 
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detected in the hypothalamic tuberomammillary nucleus, median eminence, and 
infundibular stem (Figure 17B). 
Figure 17. Photographs of G protein labeling in the thalamus, infundibular stem, 
and white matter fiber tracts. A: Gil and 2 labeling (intensified with silver) in the ventral 
posterior thalamus. See figure 18 for orientation. Immunopositive white matter fibers of 
the internal capsule are indicated by a white arrow. X25 . B: Gs labeling in the 
infundibular stem X200. C: Gi1 and 2 labeling (in the mammilothalamic tract (mt) and 
fornix (fx). 3v, third ventricle. X25. 
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Fiber Tracts and Choroid Plexus 
In general, the G0 and Gil and 2 -like immunoreactivity was very intense in most of the 
forebrain white matter fiber tracts. The mammilothalamic (Figure 17C), fornix (Figure 
17C), optic tract, medial lemniscus, internal capsule (Figure 17 A), and lateroventral 
aspect of the external capsule were heavily labeled by the G0 and Gi 1 and 2 antibodies. The 
fasciculus retroflexus was the area with the heaviest labeling of Go. Gs -like 
immunoreactivity was not readily found within white matter fiber tracts. In several 
sections, the fornix and mammillothalamic tract were actually lighter than the 
surrounding background (data not shown). The choroid plexus was labeled by all three 
antibodies and was the location of intense Gs staining. Table 7 and Figure 18 highlight 
the G protein labeling patterns. 
Discussion 
We compared the anatomical and intracellular distribution of the G proteins Gs, G0 
and Gil and 2 in the rat forebrain and our results suggest that the a-subunits of Gs, G0 and 
Gi1 and 2 are differentially located both within neurons and among different brain areas. 
G0 was detected in the neuropil throughout all areas of the brain. Cell bodies and 
dendritic processes were often immunonegative. Gi1 and 2 labeling was also located in the 
neuropil but produced a very fibrous pattern throughout many brain areas. Cell bodies 
were immunonegative but the dendritic and axonal processes in certain brain areas were 
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Table 7.--G protein like immunoreactivity in medial rat brain sections 
Brain region Gs Gil aod2 Ga 
Cortex 
layer 1 ++d ++d ++++d 
middle and deep layers +c +++f +++d 
entorhinal cortex +++d +++d +++d 
corpus callosum (cc) ++ ++ 
alveus ( alv) ++++ ++ 
cingulum (cg) ++++ ++ 
Hippocampus 
CAI pyramidal (Py) ++c 
oriens layer (Or) +d ++d +++d 
radiatum (Rad) +d ++d +++d 
CA2-4 pyramidal (Py) +++c +++f 
oriens layer (Or) +d +d ++d 
radiatum (Rad) +d +d ++d 
dentate granular ++d 
Habenula +++c +++f +++d 
Thalamus 
ventral posterior (VPT) ++c +++f +++d 
central medial (CM) ++c +f ++d 
mediodorsal (MD) ++c +f ++d 
para ventricular (Pv) ++c +f ++d 
lateral post (LP) ++c ++f ++d 
dorsal (DLG) and ventral 
(VLG) lateral geniculate ++f +++d 
nucleus 
Hypothalamus 
tuberal nucleus (TMC) ++c +d +d 
dorsomedial (DM) ++c +d +d 
arcuate nucleus (Arc) ++c +d +d 
median eminence (J\1£) ++++ ++ ++ 
infundibular stem (InfS) ++++ ++ ++ 
Striatum parenchyma (stm) +++d +d +d 
pencil fibers (pt) ++++ +++ 
optic tract (opt) ++++ +++ 
Continued next page 
Table 7.-- Continued 
Brain region 
Internal capsule (ic) 
External capsule ( ec) 
mediodorsal 
lateroventral 
Medial lemniscus (ml) 
Fornix (fx) 
Mammilothalamic tract (mt) 
Choroid plexus ( cp) 
Fasiculus retroflexus (fr) 
+ 
+ 
+ 
+ 
++++ 
G;1 and2 
++++ 
+++ 
+++ 
++++ 
++ 
++ 
++to 
+++ 
Ga 
+++ 
+++ 
+++ 
++ 
++ 
++ 
+++ ++to +++ 
++++ 
Direct comparisons are made within a column. Indirect comparisons may be made 
between columns. 
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Key: negative-; light+; moderate,++; intense+++; highest amount of staining,++++. 
d diffuse neuropil 
f fibrous neuropil 
c cytoplasm. 
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Figure 18. Camera lucida of G protein labeling in the subcortex. Cytoplasmic Gs 
labeling is indicated by dots in upper figure while Gil and 2 neuropil and white matter fiber 
tract labeling is indicated by diagonal lines in the lower figure. A star marks the area of 
the photomicrograph in figure 17 A. Abbreviations: ARC, hypothalamic arcuate nucleus; 
CM, thalamic central medial nucleus; DLG, thalamic dorsal lateral geniculate nucleus; 
DM, hypothalamic do~sal medial nucleus; fr, fasiculus retroflexus; fx, fornix; Hb, 
habenula; ic, internal capsule; InfS; infundibular stem; LP, thalamic lateral posterior 
nucleus; :MD, thalamic mediodorsal nucleus; ml, medial lemniscus; mt, mammilothalamic 
tract; optic tract; Pv, thalamic paraventricular nucleus; stm, striatum; TMC, 
hypothalamic tuberal nucleus; VLG, thalamic ventral lateral geniculate nucleus; VPT, 
thalamic ventral posterior nucleus; 3v, third ventricle. 
immunopositive. In contrast to G0 and Gil and 2, Gs was detected primarily in the 
neuronal cytoplasm. 
Cortex 
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In our investigation, the three different antibodies label the cortex with different 
intensities with G0 > Gi1 andl >Gs, consistent with quantitative Western blot studies 
(Saito et al., 1989). The cortex is enriched with neurotransmitter receptors that couple 
to G0 , Gil and 2, or Gs (McCormick, 1992). Our results show that G0 immunoreactivity in 
the cortex is located in the synaptic rich neuropil and is consistent with those reported by 
other investigators (Worley et al., 1986; Asano et al., 1987; Terashima et al., 1988; 
Aoki et al., 1992). Interestingly, we did not observe any G0 labeling within the 
perikarya as described by Aoki et al., (1992) and Jordon (1990). There are a number of 
reasons for the discrepancy concerning the morphological location of G0 • Different 
antibody sources and immunohistochemical protocols were used in previous reports. 
Indeed, Aoki et al., (1992) report that G0 labeling in the perikarya was observed only 
after higher dilutions of the primary antibody were used to decrease the signal in the 
neuropil. 
Our detection of Gi1 and 2 in the neuropil agrees with the observations of Asano et al., 
(l 990b) and Aoki et a!-, (1992). However, we also detected Gi1 and 2 in the fibers arising 
from the external capsule. The Gil and 2 immunoreactivity may be located in a subset of 
cortical fibers since the antibody labeled discrete individual fibers. 
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There is very little information available from previous reports on the morphological 
location of Gs in cortical neurons. The low abundance of Gs in the central nervous 
system and antibody specificity contribute to the difficulty of analyzing the distribution of 
Gs using immunohistochemical techniques. However, we detected Gs in the cytoplasm of 
some cortical neurons. It is unlikely that our observations are due to a cross-reactivity 
with Golf since a previous study reported that the cortex did not contain detectable 
levels of G0 lf protein or mRNA (Herve et al., 1993). 
Hippocampus 
Our results generally agree with earlier investigations which established the location 
ofG proteins in the hippocampus (Worley, et al., 1986; Terashima et al., 1988, 1993; 
Asano et al., l 990b; Aoki et al., 1992). In addition, we also report that the different 
G protein antibodies produced different labeling patterns within the same subfield. The 
differential labeling patterns may represent different synaptic locations for the G proteins. 
The patchy Gil and 2 immunoreactivity concentrated near the perimeter of the pyramidal 
cell body in subfield CA3, suggests that the G proteins are located at terminals near the 
cell soma. A previous report by Aoki et al. (1992) described G0 and Gi1 and 2 
immunoreactivity within neuronal postsynaptic densities, axons, somata, and dendrites 
using electron microscopy. The contrasting locations of G0 (diffuse neuropil) and Gs 
(cytoplasm) is also very interesting. Different locations of the G proteins may reflect 
different synaptic locations but other factors may also contribute to the different labeling 
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patterns. Some of these factors include differences in cell function and G protein 
storage. Our results also extend into subfield CA3 where we observed different 
immunoreactive patterns when compared to subfield CA 1. The different labeling 
patterns maybe due to differences in synaptic locations or differences in cell size or type. 
The hippocampus contains several types of G protein-linked receptors. The 5-HT 1A, 
adenosine, and GABA8 receptors all couple to PTX-sensitive G proteins (i.e., G0 and G) 
(Andrade et al., 1984; Zgombick et al., 1989; Okuhara and Beck, 1994) but it is not 
known if these receptors couple to the same PIX-sensitive G protein. Our results 
suggest that if these receptors are located at different sites on the neuron, they may 
indeed couple to different PIX-sensitive G proteins. 
The different labeling patterns for Gi and G0 in subfields CA 1 and CA3 may provide 
an explanation for the differences in 5-HT concentration-response curves in the two 
subfields. In the hippocampus, 5-HT1A receptor-activation increases an inward rectifying 
potassium current in both subfields CAI (Andrade and Nicoll, I 987; Colino and 
Halliwell, I 987) and CA3 (Okuhara and Beck, I 994). However, 5-HT has a smaller 
maximal response and is more potent in subfield CAI (Beck et al., I 992). One possible 
explanation for this difference is that the 5-HT lA receptor may couple to different 
G proteins in the two subfields. Both the 5-HT lA receptor and G protein appear to be at 
different sites along the neuron in subfields CAI and CA3. The 5-HT lA receptor is 
closer to the cell body in subfield CA3 than in subfield CAI (Pazos and Palacios, I 985). 
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Therefore, based on our observations, the 5-HT lA receptor may couple to Gi in subfield 
CA3 and couple with either Gi or G0 in subfield CAI. 
Striatum 
The presence of all three G protein types in the striatum is not surprising since these 
nuclei contain many different G protein-linked receptors (Graybiel, 1990) along with 
mRNA for Gs and G0 (Brann et al., 1987; Largent et al., 1988). There is very little 
Gi mRNA in the striatum (Aronin and DiFiglia, 1992), suggesting that the Git and 2 
immunoreactivity observed in the parenchyma in our study and in the study by Aronin 
and DiFiglia (1992) is located in the axon terminals. However, based on the detailed 
light and electron microscopic localization of Gi in the different basal ganglia structures 
(Aronin and DiFiglia, 1992) cytoplasmic labeling cannot be ruled out. While the 
immunohistochemical localization of the G proteins in the striatum is not a novel finding, 
there are several differences between our observations and previous reports. The 
G protein labeling pattern in our investigation and others (Worley et al., 1986; Aronin 
and DiFiglia, 1992) does not resemble the patch-matrix distribution often observed in the 
striatum with antibodies against tyrosine hydroxylase or autoradiographic localization of 
µ-opiate receptor binding sites (Gerfen et al., 1987). However, while the detection of 
G0 and Gitand 2 in the striatal pencil fibers is the outstanding feature in our investigation, 
G0 and Gitand 2 labeling in the parenchyma is the outstanding feature in previous reports 
(Worley et al., 1986; Aronin and DiFiglia, 1992). 
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RMI labeling in the striatum is difficult to interpret because this antibody cross-
reacts with Golf· Previous studies with the RMI antibody (Cooper et al., I 990; Drinnan 
et al., I99I) report at least two immunoreactive bands on Western blots prepared with 
tissue from the striatum. One of these bands corresponds to Golf based on 
immunological and mRNA analysis (Drinnan et al., I99I; Herve et al., I993). Our 
observations in the striatum with RMI may reflect G0 lf labeling since our labeling pattern 
resembles the one previously reported for G0 lf (Herve et al., 1993). However, it is clear 
from our results that neither Gs nor Golf is located with the striatal pencil fibers. 
Thalamus 
The homogeneous distribution of G0 throughout the different thalamic nuclei is in 
agreement with a previous study by Worley et al. {1986). However, the fibrous labeling 
pattern of Gii and 2 in the neuropil is a novel finding. The thalamus contains a variety of 
neurotransmitter systems, including G protein-linked receptors, enabling it to function as 
a relay between the cortex and several sensory systems (McCormick, 1992). The 
moderate to intense presence of both Git and 2 and G0 in the ventral posterior thalamic 
nuclei, medial lemniscus, and internal capsule suggest that these G proteins have 
important roles in conveying somatosensory signals. The ventral posterior nuclei relay 
somatosensory information from the dorsal column-medial lemniscal system to the 
somatosensory cortex via the posterior limb of the internal capsule. The geniculate 
nucleus also contains neurotransmitter receptors that link to G proteins (Matute et al., 
130 
1993). The moderate to intense Gitand 2 and G0 immunoreactivity in the optic tract and 
lateral geniculate nuclei suggests that these G proteins may also have important roles in 
conveying visual signals. 
Hypothalamus 
In our study we demonstrate that the G proteins are differentially localized in cells 
of the hypothalamus, median eminence, and arcuate nucleus. Our results are consistent 
with previous mRNA and Western blot analysis detecting G protein expression in the 
hypothalamus (Largent et al., 1988; Viollet et al., 1994). The detection of PTX-
sensitive G proteins Gi and G0 in the median eminence and infundibular stem coincide 
with the presence of 5-HT 1 (Biegon et al., 1982) and melatonin receptors (Vanecek et 
al., 1987; Lopez-Gonzalez et al., 1991), two receptors which couple to PTX-sensitive 
G proteins (Andrade et al., 1986; Reppert et al., 1994). The detection of Gi and G0 
immunoreactivity in the median eminence and infundibular stem suggests that these 
G proteins may be important in the secretions of hormones at these sites. 
The release of growth hormone-releasing hormone and dopamine by the 
parvocellular neurons in the arcuate nucleus is regulated by G protein-linked 
neurotransmitter receptors. For example, growth hormone-releasing hormone and the 
somatostatin receptor have been shown to colocalize within the same neurons in the 
arcuate nucleus (Bertherat et al., 1992; McCarthy et al., 1992). The detection of Gs, 
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Gil and 2, and G0 in the arcuate nucleus supports the observations that G protein-linked 
receptors play a role in hormone secretion in the hypothalamus (reviewed by Renaud et 
al., 1992; Liposits, 1993). 
Very little is known about the function of the tuberomamillary nucleus and the types 
of neurotransmitter receptors located in the nucleus. However, our detection of 
G proteins in the tuberomamillary nucleus suggests that these neurons may contain 
neurotransmitter receptors that link to G proteins and may also help to explain the 
nucleus' role in Alzheimer's disease. The tuberomamillary nucleus projects to the 
cerebral cortex and is ~everely affected in Alzheimer's and Parkinson's disease (Braak 
and Braak, 1992). Furthermore, G protein and neurotransmitter receptor coupling are 
attenuated in cortical tissue isolated from Alzheimer's disease patients (Warpman et al., 
1993; Wang and Friedman, 1994). Therefore, altered coupling between neurotransmitter 
receptors and G proteins in the tuberomamillary nucleus may contribute to some of the 
symptoms observed in patients with Alzheimer's disease. 
Fiber Tracts and Choroid Plexus 
Our novel detection of G proteins within white matter fiber tracts should be 
interpreted cautiously, especially since previous immunohistochemical studies have not 
described the labeling of G proteins in white matter fiber tracts. It is unlikely that our 
detection of G0 and Gi1 and 2 is due to nonspecific labeling since the labeling intensity and 
distribution were different in at least three tracts: the alveus, hippocampal fissure, and the 
dorsomedial and lateroventral aspects of the external capsule. Furthermore, we also 
observed white matter fiber tract labeling using a different immunohistochemical 
protocol utilizing a substantially lower antibody concentration. 
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Since the G proteins are located at axon terminals {Aoki et al., 1992; Aronin and 
DiFiglia, 1992), G protein immunoreactivity within fiber tracts may be due to axonal 
transport of the proteins (Hendry and Crouch, 1991; Crouch et al., 1994). The 
presence of G protein immunoreactivity may also be due to the labeling of G proteins in 
oligodendrocytes. Indeed, neurotransmitter receptors have been detected in glial cells 
(reviewed by Ransom and Sontheimer, 1992; Chiu and Kriegler, 1994). It is clear from 
our investigation and previous reports that the G proteins are located and serve functions 
at sites beyond the synapse. 
All three antibodies labeled the choroid plexus and this was the area of intense G5 
immunoreactivity. Th~ presence of G0 in the choroid was previously described by 
Peraldi et al. {1989) where it was detected at the apical pole of choroidal 
ependymocytes. The distribution of G proteins, Na-K-ATPase (Ernst et al., 1986), 
neurotransmitter receptors (Y agaloff and Hartig, 1985; Conn et al., 1986), and other ion 
channels in the choroid plexus suggests that the function of the choroid may be 
modulated by molecules in the cerebral spinal fluid or neuronal innervation (Peraldi et 
al., 1989). 
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Concluding remarks 
The differential distribution of G proteins and neurotransmitter receptors within 
neurons and in different brain areas may contribute to the coupling specificity between 
the receptors and G proteins. In our investigation, we observed that the G proteins Gs, 
G0 and Gi1 and 2 are distributed differently within the rat forebrain. We also observed 
differences in the intraneuronal labeling patterns between the G proteins. Gs labeling was 
observed in the cytoplasm while G0 and Gi1 and 2 labeling was located in the neuropil. 
G0 and Gi1 and 2 labeling in the neuropil also produced different patterns. G0 labeling was 
diffuse while Gi1 and 2 labeling was fibrous. The differences in G protein labeling patterns 
between brain areas and in neurons suggests that unique synaptic organizations may exist 
between the different brain nuclei. For example, certain brain areas may contain a high 
concentration of dendrodendritic synapses while other areas are characterized by 
dendrosomatic synapses. Unique synaptic organizations may also exist among different 
cell types. The co localization of receptor and G proteins may be different between a 
mossy fiber and pyramidal cell synapse when compared to one between a basket cell and 
pyramidal cell. In order to determine if unique synaptic organizations do exists among 
the different brain areas, the brain nuclei in which differential labeling patterns for the 
G proteins were observed (i.e., hypothalamus, white matter fiber tracts, and habenula) 
should be analyzed, in detail, at the electron microscopic level. 
CHAPTER VI 
CORTICOSTERONE ALTERS G PROTEIN a.-SUBUNIT 
LEVELS IN THE RAT IIlPPOCAMPUS. 
Abstract 
The HP A axis regulates the synthesis and secretion of glucocorticoid steroid 
hormones. The hippocampus, a component of the limbic system, contains the highest 
concentration of corticosteroid receptors in the brain and may play an important role in 
regulating hypothalamic-pituitary-adrenal axis activity and mediating physiological 
responses to stress. In Chapter IV, it was concluded that corticosterone treatment alters 
the 5-HT lA receptor signal transduction system at sites downstream of the receptor. The 
5-HT lA receptor couples to a PTX-sensitive G protein, therefore, corticosteroids may 
influence G protein levels and/or their intracellular location. The glucocorticoid 
corticosterone alters the response elicited by activation of several different G protein-
linked neurotransmitter receptors in the hippocampus. In the present study we used 
Western blot and immunohistochemical techniques to determine the effects of chronic 
adrenalectomy (AD:X), low (CT) and high (HCT) plasma corticosterone concentrations 
on Gs, Gi1 and 2 and Go a.-subunit levels and intracellular location in the rat hippocampus. 
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CT treatment increased Gs a-subunit levels and HCT treatment increased the levels 
of Gs, Gi I and 2 and Go a-subunits when compared to sham as detected on Western blots. 
No change in the intracellular location of the G protein a-subunits was detected using 
immunohistochemistry. Based on our results, we conclude that corticosterone alters 
G protein a-subunit levels in the rat hippocampus without altering their intracellular 
location. These results provide an important piece of information towards understanding 
how glucocorticoids alter G protein-linked neurotransmitter responses. 
Introduction 
Glucocorticoids directly influence protein expression by binding to intracellular 
steroid receptors designated as :MR and GR. In rats, the two corticosteroid receptors 
have different affinities for the glucocorticoid corticosterone (Corini et al., 1985~ Reul 
and de Kloet, 1985). ?:JR binds to corticosterone with a Kn= 0.5 nM. GR has a lower 
affinity for corticosterone with a Kn= 2.5 - 5 nM. The corticosteroid receptors in 
humans and other primates have affinities for corticosterone that are similar to rats 
(Tsuboi et al., 1979; Yu et al., 1981; Brooke et al., 1994). The hippocampus contains 
the highest concentration of corticosteroid receptors in the central nervous system 
(McEwen et al., 1968; Gerlach and McEwen, 1972; Maraginos et al., 1990) 
consequently, the function of corticosteroid receptors in the hippocampus is under 
intense investigation (review by de Kloet et al., 1993; J oels and de Kloet, 1994). 
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Corticosterone alters the response elicited by the activation of several different 
G protein-linked neurotransmitter receptors. For example, in the rat hippocampus, 
corticosterone alters the responses elicited by activation of 5-HT IA receptors linked to 
G/Go (Joels et al., 1991; Joels and de Kloet, 1992; Beck et al., 1996) and 5-HT4 
(Bimsteil and Beck, 1995) and P-adrenergic receptors linked to G1 (Roberts et al., 1984; 
Harrelson et al., 1987; Joels et al., 1989; Gannon and McEwen, 1990). In Chapter IV it 
was concluded that corticosteroids also alter the response elicited by activation of 5-
HT IA receptors in hippocampal subfield CA3. The mechanism by which glucocorticoids 
alter the G protein-linked neurotransmitter receptor responses is not completely known 
and is currently under investigation. Depending on the receptor system, glucocorticoids 
may alter the receptor, G protein, and/or effector molecules. For example, in the rat 
brain glucocorticoids alter dopamine D 1 and D2 (Biron et al., 1992) and serotonin 
5-HT 2c (Holmes et al., l 995a,b) receptor mRNA levels, P-adrenergic receptor binding 
levels (Roberts and Bloom, 1981 ), and 5-HT IA receptor binding and mRNA levels 
(reviewed by Chaouloff, 1995). Glucocorticoids also modulate effector molecule 
function and expression. For example, glucocorticoids alter adenylyl cyclase activity and 
mRNA levels (Gannon et al., 1994; Wolfgang et al., 1995) in the rat hippocampus. 
In addition to the changes in neurotransmitter receptor levels and effector molecule 
activity, glucocorticoids may also alter G protein expression or activity. The regulation 
of G protein levels by ~ucocorticoids has been examined in several tissue types including 
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liver (Kawai and Arinze, 1993), aorta (Haigh et al., 1990), fetal forebrain tissue (Slotkin 
et al., 1994), and vascular smooth muscle (Schelling et al., 1994). However, there is 
little information on the effects of corticosterone on G protein expression and function in 
the hippocampus. In Chapter IV it was concluded that corticosteroids altered the 
outward current evoked by the activation of G proteins with GTPyS. Changes in 
G protein function may reflect changes in protein levels and/or intracellular location, 
altering the interaction between specific receptor-G protein-effector molecule complexes. 
Therefore, in the present study, we used Western blotting and immunohistochemical 
techniques to determine the effects of corticosterone on G protein a-subunit levels and 
distribution in the hippocampus. 
Materials And Methods 
Materials 
Corticosterone pellets were purchased from Innovative Research of America 
(Sarasota, FL). G protein a-subunit polyclonal antibodies RMI (GJ, AS7, (Gi1 and 2), 
and GC2 (G0 ) were purchased from Dupont-New England Nuclear (Wilmington, DE). 
Monoclonal rabbit peroxidase-antiperoxidase antibody was purchased from Cappel 
(Durham, NC). Picric acid was purchased from Aldrich (Milwaukee, WI). 3,3'-
diaminobenzidine tetrachloride (DAB) was purchased from Sigma (St. Louis, MO). All 
other chemicals were obtained from commercial sources. 
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Animals 
Male Sprague-Dawley rats (75-100 g; Harlan) were maintained on a twelve hour 
light-dark cycle (7 a.m. to 7 p.m. light on). Bilateral adrenalectomies (ADX) were 
performed under ether anesthesia. An incision was made just below the rib cage and the 
adrenal gland removed. The muscle wall was then sutured and the skin closed using 
wound clips. To predominately activate MR and mimic basal levels of plasma 
corticosterone, one group of animals (CT) received a subcutaneous 12.5 mg 
corticosterone pellet. To activate both MR and GR, another group of animals (HCT) 
received 300 mg corticosterone pellets subcutaneously. A sham group of animals was 
produced by visualizing the adrenal glands but leaving them intact. Following surgery, 
all animals were given standard laboratory chow ad libitum. SHAM animals were given 
standard drinking water while the ADX, CT, and HCT animals were given 0.9 % NaCl 
drinking water ad /ibitum. All animals were sacrificed 2 weeks after surgery. Sacrifices 
occurred before 12:00 noon and blood samples were collected at that time to determine 
plasma corticosterone levels (Burgess and Handa, 1992). 
Membrane Preparation 
Membrane protei~s were isolated from hippocampal tissue using a procedure 
described elsewhere (Stemweis and Robinshaw, 1984; Okuhara et al., 1996c). Protein 
isolation procedures were carried out at 4°C. Briefly, the animals were decapitated and 
the hippocampus dissected free. The hippocampus was homogenized with a hand-held 
139 
dounce homogenizer in TBS (10 mM Tris, pH 7.6 and 150 mMNaCl), 10% sucrose, 
and 0.5 mM phenylmethansulfonyl fluoride. The homogenate was then centrifuged at 
20,000 X g for 30 min. The supernatant was removed and the membrane pellet was 
resuspended in a second identical wash and centrifuged again at 20,000 X g for 30 min. 
The supernatant was removed and the membrane pellet was resuspended in TBS, 1 mM 
EDT A and 1 % sodium cholate and incubated for 60 min with constant mixing. The 
supernatant containing the soluble membrane protein was separated by centrifugation at 
35,000 rpm for 60 min and stored at -80 °C. 
Western Blot Analysis 
Western blotting techniques used in this investigation are described elsewhere 
(Lesch and Manji, 1992. Briefly, membrane proteins ( 6 µg) were resolved by SD S-
p AGE and electrophoretically transferred to nitrocellulose membrane filters. Equal 
loading of protein samples was verified by staining a parallel polyacrylamide gel with 
Coomassie blue. After transfer, the nitrocellulose was incubated in TBS, 0.2% NP-40, 
and 5% nonfat dry milk at room temperature to block non-specific binding. After 60 
min the nitrocellulose was incubated with a 1/10,000 dilution of AS7, RMI, or GC2 
overnight at 4°C. The nitrocellulose was then incubated with a 1/10,000 dilution of goat 
anti-rabbit IgG for 60 min at room temperature followed by an incubation with 1/10,000 
dilution of rabbit PAP. The blots were developed with the ECL chemiluminiscent 
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detection kit (Amersham, Arlington Heights, IL} and exposed to x-ray film. All antibody 
dilutions were in TBS, 5% BSA, and 0.2% NP-40. The nitrocellulose filter was washed 
with TBS/0.2% NP-40 between every antibody incubation and prior to development 
with the ECL kit. 
The optical density and area of the G protein bands were obtained using the NIH 
Image analysis program. Gray scale density readings were calibrated using a transmission 
step wedge standard fitted to the Rodbard equation. An integrated optical density (IOD) 
was calculated by summing the optical densities within the area of a band. To determine 
the IOD of the G protein bands, the bands were outlined three times and the mean IOD 
was calculated. An area adjacent to the G protein band was used to calculate the 
background optical density of the film and was subtracted from the integrated optical 
density of the G protein band. The linear range of the XAR film was determined by 
including a range ofhippocampal protein (0.5 to 3 fold) in each Western blot. Five 
animals were used for each treatment group. Western blot experiments were repeated 
three times for each antibody. Each blot contained tissue samples from SHAM and 
either ADX, CT, and HCT treated animals, therefore, the IOD values for the ADX, CT, 
and HCT groups were standardized to their respective SHAM values and reported as 
% change from S~ (SHAM= 0%). The results from three Western blot experiments 
were averaged and a two-way analysis of variance was performed using ADX, CT, and 
HCT treatment as one factor and G protein a.-subunit as another factor. The Student-
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Newman-Keuls method was used as the post-hoc test. To compare the effects of ADX, 
CT, or HCT directly to the effects of SHAM treatment, the IOD of the G protein bands 
on each Western blot were compared using a Student's I-test. 
Immunohistochemical Procedure 
The animals were sacrificed with a lethal injection of phenobarbital and perfused 
with 200 ml PBS (IO mM Nal-IP04, pH 7.4, and I50 mM NaCl) via the aorta at 650 
ml/h, followed by 250 ml PA fixative ( 4% paraformaldehyde, I% glutaraldehyde, 0.2% 
picric acid, 2% sucrose, 0.1 M acetate buffer, pH 6.0) as described previously (Asano et 
al., I 990; Okuhara et al., l 996c ). After fixation, the brain was removed, blocked, and 
placed in PA for 4-6 h. After rinsing and overnight incubation in TBS/I 0% sucrose, the 
tissue was embedded in paraffin, sectioned at 7 µm, and mounted on microscope slides. 
Immunohistochemical labeling of Gs and Go a-subunits was performed following 
protocols described by Sternberger et al., (I 970). Briefly, tissue sections were blocked 
with TBS/5% bovine ~rum albumin (BSA)/3% normal goat serum (NGS) for I hour at 
room temperature. After washing the sections with TBS, three times for 10 min each, 
they were incubated with RMI diluted I: 50 or GC2 diluted I: I 00 overnight at room 
temperature. Several ~ctions were incubated with 2% NGS in place of primary 
antibody to determine the level of nonspecific labeling. Sections were then washed with 
TBS, three times for IO min each, and incubated with goat anti-rabbit IgG diluted I:20. 
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After I h, sections were washed with TBS and incubated with rabbit peroxidase-
antiperoxidase for I h. All antibody dilutions were made in TBS/5% BSA/3% NGS. 
Immunohistochemical labeling of Gil and 2 a-subunits was performed with the Vectastain 
Elite kit (Vector Laboratories, Inc., Burlingame, CA). Briefly, after blocking with NGS, 
tissue sections were incubated overnight with AS7 diluted I :400. All sections were 
washed in TBS and developed with hydrogen peroxide and DAB as the chromagen. 
Each immunohistochemistry experiment was repeated once and analyzed 
independently without knowledge of the treatment. The location of the antibody label 
within the dorsal hippocampus was recorded for each slide. Three animals were used for 
each treatment group. 
Results 
Corticosterone Plasma Levels 
The mean plasma corticosterone levels were (mean± SD, n=3): 3.2 ± 4.2 µg/dl for 
SHAM, 0 ± 0 for ADX, 3.1±1.5 for CT, and 25.1±6.4 for HCT. These corticosterone 
levels are comparable to those reported previously by our laboratory (Beck et al., 1994; 
1996; Bimstiel and Beck 1995) and other investigators (Reul and de Kloet, 1985; 
Holmes et al., l 995a). 
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Western Blots 
On Western blots prepared with the membrane fraction from hippocampal tissue, 
antibodies labeled the appropriate size bands (Okuhara et al., 1996c). The RMI 
antibody labeled a 45 kDa and 54 kDa protein (Figure 19A) corresponding to the short 
and long forms of the G1 a-subunit (Bray et al., 1986; Robinshaw et al., 1986; Kozasa et 
al., 1988). Detection of the 54 kDa band was inconsistent. When the band was 
detected, it was a faint and indistinct. The AS7 and GC2 antibodies labeled a 40 kDa 
band (Figure 19A) corresponding to the appropriate size bands for Gi1and2 and G0 
a-subunits respectively (Goldsmith et al., 1987; Cooper et al., 1990). 
The coefficient of variation (standard deviation+ mean) for the SHAM IOD values 
were calculated for each antibody to determine the variability in the control data. The 
mean coefficient of variation (mean± S.E.M, n = 9 for all antibodies) was 0.20 ± 0.05, 
0.15 ± 0.01, and 0.14 * 0.02 for the AS7, GC2, and RMI antibodies respectively. 
A two-way analysis of variance of the data indicated that corticosterone treatment 
produced a significant effect (F = 11.3, P < 0.001) on G protein a-subunit levels. The 
percent change in G protein a-subunit levels relative to SHAM was greater in tissue 
from HCT treated animals compared to ADX (q = 6.390, p < 0.05) and CT (q = 5.037, 
p < 0.05) based on Student-Newman-Keuls post hoc tests. In comparison to the SHAM 
group, ADX treatment did not alter the levels of Gs, Gil and 2 and Go a-subunits. CT 
treatment only increased G1 a-subunit levels. HCT treatment increased the levels of G1, 
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FIGURE .19. Western blots of G protein a-subunits prepared from hippocampal 
membrane fractions. A: Antibody labeling of G protein a-subunits. Lane 1, anti-Gs 
(RMI). Lane 2, anti-Gi1and2 (AS7). Lane 3, anti-G0 (GC2). B: Antibody labeling of 
G protein a-subunits isolated from five SHAM (S) and five HCT (HCT) animals. 
G protein a-subunit subtype is indicated on the left. 
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Gn and 2 and Go a-subunits when compared to SHAM (Figure 19B). Analysis of 
Coomassie blue stained gels verified that equal amounts of protein were loaded into each 
lane and that there were no overall changes in total protein levels. However, the 
Coomassie stained gels revealed that HCT appeared to alter the protein levels for several 
bands when compared to SHAM; some bands increased while others decreased (Figure 
20). Based on the similar migration of the labeled bands, neither ADX, CT, or HCT 
treatment appeared to alter G protein size. Figure 21 summarizes the results from three 
different Western blot experiments for each G protein a-subunit antibody. 
202 .... 
133 .... 
71 .... 
41.8 .... 
30.6 .... 
s H 
Figure 20. Coomassie blue stained gel of tissue samples used for Western Blots. A 
SDS-P AGE gel was prepared identically as in figure 19 and stained with Coomassie 
blue. S, SHAM; H, HCT. Molecular weight markers are in the first lane on the left. 
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Figure 21. Changes in G protein a-subunit levels with different corticosterone 
treatments. The graph summarizes the results from three Western blot experiments 
(mean± SEM), n = 3. ·The bars are grouped by G protein a-subunit subtype; G0 (open), 
Gs (light stippled gray), and Gi1and 2 (dark stippled gray). Treatment group and G protein 
a-subunit type is indicated along the x-axis. 
* Significantly different from SHAM, Students I-test, P < 0.05. SHAM is 0%. 
Immunohistochemistry 
While Western blot analysis can be used to detect a change in G protein levels, 
changes in the location of G protein a-subunits within specific areas of the hippocampus 
or in specific locations within neurons cannot be determined. Therefore, we used 
immunohistochemistry techniques to address these questions. As reported previously, 
the labeling pattern for the G protein a-subunits varied across subfields and among the 
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different G proteins examined (Okuhara et al., 1996c). G, a-subunit labeling was 
located in the cytosol of the soma in hippocampal subfields CAI-CA4 (Figure 22B). In 
contrast to Gs, the labeling of Go a-subunits was located in the neuropil in subfields 
CAI-CA4 (Figure 22D) and dentate gyrus (Figure 22F). Gii and 2 a-subunits labeling 
was equally intense in the soma cytosol and neuropil. In control tissue sections, where 
the primary antibody was omitted, nonspecific labeling was very faint and 
distributed.evenly throughout the entire tissue section (data not shown). The distribution 
of the G proteins among the various hippocampal subfields and their location within 
neurons was not altered in any treatment group. 
Discussion 
G proteins couple plasma membrane receptors to intracellular effector molecules to 
transduce extracellular signals into biochemical and physiological changes within a cell. 
In the present study, we examined the effects of several chronic corticosterone 
treatments on G protein a-subunit levels and distribution in the hippocampus. Chronic 
basal concentrations of corticosterone increased G, a-subunit levels while higher 
concentrations of corticosterone increased the a-subunit levels of Gs, Gi1 and 2 and Go as 
detennined by Western blot analysis. None of the corticosterone treatments altered the 
intracellular location of G proteins based on our immunohistochemistry results. 
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Figure 22. Imunohistochemical labeling of G protein a-subunits and cresyl violet 
staining of nissel bodies in the hippocampus. B: G, labeling in subfield CA3 in 
sections from a SHAM animal. X200. Or, oriens layer; Py, pyramidal layer; rad, radiatum 
layer. D: Cytoplasmic labeling of G1 in a pyramidal cell (arrow head). Or, oriens layer; 
Py, pyramidal layer; rad, radiatum layer. G0 labeling in subfield CAI in sections from a 
SHAM animal. X200. F: Go labeling in the dentate gyrus in sections from a ADX 
animal. XIOO. g, granular layer. Panels A, C, and E are photomicrographs of cresyl 
violet stained nissel bodies from similar tissue sections of subfields CA3, CAI, and 
dentate gyros respectively. 
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Adrenalectomy had no effect on G protein ct-subunit levels or distribution. Two other 
studies examined the effects of corticosterone on G protein ct-subunit levels in the 
hippocampus. The increase in Gs and Go ct-subunit levels that we observed with high 
corticosterone concentrations was also reported by Wolfgang et al., (1995) using 
animals subjected to restraint stress. Gannon et al., (1994) reported that neither 
adrenalectomy nor corticosterone treatment altered the levels of Gs or Gi ct-subunits in 
the hippocampus. We also observed no change in the a-subunit levels of Gi1 and 2 with 
adrenalectomy or basal concentrations of corticosterone. We did detect an increase in 
the ct-subunit levels of Gs with basal corticosterone concentrations and this increase may 
not have been detected by Gannon due to important differences in the treatment . 
paradigms. In Gannon's study, the animals were sacrificed at the peak of the diurnal 
surge when both :MR and GR are occupied in the sham animals. In contrast, our animals 
were sacrificed during the trough of the diurnal surge when only a small fraction of GR is 
occupied. The time of sacrifice maybe a very important experimental parameter to take 
into account since both GR and :MR mRN A levels show circadian variation (Holmes et 
al., l 9995a). 
The effects of glucocorticoids on G protein expression have been examined in other 
tissue with various results. Adrenalectomy decreased Gi and increased Gs a-subunit 
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levels in the rat aorta when compared to sham (Haigh et al., 1990). In the cerebral 
cortex, corticosterone replacement decreased Gi and increased Gs a.-subunit levels when 
compared to adrenalectomy (Saito et al., 1989). Finally, in the liver, dexamethasone 
(which selectively activates GR) increased the a-subunit levels of both Gs and Gi (Kawai 
and Arinze, (1993). It is clear from the various effects of glucocorticoids on G protein 
levels in different tissue types that the effects of glucocorticoids are tissue specific. 
Examining the effects of glucocorticoids on G protein levels may help to determine 
the mechanism by which glucocorticoids modulate the responses associated with 
different G protein-linked neurotransmitter receptors. For example, it is known that 
glucocorticoids modulate neurotransmitter stimulated cAMP accumulation in both 
periphery and central nervous systems (reviewed by Harrelson and McEwen, 1987). For 
example, adrenalectomy increases NA stimulated cAMP accumulation in the limbic 
forebrain and frontal cortex (Mobley and Sulser, 1980a,b). Adrenalectomy also increased 
cAMP accumulation in response to vasoactive intestinal peptide but decreased the same 
response to histamine (Harrelson et al., 1987). In the hippocampus, adrenalectomy 
increased the NA stimulated cAMP accumulation (Roberts et al., 1984; Harrelson et al., 
1987) without altering '3-adrenergic receptor binding (Roberts et al., 1984) or forskolin-
stimulated adenylyl cyclase activity (Mobley et al., 1983; Harrelson et al., 1987; Gannon 
and McEwen, 1990). The administration of corticosterone reversed the effects of 
adrenalectomy in the hippocampus (Roberts et al., 1984) and cortex (Mobley et al., 
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1983) while even higher levels of corticosterone attenuated the NA response below 
control levels in the hippocampus (Gannon and McEwen, 1990). We observed no 
change in G protein a-subunit levels with ADX. Therefore, the glucocorticoid-induced 
effects on NA stimulated cAMP accumulation are not occurring by directly altering 
neurotransmitter receptor binding or G protein levels. Adrenalectomy may be altering 
the coupling between signal transduction components. 
Unlike the noradrenergic receptors, several studies have shown that glucocorticoids 
modulate 5-HT IA receptor expression in the hippocampus. Despite some conflict on the 
effects of glucocorticoids among the various subfields (reviewed by Chaouloff, 1995), 
adrenalectomy appears to increase 5-HT IA receptor binding (Mendelsohn and McEwen, 
l 992a,b; Chalmers et al., 1993; Kuroda et al., 1994; Tejani-Butt and Lablow, 1994; 
Zhong and Ciaranello, 1995) and mRNA levels (Chalmers et al., 1993; Meijer and de 
Kloet, 1994; Zhong and Ciaranello, 1995). The effects of adrenalectomy on 5-HT IA 
expression and binding is reversed with corticosterone. 
In the present study, ADX did not alter the a-subunit levels of Gi and Go, the 
G proteins probably linked to the 5-HT IA receptor in subfield CA3 (Okuhara et al., 
1994). Therefore, neither the smaller EC5o value nor the larger GTPyS evoked current 
observed in cells from ADX treated animals reported in Chapter IV is due to changes in 
Gi or G0 a-subunit levels. Furthermore, the HCT-induced increase in Gi or G0 a-subunit 
levels observed in the present investigation also does not account for the larger EC5o 
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value or smaller GTPyS evoked current observed in cells from HCT treated animals 
reported in Chapter IV. The increase in G protein a-subunit levels may be a 
compensatory response to changes in the receptor signal transduction system. Therefore, 
corticosteroids may be altering the 5-HT tA receptor signal transduction system by 
modulating the kinetic properties of the potassium channel linked to the receptor, 
coupling between the G protein and potassium channel, or G protein activity. 
There are several reasons why changes in G protein levels and neurotransmitter 
receptor responses may not coincide. Neurotransmitter receptors, G proteins, and 
effector molecules are all targets for post-translational modifications, such as 
phosphorylation (Bushfield et al., 1990; Akiho et al., 1993; Girault, 1993; Yamane and 
Fung, 1993; Levitan, 1994; Morris et al., 1994; Siegelbaum, 1994; Levistre et al., 1995; 
Neer, 1995; Pfeifer et al., 1995; Premont et al., 1995). Post-translational modifications 
may alter the coupling of receptor, G proteins, and effector molecules and therefore their 
ability to function (reviewed by Girault, 1993; Yamane and Fung, 1993; Levitan, 1994; 
Siegelbaum, 1994; Neer, 1995; Premont et al., 1995). Future studies will address issues 
of the phosphorylation state of the G protein signal transduction components. 
Another reason why it is difficult to correlate changes in G protein levels with 
changes in receptor-mediated responses is the potential interaction of the different 
G protein subunits and effector molecules. It is clear the ~y-subunits as well as 
154 
a-subunits modulate the activity of the various adenylyl cyclase isoforms (reviewed by 
Bimbaumer and Bimbaumer, 1995) and ion channel activity (Kofuji et al., 1995). 
Although glucocorticoids do regulate '3-subunit levels in the rat aorta (Haigh et al., 
1990), adipocytes (Ros et al., 1989), and liver (Kawai and Arinze, 1993), they do not 
regulate '3-subunit expression in the rat cortex (Saito et al., 1989. Glucocorticoid effects 
on J3y-subunits in the hippocampus are not known. 
In conclusion, G proteins are associated with a large number of biochemical and 
physiological processes including hormone, neurotransmitter, and growth factor receptor 
mediated responses. The steroid hormone corticosterone alters the responses of 
neurotransmitter receptors which are linked to G proteins. In the present study, high 
concentrations of corticosterone increased the G protein a-subunit levels of Gs, G0 , and 
Giland 2 in the hippocampus. Our results provide important information towards 
understanding how corticosterone modulates neurotransmitter receptor-mediated 
responses in the hippocampus. 
CHAPTER VII 
DISCUSSION 
Major Findings 
The hippocampus contains the highest density of corticosteroid receptors in the 
brain, which leads to the suggestion that corticosteroids may have a profound influence 
on hippocampal signal processing. Previous investigations have demonstrated that 
corticosteroids modulate hippocampal pyramidal cell membrane electrophysiological 
characteristics and responses elicited by the activation of different neurotransmitter 
receptors (Joels and de Kloet, 1992; Beck et al., 1994; Bimstiel and Beck, 1995; Beck 
et al., 1996). However, these findings are limited to the cells in subfield CAI. The 
effects of corticosteroids on neuron cell properties for other hippocampal regions (i.e., 
dentate gyrus and subiculum) and subfields (i.e., CA2 and CA3) are not known. 
Information on the actions of corticosteroids in all regions of the hippocampus is 
essential to determine how corticosteroids modulate signal processing in the 
hippocampus. Therefore, it was the goal of this dissertation to examine the actions of 
corticosteroids on cell membrane electrophysiological characteristics and the 5-HT IA 
receptor signal transduction system in subfield CA3 pyramidal cells. There are two 
basic hypotheses for this dissertation. First, corticosteroids influence cell membrane 
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electrophysiological properties in subfield CA3 pyramidal cells. Second, cortico-
steroids modulate the response elicited by the activation of the 5-HT IA receptor. 
Furthermore, corticosteroids modulate the 5-HT IA receptor-mediated response by 
altering different components (i.e., receptor, G protein, potassium channel) of the 
5-HT IA receptor signal transduction system. 
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One major finding of this dissertation is that chronic corticosteroid treatment 
influenced pyramidal cell membrane electrical properties in subfield CA3. Cortico-
steroid treatment shifted the ratio of nonburst and burst firing neurons and the action 
potential duration in subfield CA3. The effects of corticosteroids on the cell firing 
mode and action potential duration are not likely to be due to changes in cell viability. 
The cell membrane potential, resistance, and time constant were the same in all 
treatment groups and similar to those reported in naive animals (Beck et al., I 992). 
The effects of corticosteroids on the cell firing mode and action potential duration may 
be secondary to changes in CA3 cell morphology. However, it unlikely that changes in 
cell morphology would only affect the cell firing mode and action potential duration. 
The alteration in cell firing pattern and action potential duration may have a 
significant effect on the synaptically encoded signals sent from subfield CA3 to CAI. 
Shifting the firing pattern of subfield CA3 cells represents a prominent and critical 
change in the pattern of communication between subfields CAI and CA3. Further 
experiments are required to determine the ion channels and mechanism underlying the 
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corticosteroid-induced changes in cell firing pattern and action potential duration. It is 
also important to determine if the ratio of burst and nonburst firing cells changes 
during the diurnal surge of corticosteroids. 
Another major finding of this disseration is that chronic corticosteroid treatment 
altered the 5-HT concentration-response curve characteristics for the 5-HT IA receptor 
on subfield CA3 pyramidal cells. Furthermore, corticosteroids altered the 5-HT IA 
receptor signal transduction system at sites (i.e., G protein) downstream of the 
receptor. The corticosteroid-induced changes in the 5-HT concentration-response 
curve characteristics for the 5-HT IA receptor may be due to changes in G protein 
function. The smaller EC50 and greater Emax value observed in cells from ADX 
treated animals was also accompanied by an increase in the current evoked by the 
activation of G proteins with GTPyS . Similarly the larger EC5o and smaller Emax 
value observed in cells from HCT treated animals was accompanied by a decrease in 
the current evoked by the activation of G proteins. However, the ADX- and HCT-
induced effects are not directly due to changes in G protein Gi1and2 or Go a-subunit 
levels. Based on Western blot analysis, ADX treatment had no effect while HCT 
treatment increased Gi1and2 and Go a-subunit levels when compared to SHAM. 
Based on these results, there are several possible mechanisms by which 
corticosteroid treatment may be altering the 5-HT IA receptor system. Corticosteroids 
may influence the kinetic properties of the potassium channel linked to the 5-HT IA 
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receptor. Cortiocosteroid may also modulate G protein function by altering the 
coupling between G protein and potassium channels, GTP hyrolysis, or the exchange 
rate of GDP for GTP. These changes in G protein activity or ion channel kinetics may 
occur through post-translational modification mechanisms (i.e., phosphorylation). 
Based on the results from this dissertation and those previously reported by 
collaborating colleagues (Beck et al., I994, I996), it can be concluded that 
corticosteroids also modulate neural signal processesing in the hippocampus by 
differentially modulating neuron membrane properties in subfields CA I and CA3. 
Adrenalectomy and lvfR activation have opposite effects on action potential duration in 
subfield CAI and CA3 cells. There was no difference in the 5-HT concentration-
response curve characteristics for the 5-HT IA receptor in cells from SHAM and ADX 
treated animals in subfield CAI. In contrast, the ECso value was shifted in cells from 
ADX compared to SHAM treated animals in subfield CA3. The different effects of 
corticosteroids on neuron membrane electrical properties in subfields CAI and CA3 
further supports the critical roles that the different hippocampal subfields have on HP A 
axis activity. One future study that may help to determine the roles ofhippocampal 
subfields CA I and CA3 on HP A axis activity is examining the effects of stimulating 
subfields CAI and CA3 in different treatment groups (i.e. HCT and lvfR) on 
corticosterone plasma levels. 
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Synaptic Activity 
The new findings resulting from this dissertation work provide important 
information on the action of corticosteroids on neural signal processing in the 
hippocampus. Earlier investigations examined the action of corticosteroids on 
synaptically driven field potentials in subfield CAI. Stimulating the Schaffer collaterals 
arising from subfield CAJ pyramidal cells evokes action potentials in CA 1 pyramidal 
cells that summate and produce a corresponding population spike (Andersen et al., 
1971). The population spike amplitude in subfield CAI is decreased in hippocampal 
sections from adrenalectomized compared to adrenally-intact animals (Rey et al., 
1987a,b; Doi et al., 1991; Joels and Femhout, 1993). The adrenalectomy-induced 
effect was reversed when the slice was perfused with basal physiological concentrations 
of corticosterone. Consistent with the decrease in population spike amplitude, a study 
using intracellular recording techniques reported that the probability for inducing 
synaptically driven action potentials was decreased in adrenalectomized compared to 
adrenally-intact animals (Joels and de Kloet, 1993). However, the decrease in firing 
probability was not accompanied by a decrease in the excitatory postsynaptic potential 
(EPSP) amplitude (Joels and de Kloet, 1993). Recently, it was demonstrated that the 
EPSP and inhibitory postsynaptic potential (IPSP) both are decreased in cells from 
adrenalectomized compared to adrenally-intact animals (Bimstiel and Beck, 1995). 
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The decrease in population spike amplitude may be explained by the change in 
pyramidal cell nonbursting to burst firing ratio observed in this dissertation work. A 
shift in the pyramidal cell's firing pattern in subfield CA3 may decrease the population 
spike amplitude evoked in subfield CAI. However, this is only a conjecture since the 
relationship between subfield CA3 nonburst and burst firing cells with the EPSP and 
population spike amplitude in CA I cells is not known. 
Several important questions have developed from this dissertation. First, what are 
the mechanisms underlying the shift in the ratio of nonburst to burst firing cells? Since 
the current( s) underlying burst firing have not been fully characterized, this is a difficult 
question to address. Second, how is the ratio of nonburst to burst firing cells in 
subfield CA3 related to the population spike, or EPSP, recorded in subfield CAI? 
Finally, does corticosteroid treatment also shift the ratio of nonburst to burst firing cells 
in other regions of the hippocampus? The answers to these questions will provide 
more insight into the mechanism by which corticosteroids alter neuronal signal 
processing in the hippocampus. 
Chronic Corticosteroid Treatment 
Normally, plasma corticosteroid concentrations fluctuate according to circadian 
rhythm or acute stress (reviewed by Dallman et al., I 987). However long-term 
increases in plasma corticosteroid concentrations are observed during chronic stress 
and senescence and are accompanied by changes in hippocampal physiology (Sapolsky 
1985; Sapolsky et al., 1985a, 1986; Stein-Behrens et al., 1994). Therefore, 
investigators have focused on elucidating the mechanisms underlying the changes in 
hippocampal physiology observed with long-term exposures to high corticosteroid 
concentrations. 
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Briefly, chronically high levels of corticosteroids increase the vulnerability of 
hippocampal CA3 neurons to cell damage (Sapolsky 1985; Sapolsky et al., l 985a; 
Stein-Behrens et al., 1994). An alteration in Ca2+ homeostasis is proposed as one 
factor that may increase the vulnerability of hippocampal CA3 neurons to cell damage. 
Increasing the excitability of neurons may elevate intracellular Ca2+ concentrations 
enough to damage a cell (Landfield and Eldridge, 1994). However, HCT treatment did 
not selectively alter any of the cell membrane properties examined in this dissertation 
work. Therefore, a two week chronic treatment with high concentrations of 
corticosterone does not appear to lead to changes in membrane electrical properties 
that influence neuron excitability in subfield CA3. The effects of HCT treatment on 
Ca2+ homeostasis or isolated Ca2+ currents were not examined in this dissertation. 
An increase in CA3 pyramidal cell excitability may occur from alterations in the 
5-HT IA receptor-mediated response observed in this dissertation work. A decrease in 
the maximum current elicited by the activation of 5-HT IA receptors was observed in 
cells from HCT compared to SHAM treated animals. Physiologically, the HCT-
induced change decreases the inhibitory response of CA3 pyramidal cells to 5-HT, 
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which may lead to an increase in the cell's response to excitatory inputs. This question 
may be addressed by using extracellular recording techniques and examining the effects 
ofHCT treatment on the response ofCA3 cells to the stimulation of 5-HT inputs (i.e., 
raphe). 
G protein-linked Receptor Signal Transduction System 
Previous investigators have demonstrated that corticosteroids influence the 
hippocampal 5-HT system in at least two ways. First, corticosteroids alter the response 
elicited by the activation of either the 5-HT lA (Joels et al., 1991, Joels and de Kloet, 
1992; Beck et al., 1996) or 5-HT 4 receptors (Birnstiel and Beck, 1995). Second, 
corticosteroids modulate the number of 5-HT iA receptor binding sites and mRNA 
expression (reviewed by Chaouloff, 1995). Based on the results from this dissertation 
work, it was shown that corticosteroids also alter the 5-HT IA signal transduction 
system at site(s) downstream from the receptor. This observation bears an interesting 
question. Are other G protein-linked receptor signal transduction systems altered by 
corticosteroids? 
Similar to the results in this dissertation work, the ~-adrenergic receptor-mediated 
response in the hippocampus is also increased in adrenalectomized animals compared to 
adrenally-intact animals. Adrenalectomy increases NA stimulated cAMP accumulation 
(Roberts et al., 1984; Harrelson et al., 1987) without altering ~-adrenergic receptor 
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binding (Roberts et al., 1984) or forskolin-stimulated adenylyl cyclase activity (Mobley 
et al., 1983 ~ Harrelson et al., 1987~ Gannon and McEwen, 1990). 
No changes in G protein a-subunit levels with ADX were observed in this thesis 
work. Therefore, the adrenalectomy-induced effect on NA stimulated cAMP 
accumulation is not occurring by directly altering neurotransmitter receptor binding or 
G protein levels. Adrenalectomy may be altering the coupling between signal 
transduction components. In support of this hypothesis, it was observed in this thesis 
work that the ECso value for the 5-HT IA receptor-mediated response was smaller (i.e. 
5-HT was more potent) in cells from ADX compared to SHAM animals. Furthermore, 
the current elicited by the activation of G proteins with GTPyS was also greater in cells 
from ADX compared to SHAM animals. Therefore, adrenalectomy may alter the 
coupling or activity of signal transduction components downstream of the receptor for 
either the ~-adrenergic or 5-HT IA receptors. 
The Hippocampus and HP A Axis Feedback 
Finally, the results from this dissertation work provide some insight into how the 
hippocampus processes its feedback signal to the HP A axis. :rv1R activation is 
important for maintaining the cell's firing pattern, action potential duration, and 
sensitivity to 5-HT in subfield CA3 pyramidal cells. Since :rv1R activation modulates 
pyramidal cell characteristics as well as the 5-HT IA receptor-mediated response, the 
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activation of :MR. influences any input signals arriving at subfield CA3 cells. 
In contrast, chronic activation of :MR. and GR together, had no selective effects on 
cell membrane electrophysiological characteristics but did decrease the inhibitory 
response of CA3 pyramidal cells to 5-HT. Therefore, the feedback signal from the 
hippocampus during chronic :MR. and GR activation may depend on the attenuation of 
5-HT mediated responses in the hippocampus. 
This dissertation work has contributed new and important information towards 
elucidating the mechanism by which corticosteroids modulate neural signal processing 
in the hippocampus. It is now clear that corticosteroids have different effects on cell 
membrane characteristics and 5-HT I..\ receptor-mediated responses in subfields CAI 
and CA3. Furthermore the selective actions of corticosteroids in the hippocampus may 
have important ramifications on the development of the HP A axis feedback signal and 
hippocampus related behaviors. 
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